{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 689, "items": [{"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T21:39:43Z", "timestamp": 1574372383458}, "reference-count": 255, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2634, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis Rheum"], "published-print": {"date-parts": [[2008, 6, 15]]}, "DOI": "10.1002/art.23721", "type": "journal-article", "created": {"date-parts": [[2008, 5, 30]], "date-time": "2008-05-30T16:46:25Z", "timestamp": 1212165985000}, "page": "762-784", "source": "Crossref", "is-referenced-by-count": 911, "title": ["American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis"], "prefix": "10.1002", "volume": "59", "author": [{"given": "Kenneth G.", "family": "Saag", "sequence": "first", "affiliation": []}, {"given": "Gim Gee", "family": "Teng", "sequence": "additional", "affiliation": []}, {"given": "Nivedita M.", "family": "Patkar", "sequence": "additional", "affiliation": []}, {"given": "Jeremy", "family": "Anuntiyo", "sequence": "additional", "affiliation": []}, {"given": "Catherine", "family": "Finney", "sequence": "additional", "affiliation": []}, {"given": "Jeffrey R.", "family": "Curtis", "sequence": "additional", "affiliation": []}, {"given": "Harold E.", "family": "Paulus", "sequence": "additional", "affiliation": []}, {"given": "Amy", "family": "Mudano", "sequence": "additional", "affiliation": []}, {"given": "Maria", "family": "Pisu", "sequence": "additional", "affiliation": []}, {"given": "Mary", "family": "Elkins-Melton", "sequence": "additional", "affiliation": []}, {"given": "Ryan", "family": "Outman", "sequence": "additional", "affiliation": []}, {"given": "Jeroan J.", "family": "Allison", "sequence": "additional", "affiliation": []}, {"given": "Maria Suarez", "family": "Almazor", "sequence": "additional", "affiliation": []}, {"suffix": "Jr.", "given": "S. Louis", "family": "Bridges", "sequence": "additional", "affiliation": []}, {"given": "W. Winn", "family": "Chatham", "sequence": "additional", "affiliation": []}, {"given": "Marc", "family": "Hochberg", "sequence": "additional", "affiliation": []}, {"given": "Catherine", "family": "Maclean", "sequence": "additional", "affiliation": []}, {"given": "Ted", "family": "Mikuls", "sequence": "additional", "affiliation": []}, {"given": "Larry W.", "family": "Moreland", "sequence": "additional", "affiliation": []}, {"given": "James", "family": "O'dell", "sequence": "additional", "affiliation": []}, {"given": "Anthony M.", "family": "Turkiewicz", "sequence": "additional", "affiliation": []}, {"given": "Daniel E.", "family": "Furst", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/art.23721-BIB1", "doi-asserted-by": "crossref", "first-page": "3229", "DOI": "10.1001/jama.289.24.3229", "article-title": "Use of biologics for rheumatoid arthritis tempered by concerns over safety, cost", "volume": "289", "author": "Pressman Lovinger", "year": "2003", "journal-title": "JAMA"}, {"key": "10.1002/art.23721-BIB2", "doi-asserted-by": "crossref", "first-page": "704", "DOI": "10.1056/NEJMct055183", "article-title": "Tumor necrosis factor inhibitors for rheumatoid arthritis", "volume": "355", "author": "Scott", "year": "2006", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.23721-BIB3", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1002/art.10148", "article-title": "Guidelines for the management of rheumatoid arthritis: 2002 update", "volume": "46", "author": "American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines", "year": "2002", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB4", "unstructured": "The Appraisal of Guidelines for Research and Evaluation (AGREE) Collaboration. Introduction to the AGREE Collaboration. 2001. URL: www.agreecollaboration.org."}, {"key": "10.1002/art.23721-BIB5", "author": "Fitch", "year": "2001", "volume-title": "The RAND/UCLA Appropriateness Method user's manual"}, {"key": "10.1002/art.23721-BIB6", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0197-2456(95)00134-4", "article-title": "Assessing the quality of reports of randomized clinical trials: is blinding necessary?", "volume": "17", "author": "Jadad", "year": "1996", "journal-title": "Control Clin Trials"}, {"key": "10.1002/art.23721-BIB7", "author": "Wells", "year": "1999", "volume-title": "The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses"}, {"key": "10.1002/art.23721-BIB8", "doi-asserted-by": "crossref", "first-page": "669", "DOI": "10.1136/ard.2004.028886", "article-title": "EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)", "volume": "64", "author": "Zhang", "year": "2005", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB9", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/j.rdc.2005.09.005", "article-title": "The definition and measurement of disease modification in inflammatory rheumatic diseases", "volume": "32", "author": "Aletaha", "year": "2006", "journal-title": "Rheum Dis Clin North Am"}, {"key": "10.1002/art.23721-BIB10", "doi-asserted-by": "crossref", "first-page": "2625", "DOI": "10.1002/art.21235", "article-title": "Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states", "volume": "52", "author": "Aletaha", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB11", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.1002/art.1780380602", "article-title": "American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis", "volume": "38", "author": "Felson", "year": "1995", "journal-title": "Arthritis Rheum"}, {"issue": "5", "key": "10.1002/art.23721-BIB12", "first-page": "S109", "article-title": "The American College of Rheumatology (ACR) core data set and derivative \u201cpatient only\u201d indices to assess rheumatoid arthritis", "volume": "23", "author": "Pincus", "year": "2005", "journal-title": "Clin Exp Rheumatol"}, {"key": "10.1002/art.23721-BIB13", "first-page": "2016", "article-title": "Minimal disease activity for rheumatoid arthritis: a preliminary definition", "volume": "32", "author": "Wells", "year": "2005", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB14", "first-page": "2410", "article-title": "A composite disease activity scale for clinical practice, observational studies, and clinical trials: the Patient Activity Scale (PAS/PAS-II)", "volume": "32", "author": "Wolfe", "year": "2005", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB15", "doi-asserted-by": "crossref", "first-page": "3873", "DOI": "10.1002/art.21494", "article-title": "The Disease Activity Score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes", "volume": "52", "author": "Wolfe", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB16", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1007/s10067-006-0275-5", "article-title": "Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA", "volume": "26", "author": "Agrawal", "year": "2007", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/art.23721-BIB17", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1007/s10067-006-0343-x", "article-title": "Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study", "volume": "26", "author": "Ates", "year": "2007", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/art.23721-BIB18", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1136/ard.2005.041376", "article-title": "Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset", "volume": "65", "author": "Berglin", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB19", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1136/ard.62.2.120", "article-title": "Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage", "volume": "62", "author": "Meyer", "year": "2003", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB20", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1136/ard.62.5.427", "article-title": "Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis", "volume": "62", "author": "Vencovsky", "year": "2003", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB21", "doi-asserted-by": "crossref", "first-page": "290", "DOI": "10.1136/ard.61.4.290", "article-title": "Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide", "volume": "61", "author": "Emery", "year": "2002", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB22", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1136/ard.2003.010611", "article-title": "Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study", "volume": "63", "author": "Gossec", "year": "2004", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB23", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1136/ard.62.7.611", "article-title": "Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis", "volume": "62", "author": "Lindqvist", "year": "2003", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB24", "doi-asserted-by": "crossref", "first-page": "1055", "DOI": "10.1136/ard.61.12.1055", "article-title": "Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage", "volume": "61", "author": "Lindqvist", "year": "2002", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB25", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1136/ard.36.3.274", "article-title": "Relationship of radiological change to clinical outcome in rheumatoid arthritis", "volume": "36", "author": "Brook", "year": "1977", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB26", "first-page": "1936", "article-title": "Health Assessment Questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis", "volume": "33", "author": "Cohen", "year": "2006", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB27", "doi-asserted-by": "crossref", "first-page": "717", "DOI": "10.1093/rheumatology/32.8.717", "article-title": "Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years", "volume": "32", "author": "Corbett", "year": "1993", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB28", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1136/ard.45.5.373", "article-title": "Long term progression of joint damage in rheumatoid arthritis", "volume": "45", "author": "Scott", "year": "1986", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB29", "doi-asserted-by": "crossref", "first-page": "1571", "DOI": "10.1002/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R", "article-title": "Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression", "volume": "41", "author": "Wolfe", "year": "1998", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB30", "doi-asserted-by": "crossref", "first-page": "1072", "DOI": "10.1002/1529-0131(199806)41:6<1072::AID-ART14>3.0.CO;2-G", "article-title": "The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis", "volume": "41", "author": "Wolfe", "year": "1998", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB31", "doi-asserted-by": "crossref", "first-page": "899", "DOI": "10.1093/rheumatology/32.10.899", "article-title": "Major histocompatibility complex variants and articular disease severity in rheumatoid arthritis", "volume": "32", "author": "McMahon", "year": "1993", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB32", "doi-asserted-by": "crossref", "first-page": "870", "DOI": "10.1016/j.jamcollsurg.2005.07.009", "article-title": "Developing quality indicators for elderly patients undergoing abdominal operations", "volume": "201", "author": "McGory", "year": "2005", "journal-title": "J Am Coll Surg"}, {"key": "10.1002/art.23721-BIB33", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1177/0272989X04264212", "article-title": "The Appropriateness Method", "volume": "24", "author": "Shekelle", "year": "2004", "journal-title": "Med Decis Making"}, {"key": "10.1002/art.23721-BIB34", "doi-asserted-by": "crossref", "first-page": "1004", "DOI": "10.1016/S0895-4356(01)00365-1", "article-title": "Sensitivity and specificity of the RAND/UCLA Appropriateness Method to identify the overuse and underuse of coronary revascularization and hysterectomy", "volume": "54", "author": "Shekelle", "year": "2001", "journal-title": "J Clin Epidemiol"}, {"key": "10.1002/art.23721-BIB35", "first-page": "e154", "article-title": "ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)", "volume": "112", "author": "Hunt", "year": "2005", "journal-title": "Circulation"}, {"key": "10.1002/art.23721-BIB36", "doi-asserted-by": "crossref", "first-page": "1394", "DOI": "10.1093/rheumatology/kei024", "article-title": "The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database", "volume": "44", "author": "Edwards", "year": "2005", "journal-title": "Rheumatology (Oxford)"}, {"key": "10.1002/art.23721-BIB37", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1185/030079906X80341", "article-title": "Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study", "volume": "22", "author": "Gibofsky", "year": "2006", "journal-title": "Curr Med Res Opin"}, {"key": "10.1002/art.23721-BIB38", "first-page": "442", "article-title": "Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis", "volume": "4", "author": "Wendt", "year": "1999", "journal-title": "Eur J Med Res"}, {"key": "10.1002/art.23721-BIB39", "doi-asserted-by": "crossref", "first-page": "961", "DOI": "10.1002/art.1780340805", "article-title": "Methotrexate versus azathioprine in the treatment of rheumatoid arthritis: a forty-eight-week randomized, double-blind trial", "volume": "34", "author": "Jeurissen", "year": "1991", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB40", "doi-asserted-by": "crossref", "first-page": "1360", "DOI": "10.1002/art.21018", "article-title": "A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study", "volume": "52", "author": "Lehman", "year": "2005", "journal-title": "Arthritis Rheum"}, {"issue": "2", "key": "10.1002/art.23721-BIB41", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/0049-0172(91)90047-4", "article-title": "A double-blind comparison of parenteral methotrexate and parenteral gold in the treatment of early erosive rheumatoid arthritis: an interim report on 102 patients after 12 months", "volume": "21", "author": "Rau", "year": "1991", "journal-title": "Semin Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB42", "first-page": "328", "article-title": "A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis", "volume": "18", "author": "Rau", "year": "1991", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB43", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1136/ard.58.4.220", "article-title": "Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components", "volume": "58", "author": "Dougados", "year": "1999", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB44", "doi-asserted-by": "crossref", "first-page": "1082", "DOI": "10.1093/rheumatology/36.10.1082", "article-title": "Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial", "volume": "36", "author": "Haagsma", "year": "1997", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB45", "doi-asserted-by": "crossref", "first-page": "849", "DOI": "10.1002/art.1780350802", "article-title": "Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis: a controlled clinical trial", "volume": "35", "author": "Willkens", "year": "1992", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB46", "doi-asserted-by": "crossref", "first-page": "1049", "DOI": "10.1093/rheumatology/33.11.1049", "article-title": "Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy", "volume": "33", "author": "Haagsma", "year": "1994", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB47", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1056/NEJM199605163342002", "article-title": "Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications", "volume": "334", "author": "O'Dell", "year": "1996", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.23721-BIB48", "doi-asserted-by": "crossref", "first-page": "2542", "DOI": "10.1001/archinte.159.21.2542", "article-title": "Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate", "volume": "159", "author": "Strand", "year": "1999", "journal-title": "Arch Intern Med"}, {"key": "10.1002/art.23721-BIB49", "doi-asserted-by": "crossref", "first-page": "726", "DOI": "10.7326/0003-4819-137-9-200211050-00007", "article-title": "Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial", "volume": "137", "author": "Kremer", "year": "2002", "journal-title": "Ann Intern Med"}, {"key": "10.1002/art.23721-BIB50", "doi-asserted-by": "crossref", "first-page": "1595", "DOI": "10.1002/art.1780381111", "article-title": "Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis: results of a randomized, placebo-controlled, phase II study", "volume": "38", "author": "Mladenovic", "year": "1995", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB51", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1016/S0140-6736(98)09403-3", "article-title": "Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial", "volume": "353", "author": "Smolen", "year": "1999", "journal-title": "Lancet"}, {"key": "10.1002/art.23721-BIB52", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1093/rheumatology/30.6.451", "article-title": "Should disease-modifying agents be used in mild rheumatoid arthritis?", "volume": "30", "author": "Davis", "year": "1991", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB53", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1016/S0002-9343(99)80399-4", "article-title": "A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA study", "volume": "98", "year": "1995", "unstructured": "A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA study. Am J Med 1995; 98: 156-68.", "journal-title": "Am J Med"}, {"key": "10.1002/art.23721-BIB54", "doi-asserted-by": "crossref", "first-page": "1067", "DOI": "10.7326/0003-4819-119-11-199312010-00002", "article-title": "Hydroxychloroquine compared with placebo in rheumatoid arthritis: a randomized controlled trial", "volume": "119", "author": "Clark", "year": "1993", "journal-title": "Ann Intern Med"}, {"key": "10.1002/art.23721-BIB55", "doi-asserted-by": "crossref", "first-page": "2235", "DOI": "10.1002/1529-0131(200110)44:10<2235::AID-ART385>3.0.CO;2-A", "article-title": "Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine", "volume": "44", "author": "O'Dell", "year": "2001", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB56", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1136/ard.48.5.389", "article-title": "A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine", "volume": "48", "author": "Nuver-Zwart", "year": "1989", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB57", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.7326/0003-4819-122-2-199501150-00001", "article-title": "Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial", "volume": "122", "author": "Tilley", "year": "1995", "journal-title": "Ann Intern Med"}, {"key": "10.1002/art.23721-BIB58", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1002/art.1780370505", "article-title": "Minocycline in active rheumatoid arthritis: a double-blind, placebo-controlled trial", "volume": "37", "author": "Kloppenburg", "year": "1994", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB59", "doi-asserted-by": "crossref", "first-page": "842", "DOI": "10.1002/art.1780400510", "article-title": "Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial", "volume": "40", "author": "O'Dell", "year": "1997", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB60", "doi-asserted-by": "crossref", "first-page": "702", "DOI": "10.1002/art.1780310602", "article-title": "A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis", "volume": "31", "author": "Williams", "year": "1988", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB61", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.1136/ard.60.10.913", "article-title": "Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine", "volume": "60", "author": "Scott", "year": "2001", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB62", "first-page": "1983", "article-title": "Improved functional ability in patients with rheumatoid arthritis: longterm treatment with leflunomide versus sulfasalazine", "volume": "28", "author": "Kalden", "year": "2001", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB63", "first-page": "1672", "article-title": "Sulfasalazine in early rheumatoid arthritis", "volume": "19", "author": "The Australian Multicentre Clinical Trial Group", "year": "1992", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB64", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1007/BF02208150", "article-title": "A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis", "volume": "14", "author": "Farr", "year": "1995", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/art.23721-BIB65", "doi-asserted-by": "crossref", "first-page": "1164", "DOI": "10.1002/art.10228", "article-title": "Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial", "volume": "46", "author": "O'Dell", "year": "2002", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB66", "first-page": "1639", "article-title": "Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects", "volume": "29", "author": "Hurst", "year": "2002", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB67", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/S0140-6736(97)01300-7", "article-title": "Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis", "volume": "350", "author": "Boers", "year": "1997", "journal-title": "Lancet"}, {"key": "10.1002/art.23721-BIB68", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1002/art.21519", "article-title": "The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment", "volume": "54", "author": "Breedveld", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB69", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1002/art.20712", "article-title": "Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial", "volume": "52", "author": "Quinn", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB70", "doi-asserted-by": "crossref", "first-page": "3432", "DOI": "10.1002/art.20568", "article-title": "Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial", "volume": "50", "author": "St.Clair", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB71", "doi-asserted-by": "crossref", "first-page": "406", "DOI": "10.7326/0003-4819-146-6-200703200-00005", "article-title": "Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial", "volume": "146", "author": "Goekoop-Ruiterman", "year": "2007", "journal-title": "Ann Intern Med"}, {"key": "10.1002/art.23721-BIB72", "doi-asserted-by": "crossref", "first-page": "1586", "DOI": "10.1056/NEJM200011303432201", "article-title": "A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis", "volume": "343", "author": "Bathon", "year": "2000", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.23721-BIB73", "doi-asserted-by": "crossref", "first-page": "3381", "DOI": "10.1002/art.21405", "article-title": "Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial", "volume": "52", "author": "Goekoop-Ruiterman", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB74", "doi-asserted-by": "crossref", "first-page": "1443", "DOI": "10.1002/art.10308", "article-title": "Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes", "volume": "46", "author": "Genovese", "year": "2002", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB75", "first-page": "1532", "article-title": "Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability", "volume": "31", "author": "Baumgartner", "year": "2004", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB76", "first-page": "1232", "article-title": "Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis", "volume": "32", "author": "Genovese", "year": "2005", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB77", "doi-asserted-by": "crossref", "first-page": "2316", "DOI": "10.1002/1529-0131(200010)43:10<2316::AID-ANR20>3.0.CO;2-6", "article-title": "A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis", "volume": "43", "author": "Choi", "year": "2000", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB78", "doi-asserted-by": "crossref", "first-page": "400", "DOI": "10.1016/S0002-9343(02)01243-3", "article-title": "Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis", "volume": "113", "author": "Wong", "year": "2002", "journal-title": "Am J Med"}, {"key": "10.1002/art.23721-BIB79", "first-page": "1156", "article-title": "A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis", "volume": "29", "author": "Choi", "year": "2002", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB80", "doi-asserted-by": "crossref", "first-page": "1578", "DOI": "10.1136/ard.2005.038349", "article-title": "A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs", "volume": "65", "author": "Klareskog", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB81", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1016/S0140-6736(04)15640-7", "article-title": "Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial", "volume": "363", "author": "Klareskog", "year": "2004", "journal-title": "Lancet"}, {"key": "10.1002/art.23721-BIB82", "doi-asserted-by": "crossref", "first-page": "1493", "DOI": "10.1002/art.11142", "article-title": "Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations", "volume": "48", "author": "Kremer", "year": "2003", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB83", "doi-asserted-by": "crossref", "first-page": "478", "DOI": "10.7326/0003-4819-130-6-199903160-00004", "article-title": "Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial", "volume": "130", "author": "Moreland", "year": "1999", "journal-title": "Ann Intern Med"}, {"key": "10.1002/art.23721-BIB84", "first-page": "854", "article-title": "Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience", "volume": "33", "author": "Moreland", "year": "2006", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB85", "first-page": "213", "article-title": "Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis", "volume": "33", "author": "O'Dell", "year": "2006", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB86", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1111/j.1445-5994.2006.01170.x", "article-title": "Etanercept in severe active rheumatoid arthritis: first Australian experience", "volume": "36", "author": "Perera", "year": "2006", "journal-title": "Intern Med J"}, {"key": "10.1002/art.23721-BIB87", "doi-asserted-by": "crossref", "first-page": "1500", "DOI": "10.1002/art.11027", "article-title": "Clinical responses to tumor necrosis factor \u03b1 antagonists do not show a bimodal distribution: data from the Stockholm Tumor Necrosis Factor \u03b1 Followup Registry", "volume": "48", "author": "Van Vollenhoven", "year": "2003", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB88", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1136/ard.2005.035709", "article-title": "Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial", "volume": "65", "author": "Van Der Heijde", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB89", "doi-asserted-by": "crossref", "first-page": "508", "DOI": "10.1136/ard.2003.013052", "article-title": "Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed", "volume": "63", "author": "Van de Putte", "year": "2004", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB90", "doi-asserted-by": "crossref", "first-page": "1700", "DOI": "10.1016/S0149-2918(03)80164-9", "article-title": "Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-\u03b1 monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study", "volume": "25", "author": "Weisman", "year": "2003", "journal-title": "Clin Ther"}, {"key": "10.1002/art.23721-BIB91", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1136/ard.61.4.358", "article-title": "Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections", "volume": "61", "author": "Ferraccioli", "year": "2002", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB92", "doi-asserted-by": "crossref", "first-page": "472", "DOI": "10.1093/rheumatology/keh508", "article-title": "The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis: a longitudinal observational study", "volume": "44", "author": "Flendrie", "year": "2005", "journal-title": "Rheumatology (Oxford)"}, {"key": "10.1002/art.23721-BIB93", "first-page": "2563", "article-title": "Adalimumab, a fully human anti tumor necrosis factor-\u03b1 monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)", "volume": "30", "author": "Furst", "year": "2003", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB94", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1002/art.20228", "article-title": "The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis", "volume": "51", "author": "Hansen", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB95", "doi-asserted-by": "crossref", "first-page": "1379", "DOI": "10.1136/ard.2006.051540", "article-title": "Adalimumab and methotrexate is more effective than adalimumab alone in patients with established rheumatoid arthritis: results from a 6-month longitudinal, observational, multicenter study", "volume": "65", "author": "Heiberg", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB96", "doi-asserted-by": "crossref", "first-page": "1400", "DOI": "10.1002/art.20217", "article-title": "Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial", "volume": "50", "author": "Keystone", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB97", "doi-asserted-by": "crossref", "first-page": "1932", "DOI": "10.1016/S0140-6736(99)05246-0", "article-title": "Infliximab (chimeric anti-tumour necrosis factor \u03b1 monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: randomized phase III trial", "volume": "354", "author": "Maini", "year": "1999", "journal-title": "Lancet"}, {"key": "10.1002/art.23721-BIB98", "doi-asserted-by": "crossref", "first-page": "1552", "DOI": "10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W", "article-title": "Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor \u03b1 monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis", "volume": "41", "author": "Maini", "year": "1998", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB99", "doi-asserted-by": "crossref", "first-page": "1051", "DOI": "10.1002/art.20159", "article-title": "Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate", "volume": "50", "author": "Maini", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB100", "doi-asserted-by": "crossref", "first-page": "144", "DOI": "10.1136/ard.2003.015933", "article-title": "Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefit", "volume": "63", "author": "Sidiropoulos", "year": "2004", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB101", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1016/j.amjmed.2005.01.029", "article-title": "Infliximab therapy in established rheumatoid arthritis: an observational study", "volume": "118", "author": "Voulgari", "year": "2005", "journal-title": "Am J Med"}, {"key": "10.1002/art.23721-BIB102", "doi-asserted-by": "crossref", "first-page": "1594", "DOI": "10.1056/NEJM200011303432202", "article-title": "Infliximab and methotrexate in the treatment of rheumatoid arthritis", "volume": "343", "author": "Lipsky", "year": "2000", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.23721-BIB103", "doi-asserted-by": "crossref", "first-page": "1020", "DOI": "10.1002/art.20982", "article-title": "Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy study", "volume": "52", "author": "Smolen", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB104", "doi-asserted-by": "crossref", "first-page": "1063", "DOI": "10.1002/art.21655", "article-title": "Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial", "volume": "54", "author": "Van der Heijde", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB105", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1056/NEJM199901283400401", "article-title": "A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate", "volume": "340", "author": "Weinblatt", "year": "1999", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.23721-BIB106", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1136/ard.2005.044404", "article-title": "Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study", "volume": "65", "author": "Weinblatt", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB107", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1002/art.10697", "article-title": "Adalimumab, a fully human anti-tumor necrosis factor \u03b1 monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial", "volume": "48", "author": "Weinblatt", "year": "2003", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB108", "doi-asserted-by": "crossref", "first-page": "1412", "DOI": "10.1002/art.20221", "article-title": "Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate", "volume": "50", "author": "Genovese", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB109", "doi-asserted-by": "crossref", "first-page": "1357", "DOI": "10.1136/ard.2005.049650", "article-title": "Etanercept and sulphasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulphasalazine: a double-blind comparison", "volume": "65", "author": "Combe", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB110", "first-page": "681", "article-title": "Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life", "volume": "33", "author": "Emery", "year": "2006", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB111", "first-page": "57", "article-title": "Abatacept sustains inhibition of radiographic progression over 2 years in rheumatoid arthritis patients with an inadequate response to methotrexate: results from the long-term extension of the AIM trial", "volume": "65", "author": "Genant", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB112", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.7326/0003-4819-144-12-200606200-00003", "article-title": "Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial", "volume": "144", "author": "Kremer", "year": "2006", "journal-title": "Ann Intern Med"}, {"key": "10.1002/art.23721-BIB113", "doi-asserted-by": "crossref", "first-page": "2572", "DOI": "10.1056/NEJMoa032534", "article-title": "Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis", "volume": "350", "author": "Edwards", "year": "2004", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.23721-BIB114", "doi-asserted-by": "crossref", "first-page": "1390", "DOI": "10.1002/art.21778", "article-title": "The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial", "volume": "54", "author": "Emery", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB115", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.1136/ard.2004.029694", "article-title": "Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases", "volume": "64", "author": "Gottenberg", "year": "2005", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB116", "doi-asserted-by": "crossref", "first-page": "2807", "DOI": "10.1002/art.22070", "article-title": "Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: a one-year randomized, placebo-controlled study", "volume": "54", "author": "Weinblatt", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB117", "doi-asserted-by": "crossref", "first-page": "2368", "DOI": "10.1002/art.21978", "article-title": "Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register", "volume": "54", "author": "Dixon", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB118", "doi-asserted-by": "crossref", "first-page": "628", "DOI": "10.1002/art.21568", "article-title": "Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy", "volume": "54", "author": "Wolfe", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB119", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.1002/art.20009", "article-title": "Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy", "volume": "50", "author": "Wolfe", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB120", "doi-asserted-by": "crossref", "first-page": "2275", "DOI": "10.1001/jama.295.19.2275", "article-title": "Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials", "volume": "295", "author": "Bongartz", "year": "2006", "journal-title": "JAMA"}, {"key": "10.1002/art.23721-BIB121", "doi-asserted-by": "crossref", "first-page": "3403", "DOI": "10.1002/art.21386", "article-title": "Infections in patients with rheumatoid arthritis treated with biologic agents", "volume": "52", "author": "Listing", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB122", "doi-asserted-by": "crossref", "first-page": "1986", "DOI": "10.1002/art.21137", "article-title": "Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden", "volume": "52", "author": "Askling", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB123", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1016/S0755-4982(05)83925-9", "article-title": "Tuberculosis and infliximab treatment: national surveillance from January 1, 2000, through June 30, 2003", "volume": "34", "author": "Baldin", "year": "2005", "journal-title": "Presse Med"}, {"key": "10.1002/art.23721-BIB124", "doi-asserted-by": "crossref", "first-page": "717", "DOI": "10.1086/506935", "article-title": "Antirheumatic drugs and the risk of tuberculosis", "volume": "43", "author": "Brassard", "year": "2006", "journal-title": "Clin Infect Dis"}, {"key": "10.1002/art.23721-BIB125", "doi-asserted-by": "crossref", "first-page": "ii30", "DOI": "10.1136/ard.62.suppl_2.ii30", "article-title": "Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis", "volume": "62", "author": "Flendrie", "year": "2003", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB126", "doi-asserted-by": "crossref", "first-page": "1098", "DOI": "10.1056/NEJMoa011110", "article-title": "Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent", "volume": "345", "author": "Keane", "year": "2001", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.23721-BIB127", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1086/421494", "article-title": "Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor", "volume": "39", "author": "Mohan", "year": "2004", "journal-title": "Clin Infect Dis"}, {"key": "10.1002/art.23721-BIB128", "first-page": "865", "article-title": "Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice", "volume": "33", "author": "Perdriger", "year": "2006", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB129", "doi-asserted-by": "crossref", "first-page": "889", "DOI": "10.1136/ard.2005.043166", "article-title": "Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis", "volume": "65", "author": "Schiff", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB130", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1001/archinte.1989.00390030137027", "article-title": "Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis: a case-control study of 131 patients", "volume": "149", "author": "McKendry", "year": "1988", "journal-title": "Arch Intern Med"}, {"key": "10.1002/art.23721-BIB131", "doi-asserted-by": "crossref", "first-page": "1374", "DOI": "10.1093/rheumatology/39.12.1374", "article-title": "Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis", "volume": "39", "author": "Van Jaarsveld", "year": "2000", "journal-title": "Rheumatology (Oxford)"}, {"key": "10.1002/art.23721-BIB132", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1093/rheumatology/39.6.655", "article-title": "A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis", "volume": "39", "author": "Emery", "year": "2000", "journal-title": "Rheumatology (Oxford)"}, {"key": "10.1002/art.23721-BIB133", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1093/rheumatology/keh512", "article-title": "The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions", "volume": "44", "author": "Kinder", "year": "2005", "journal-title": "Rheumatology (Oxford)"}, {"key": "10.1002/art.23721-BIB134", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1007/BF02114393", "article-title": "Methotrexate therapy in rheumatoid arthritis: a two year prospective follow-up", "volume": "9", "author": "Drosos", "year": "1990", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/art.23721-BIB135", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1093/rheumatology/28.2.147", "article-title": "Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression", "volume": "28", "author": "Hanrahan", "year": "1989", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB136", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1007/BF00302669", "article-title": "Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis", "volume": "14", "author": "Schnabel", "year": "1994", "journal-title": "Rheumatol Int"}, {"key": "10.1002/art.23721-BIB137", "first-page": "639", "article-title": "Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice", "volume": "20", "author": "Buchbinder", "year": "1993", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB138", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1378/chest.109.4.933", "article-title": "Pulmonary function in patients receiving long-term low-dose methotrexate", "volume": "109", "author": "Cottin", "year": "1996", "journal-title": "Chest"}, {"key": "10.1002/art.23721-BIB139", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1093/rheumatology/35.5.441", "article-title": "Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis", "volume": "35", "author": "Hilliquin", "year": "1996", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB140", "first-page": "2299", "article-title": "Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis", "volume": "24", "author": "Ohosone", "year": "1997", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB141", "doi-asserted-by": "crossref", "first-page": "902", "DOI": "10.1002/art.1780290713", "article-title": "Treatment of Felty's syndrome with low-dose oral methotrexate", "volume": "29", "author": "Allen", "year": "1986", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB142", "first-page": "599", "article-title": "Oral methotrexate in the treatment of Felty's syndrome", "volume": "20", "author": "Tan", "year": "1993", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB143", "doi-asserted-by": "crossref", "first-page": "908", "DOI": "10.1093/rheumatology/37.8.908", "article-title": "Methotrexate treatment in Felty's syndrome", "volume": "37", "author": "Wassenberg", "year": "1998", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB144", "doi-asserted-by": "crossref", "first-page": "1414", "DOI": "10.1136/ard.2004.033241", "article-title": "Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists", "volume": "64", "author": "Askling", "year": "2005", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB145", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1136/ard.2004.023473", "article-title": "Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept", "volume": "64", "author": "Feltelius", "year": "2005", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB146", "doi-asserted-by": "crossref", "first-page": "699", "DOI": "10.1136/ard.2004.030528", "article-title": "Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas", "volume": "64", "author": "Geborek", "year": "2005", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB147", "doi-asserted-by": "crossref", "first-page": "793", "DOI": "10.1136/ard.61.9.793", "article-title": "Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden", "volume": "61", "author": "Geborek", "year": "2002", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB148", "first-page": "2557", "article-title": "Induction of autoantibodies during prolonged treatment with infliximab", "volume": "30", "author": "Louis", "year": "2003", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB149", "doi-asserted-by": "crossref", "first-page": "1740", "DOI": "10.1002/art.20311", "article-title": "Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients", "volume": "50", "author": "Wolfe", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB150", "author": "The Criteria Committee of the New York Heart Association", "first-page": "253", "year": "1994", "volume-title": "Nomenclature and criteria for diagnosis of diseases of the heart and great vessels"}, {"key": "10.1002/art.23721-BIB151", "doi-asserted-by": "crossref", "first-page": "3133", "DOI": "10.1161/01.CIR.0000077913.60364.D2", "article-title": "Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-\u03b1, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial", "volume": "107", "author": "Chung", "year": "2003", "journal-title": "Circulation"}, {"key": "10.1002/art.23721-BIB152", "doi-asserted-by": "crossref", "first-page": "1594", "DOI": "10.1161/01.CIR.0000124490.27666.B2", "article-title": "Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)", "volume": "109", "author": "Mann", "year": "2004", "journal-title": "Circulation"}, {"key": "10.1002/art.23721-BIB153", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1080/030097499750042245-1", "article-title": "Efficacy and safety of the new DMARD leflunomide: comparison to placebo and sulfasalazine in active rheumatoid arthritis", "volume": "112", "author": "Smolen", "year": "1999", "journal-title": "Scand J Rheumatol"}, {"key": "10.1002/art.23721-BIB154", "doi-asserted-by": "crossref", "first-page": "1984", "DOI": "10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B", "article-title": "Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate", "volume": "44", "author": "Cohen", "year": "2001", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB155", "first-page": "S428", "article-title": "Methotrexate, laboratory testing and risk of serious illness: analyses in 20,000 patients", "volume": "48", "author": "Cartwright", "year": "2003", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB156", "first-page": "489", "article-title": "Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate", "volume": "16", "author": "Rau", "year": "1989", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB157", "first-page": "517", "article-title": "Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities", "volume": "23", "author": "Yazici", "year": "2005", "journal-title": "Clin Exp Rheumatol"}, {"key": "10.1002/art.23721-BIB158", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1136/ard.2004.023408", "article-title": "Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities", "volume": "64", "author": "Yazici", "year": "2005", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB159", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1093/rheumatology/29.2.120", "article-title": "Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study", "volume": "29", "author": "Arnold", "year": "1990", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB160", "doi-asserted-by": "crossref", "first-page": "566", "DOI": "10.1136/ard.60.6.566", "article-title": "Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area", "volume": "60", "author": "Hamilton", "year": "2001", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB161", "first-page": "302", "article-title": "Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis: a randomized, double blind 26-week trial", "volume": "16", "author": "Morassut", "year": "1989", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB162", "first-page": "753", "article-title": "A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis", "volume": "15", "author": "Suarez-Almazor", "year": "1988", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB163", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1002/art.1780360303", "article-title": "The relative toxicity of disease-modifying antirheumatic drugs", "volume": "36", "author": "Fries", "year": "1993", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB164", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1093/rheumatology/36.3.345", "article-title": "Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients", "volume": "36", "author": "Rau", "year": "1997", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB165", "doi-asserted-by": "crossref", "first-page": "1060", "DOI": "10.1093/rheumatology/37.10.1060", "article-title": "A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis", "volume": "37", "author": "Menninger", "year": "1998", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB166", "first-page": "1906", "article-title": "Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD", "volume": "31", "author": "Cannon", "year": "2004", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB167", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1002/art.20167", "article-title": "Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial", "volume": "50", "author": "Lambert", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB168", "first-page": "1323", "article-title": "Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases", "volume": "18", "author": "Sany", "year": "1991", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB169", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1002/art.1780330305", "article-title": "Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis: a thirty-six-week, double-blind trial", "volume": "33", "author": "Weinblatt", "year": "1990", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB170", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1007/BF02030344", "article-title": "Low-dose methotrexate treatment of rheumatoid arthritis: long-term observation of efficacy and safety", "volume": "8", "author": "Szanto", "year": "1989", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/art.23721-BIB171", "doi-asserted-by": "crossref", "first-page": "654", "DOI": "10.1136/ard.47.8.654", "article-title": "Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations", "volume": "47", "author": "Tishler", "year": "1988", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB172", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1007/BF02330596", "article-title": "Low dose pulse methotrexate in rheumatoid arthritis: an 8-year experience with hepatotoxicity", "volume": "6", "author": "Leonard", "year": "1987", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/art.23721-BIB173", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/0002-9343(85)90312-2", "article-title": "Low-dose methotrexate treatment of rheumatoid arthritis: long-term observations", "volume": "79", "author": "Weinstein", "year": "1985", "journal-title": "Am J Med"}, {"key": "10.1002/art.23721-BIB174", "doi-asserted-by": "crossref", "first-page": "1492", "DOI": "10.1002/art.1780371013", "article-title": "Methotrexate in rheumatoid arthritis: a five-year prospective multicenter study", "volume": "37", "author": "Weinblatt", "year": "1994", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB175", "first-page": "1850", "article-title": "Adverse effects of low dose methotrexate therapy in rheumatoid arthritis", "volume": "20", "author": "McKendry", "year": "1993", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB176", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1007/BF00290521", "article-title": "Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis", "volume": "15", "author": "Schnabel", "year": "1996", "journal-title": "Rheumatol Int"}, {"key": "10.1002/art.23721-BIB177", "first-page": "830", "article-title": "Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects", "volume": "24", "author": "Andersen", "year": "1997", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB178", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1093/rheumatology/33.7.651", "article-title": "Methotrexate and sulphasalazine as combination therapy in rheumatoid arthritis", "volume": "33", "author": "Nisar", "year": "1994", "journal-title": "Br J Rheumatol"}, {"key": "10.1002/art.23721-BIB179", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1136/ard.62.4.291", "article-title": "Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial", "volume": "62", "author": "Gerards", "year": "2003", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB180", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.3109/03009749509095176", "article-title": "Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis: a one year prospective study", "volume": "24", "author": "Peltomaa", "year": "1995", "journal-title": "Scand J Rheumatol"}, {"key": "10.1002/art.23721-BIB181", "first-page": "195", "article-title": "Response to sulfasalazine in rheumatoid arthritis: life table analysis of a 5-year followup", "volume": "18", "author": "Jones", "year": "1991", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB182", "doi-asserted-by": "crossref", "first-page": "430", "DOI": "10.1002/hep.1840040313", "article-title": "Prognostic value of Child-Turcotte criteria in medically treated cirrhosis", "volume": "4", "author": "Christensen", "year": "1984", "journal-title": "Hepatology"}, {"key": "10.1002/art.23721-BIB183", "first-page": "1", "article-title": "Surgery and portal hypertension", "volume": "1", "author": "Child", "year": "1964", "journal-title": "Major Probl Clin Surg"}, {"key": "10.1002/art.23721-BIB184", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1002/bjs.1800600817", "article-title": "Transection of the oesophagus for bleeding oesophageal varices", "volume": "60", "author": "Pugh", "year": "1973", "journal-title": "Br J Surg"}, {"key": "10.1002/art.23721-BIB185", "doi-asserted-by": "crossref", "first-page": "971", "DOI": "10.1007/s10067-006-0218-1", "article-title": "Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease", "volume": "26", "author": "Giner Galvan", "year": "2007", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/art.23721-BIB186", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1136/gut.35.4.569", "article-title": "Fulminant hepatic failure secondary to hydroxychloroquine", "volume": "35", "author": "Makin", "year": "1994", "journal-title": "Gut"}, {"key": "10.1002/art.23721-BIB187", "first-page": "3339", "article-title": "Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis", "volume": "149", "author": "Koziel", "year": "1992", "journal-title": "J Immunol"}, {"key": "10.1002/art.23721-BIB188", "doi-asserted-by": "crossref", "first-page": "1029", "DOI": "10.1111/j.1478-3231.2006.01339.x", "article-title": "How to modulate inflammatory cytokines in liver diseases", "volume": "26", "author": "Tilg", "year": "2006", "journal-title": "Liver Int"}, {"key": "10.1002/art.23721-BIB189", "doi-asserted-by": "crossref", "first-page": "2469", "DOI": "10.1128/JVI.77.4.2469-2476.2003", "article-title": "Lack of tumor necrosis factor \u03b1 induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes", "volume": "77", "author": "Kasahara", "year": "2003", "journal-title": "J Virol"}, {"key": "10.1002/art.23721-BIB190", "doi-asserted-by": "crossref", "first-page": "1366", "DOI": "10.1111/j.1440-1746.2006.04559.x", "article-title": "Hepatitis B and C virus infections and anti-tumor necrosis factor-\u03b1 therapy: guidelines for clinical approach", "volume": "21", "author": "Nathan", "year": "2006", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/art.23721-BIB191", "first-page": "27", "article-title": "The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis: epidemiology of DMARDs treatment in Japan", "volume": "23", "author": "Nagashima", "year": "2005", "journal-title": "Clin Exp Rheumatol"}, {"key": "10.1002/art.23721-BIB192", "first-page": "313", "article-title": "Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis", "volume": "16", "author": "Furst", "year": "1989", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB193", "unstructured": "Bermas BL. Use of immunosuppressive drugs in pregnancy and lactation. 2007. URL: http://patients.uptodate.com/topic.asp?file=tx_rheum/9876."}, {"key": "10.1002/art.23721-BIB194", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1186/ar1957", "article-title": "Anti-inflammatory and immunosuppressive drugs and reproduction", "volume": "8", "author": "Ostensen", "year": "2006", "journal-title": "Arthritis Res Ther"}, {"key": "10.1002/art.23721-BIB195", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.3109/00016348709022049", "article-title": "Salazosulfapyridine and metabolites in fetal and maternal body fluids with special reference to 5-aminosalicylic acid", "volume": "66", "author": "Ambrosius Christensen", "year": "1987", "journal-title": "Acta Obstet Gynecol Scand"}, {"key": "10.1002/art.23721-BIB196", "doi-asserted-by": "crossref", "first-page": "943", "DOI": "10.1111/j.1365-2133.1996.tb06332.x", "article-title": "Black breast milk due to minocycline therapy", "volume": "134", "author": "Hunt", "year": "1996", "journal-title": "Br J Dermatol"}, {"key": "10.1002/art.23721-BIB197", "doi-asserted-by": "crossref", "first-page": "978", "DOI": "10.1016/0002-9378(72)90824-1", "article-title": "Secretion of methotrexate into human milk", "volume": "112", "author": "Johns", "year": "1972", "journal-title": "Am J Obstet Gynecol"}, {"key": "10.1002/art.23721-BIB198", "doi-asserted-by": "crossref", "first-page": "400", "DOI": "10.1038/ncprheum0532", "article-title": "Therapy insight: the use of antirheumatic drugs during nursing", "volume": "3", "author": "Ostensen", "year": "2007", "journal-title": "Nat Clin Pract Rheumatol"}, {"key": "10.1002/art.23721-BIB199", "first-page": "241", "article-title": "The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes", "volume": "30", "author": "Chakravarty", "year": "2003", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB200", "doi-asserted-by": "crossref", "first-page": "2045", "DOI": "10.1007/s10620-006-9452-2", "article-title": "The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy", "volume": "51", "author": "Coburn", "year": "2006", "journal-title": "Dig Dis Sci"}, {"key": "10.1002/art.23721-BIB201", "doi-asserted-by": "crossref", "first-page": "2385", "DOI": "10.1111/j.1572-0241.2004.30186.x", "article-title": "Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis", "volume": "99", "author": "Katz", "year": "2004", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/art.23721-BIB202", "doi-asserted-by": "crossref", "first-page": "733", "DOI": "10.1111/j.1365-2036.2005.02405.x", "article-title": "Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease", "volume": "21", "author": "Mahadevan", "year": "2005", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/art.23721-BIB203", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1038/sj.jp.7211481", "article-title": "Administration of rituximab during the first trimester of pregnancy without consequences for the newborn", "volume": "26", "author": "Ojeda-Uribe", "year": "2006", "journal-title": "J Perinatol"}, {"key": "10.1002/art.23721-BIB204", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.1093/rheumatology/kel400", "article-title": "Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-\u03b1 therapy", "volume": "46", "author": "Roux", "year": "2007", "journal-title": "Rheumatology (Oxford)"}, {"key": "10.1002/art.23721-BIB205", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1034/j.1600-0897.2001.d01-25.x", "article-title": "Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis", "volume": "46", "author": "Sills", "year": "2001", "journal-title": "Am J Reprod Immunol"}, {"key": "10.1002/art.23721-BIB206", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1016/j.semarthrit.2005.05.002", "article-title": "Antirheumatic drugs in pregnancy and lactation", "volume": "35", "author": "Temprano", "year": "2005", "journal-title": "Semin Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB207", "doi-asserted-by": "crossref", "first-page": "362", "DOI": "10.1136/gut.51.3.362", "article-title": "Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?", "volume": "51", "author": "Van Deventer", "year": "2002", "journal-title": "Gut"}, {"key": "10.1002/art.23721-BIB208", "doi-asserted-by": "crossref", "first-page": "890", "DOI": "10.1136/gut.2005.065417", "article-title": "Adalimumab use in pregnancy", "volume": "54", "author": "Vesga", "year": "2005", "journal-title": "Gut"}, {"key": "10.1002/art.23721-BIB209", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1177/107110070402500510", "article-title": "Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-\u03b1 inhibition therapy", "volume": "25", "author": "Bibbo", "year": "2004", "journal-title": "Foot Ankle Int"}, {"key": "10.1002/art.23721-BIB210", "first-page": "689", "article-title": "Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study", "volume": "34", "author": "Den Broeder", "year": "2007", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB211", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1002/art.21841", "article-title": "Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis", "volume": "55", "author": "Giles", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB212", "first-page": "465", "article-title": "Infliximab and its impact on surgical outcomes in patients with rheumatoid arthritis", "volume": "64", "author": "Shergy", "year": "2005", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB213", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1177/107110070302400106", "article-title": "The influence of rheumatoid chemotherapy, age, and presence of rheumatoid nodules on postoperative complications in rheumatoid foot and ankle surgery: analysis of 725 procedures in 104 patients", "volume": "24", "author": "Bibbo", "year": "2003", "journal-title": "Foot Ankle Int"}, {"key": "10.1002/art.23721-BIB214", "first-page": "984", "article-title": "Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis?", "volume": "18", "author": "Bridges", "year": "1991", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB215", "first-page": "207", "article-title": "Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy", "volume": "19", "author": "Carpenter", "year": "1996", "journal-title": "Orthopedics"}, {"key": "10.1002/art.23721-BIB216", "first-page": "1844", "article-title": "Risk factors for early wound complications after orthopedic surgery for rheumatoid arthritis", "volume": "22", "author": "Escalante", "year": "1995", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB217", "doi-asserted-by": "crossref", "first-page": "1138", "DOI": "10.1007/s00296-006-0138-z", "article-title": "Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery", "volume": "26", "author": "Fuerst", "year": "2006", "journal-title": "Rheumatol Int"}, {"key": "10.1002/art.23721-BIB218", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1136/ard.60.3.214", "article-title": "Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery", "volume": "60", "author": "Grennan", "year": "2001", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB219", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1053/jhsu.2002.32958", "article-title": "Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery", "volume": "27", "author": "Jain", "year": "2002", "journal-title": "J Hand Surg [Am]"}, {"key": "10.1002/art.23721-BIB220", "first-page": "1233", "article-title": "Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand", "volume": "16", "author": "Kasdan", "year": "1993", "journal-title": "Orthopedics"}, {"key": "10.1002/art.23721-BIB221", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1002/art.1780340204", "article-title": "Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate", "volume": "34", "author": "Perhala", "year": "1991", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB222", "doi-asserted-by": "crossref", "first-page": "278", "DOI": "10.1016/j.semarthrit.2006.10.003", "article-title": "Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment?", "volume": "36", "author": "Pieringer", "year": "2007", "journal-title": "Semin Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB223", "first-page": "1129", "article-title": "Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis", "volume": "20", "author": "Sany", "year": "1993", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB224", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1097/01.RHU.0000062514.54375.bd", "article-title": "Examination of the risk of continuous leflunomide treatment on the incidence of infectious complications after joint arthroplasty in patients with rheumatoid arthritis", "volume": "9", "author": "Tanaka", "year": "2003", "journal-title": "J Clin Rheumatol"}, {"key": "10.1002/art.23721-BIB225", "first-page": "S12", "article-title": "Clinical experience with interleukin-1 receptor antagonist in rheumatoid arthritis", "volume": "7", "author": "Bresnihan", "year": "2001", "journal-title": "J Clin Rheumatol"}, {"key": "10.1002/art.23721-BIB226", "doi-asserted-by": "crossref", "first-page": "723", "DOI": "10.1002/art.1780390503", "article-title": "Guidelines for monitoring drug therapy in rheumatoid arthritis", "volume": "39", "author": "American College of Rheumatology Ad Hoc Committee on Clinical Guidelines", "year": "1996", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB227", "first-page": "401", "article-title": "The use of DMARDs in women with RA of childbearing age: a survey of practice patterns and pregnancy outcomes", "volume": "31", "author": "Chakravarty", "year": "2004", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.23721-BIB228", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1001/archinte.160.5.610", "article-title": "The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation", "volume": "160", "author": "Janssen", "year": "2000", "journal-title": "Arch Intern Med"}, {"key": "10.1002/art.23721-BIB229", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.2165/00044011-200626020-00001", "article-title": "Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis", "volume": "26", "author": "Tilling", "year": "2006", "journal-title": "Clin Drug Investig"}, {"key": "10.1002/art.23721-BIB230", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.2165/00002018-200427050-00006", "article-title": "Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity", "volume": "27", "author": "Van Roon", "year": "2004", "journal-title": "Drug Saf"}, {"key": "10.1002/art.23721-BIB231", "doi-asserted-by": "crossref", "first-page": "715", "DOI": "10.7326/0003-4819-141-9-200411020-00013", "article-title": "Testing for hepatitis C virus infection should be routine for persons at increased risk for infection", "volume": "141", "author": "Alter", "year": "2004", "journal-title": "Ann Intern Med"}, {"key": "10.1002/art.23721-BIB232", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1086/339192", "article-title": "Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs", "volume": "185", "author": "Goldstein", "year": "2002", "journal-title": "J Infect Dis"}, {"key": "10.1002/art.23721-BIB233", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1086/338043", "article-title": "Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus", "volume": "34", "author": "Elkayam", "year": "2002", "journal-title": "Clin Infect Dis"}, {"key": "10.1002/art.23721-BIB234", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1136/ard.2005.036434", "article-title": "Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF \u03b1 blockers", "volume": "65", "author": "Fomin", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB235", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1093/rheumatology/kei193", "article-title": "Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis", "volume": "45", "author": "Kapetanovic", "year": "2006", "journal-title": "Rheumatology (Oxford)"}, {"key": "10.1002/art.23721-BIB236", "first-page": "1", "article-title": "General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)", "volume": "55", "author": "Kroger", "year": "2006", "journal-title": "MMWR Recomm Rep"}, {"key": "10.1002/art.23721-BIB237", "first-page": "Q1-4", "article-title": "Recommended adult immunization schedule: United States, October 2005-September 2006", "volume": "54", "author": "Centers for Disease Control and Prevention", "year": "2005", "journal-title": "MMWR Morb Mortal Wkly Rep"}, {"key": "10.1002/art.23721-BIB238", "doi-asserted-by": "crossref", "first-page": "999", "DOI": "10.7326/0003-4819-114-12-999", "article-title": "Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis: a randomized, double-blind study", "volume": "114", "author": "Jeurissen", "year": "1991", "journal-title": "Ann Intern Med"}, {"key": "10.1002/art.23721-BIB239", "unstructured": "Committee on Rheumatologic Care. Screening for hydroxychloroquine retinopathy. 2006. URL: http://www.rheumatology.org/publications/position/hydroxyp2.asp?aud=mem."}, {"key": "10.1002/art.23721-BIB240", "first-page": "304", "article-title": "Effect of adalimumab (Humira) on response to influenza virus and pneumococcal vaccines in patients with rheumatoid arthritis (RA)", "volume": "65", "author": "Kaine", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB241", "first-page": "S515", "article-title": "Vaccination against influenza in rheumatoid arthritis patients: the effect of rituximab on the humoral response", "volume": "54", "author": "Oren", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB242", "first-page": "184", "article-title": "A single dose of abatacept does not prevent the development of a positive immune response to tetanus and pneumococcal vaccines", "volume": "65", "author": "Corbo", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB243", "first-page": "184", "article-title": "Influenza vaccination as a model for testing immune modulation of anti-TNF and methotrexate therapy in rheumatoid arthritis patients", "volume": "65", "author": "Kapetanovic", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB244", "first-page": "735", "article-title": "Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection. United States, 2003", "volume": "52", "author": "Centers for Disease Control and Prevention", "year": "2003", "journal-title": "MMWR Morb Mortal Wkly Rep"}, {"key": "10.1002/art.23721-BIB245", "doi-asserted-by": "crossref", "first-page": "S221", "DOI": "10.1164/ajrccm.161.supplement_3.ats600", "article-title": "Targeted tuberculin testing and treatment of latent tuberculosis infection", "volume": "161", "year": "2000", "unstructured": "Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a joint statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000; 161: S221-47.", "journal-title": "Am J Respir Crit Care Med"}, {"key": "10.1002/art.23721-BIB246", "first-page": "49", "article-title": "Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States", "volume": "54", "author": "Mazurek", "year": "2005", "journal-title": "MMWR Recomm Rep"}, {"key": "10.1002/art.23721-BIB247", "doi-asserted-by": "crossref", "first-page": "761", "DOI": "10.1016/S1473-3099(04)01206-X", "article-title": "Interferon-\u03b3 assays in the immunodiagnosis of tuberculosis: a systematic review", "volume": "4", "author": "Pai", "year": "2004", "journal-title": "Lancet Infect Dis"}, {"key": "10.1002/art.23721-BIB248", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1136/ard.62.8.791", "article-title": "French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers", "volume": "62", "author": "Mariette", "year": "2003", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.23721-BIB249", "doi-asserted-by": "crossref", "first-page": "2968", "DOI": "10.1002/art.21382", "article-title": "Tuberculosis associated with therapy against tumor necrosis factor \u03b1", "volume": "52", "author": "Winthrop", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB250", "doi-asserted-by": "crossref", "first-page": "1075", "DOI": "10.1002/art.21734", "article-title": "The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial", "volume": "54", "author": "Westhovens", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB251", "doi-asserted-by": "crossref", "first-page": "1766", "DOI": "10.1002/art.21043", "article-title": "Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists", "volume": "52", "author": "Carmona", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB252", "doi-asserted-by": "crossref", "first-page": "800", "DOI": "10.1136/thx.2005.046797", "article-title": "BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-\u03b1 treatment", "volume": "60", "author": "British Thoracic Society Standards of Care Committee", "year": "2005", "journal-title": "Thorax"}, {"key": "10.1002/art.23721-BIB253", "doi-asserted-by": "crossref", "first-page": "S214", "DOI": "10.1002/art.11407", "article-title": "Rheumatoid Arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI)", "volume": "49", "author": "Fransen", "year": "2003", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB254", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1002/1529-0131(200101)44:1<53::AID-ANR8>3.0.CO;2-O", "article-title": "Responsiveness of the Self-Assessed Rheumatoid Arthritis Disease Activity Index to a flare of disease activity", "volume": "44", "author": "Fransen", "year": "2001", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.23721-BIB255", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1016/j.berh.2007.02.005", "article-title": "A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers", "volume": "21", "author": "Pincus", "year": "2007", "journal-title": "Best Pract Res Clin Rheumatol"}], "container-title": ["Arthritis & Rheumatism"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.23721", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 11]], "date-time": "2019-02-11T19:49:54Z", "timestamp": 1549914594000}, "score": 56.76398, "issued": {"date-parts": [[2008, 6, 15]]}, "references-count": 255, "journal-issue": {"published-print": {"date-parts": [[2008, 6, 15]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1002/art.23721", "relation": {"cites": []}, "ISSN": ["0004-3591", "1529-0131"], "issn-type": [{"value": "0004-3591", "type": "print"}, {"value": "1529-0131", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 17]], "date-time": "2019-12-17T23:03:13Z", "timestamp": 1576623793582}, "reference-count": 28, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1247, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis Care Res"], "published-print": {"date-parts": [[2012, 5]]}, "DOI": "10.1002/acr.21649", "type": "journal-article", "created": {"date-parts": [[2012, 4, 3]], "date-time": "2012-04-03T10:57:04Z", "timestamp": 1333450624000}, "page": "640-647", "source": "Crossref", "is-referenced-by-count": 292, "title": ["Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice"], "prefix": "10.1002", "volume": "64", "author": [{"given": "Jaclyn", "family": "Anderson", "sequence": "first", "affiliation": []}, {"given": "Liron", "family": "Caplan", "sequence": "additional", "affiliation": []}, {"given": "Jinoos", "family": "Yazdany", "sequence": "additional", "affiliation": []}, {"given": "Mark L.", "family": "Robbins", "sequence": "additional", "affiliation": []}, {"given": "Tuhina", "family": "Neogi", "sequence": "additional", "affiliation": []}, {"given": "Kaleb", "family": "Michaud", "sequence": "additional", "affiliation": []}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": []}, {"given": "James R.", "family": "O'dell", "sequence": "additional", "affiliation": []}, {"given": "Salahuddin", "family": "Kazi", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 4, 2]]}, "reference": [{"key": "10.1002/acr.21649-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1002/art.30129", "article-title": "American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials", "volume": "63", "author": "Felson", "year": "2011", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21649-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1136/ard.2009.123919", "article-title": "Treating rheumatoid arthritis to target: recommendations of an international task force", "volume": "69", "author": "Smolen", "year": "2010", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.21649-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/S0140-6736(04)16676-2", "article-title": "Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial", "volume": "364", "author": "Grigor", "year": "2004", "journal-title": "Lancet"}, {"key": "10.1002/acr.21649-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1443", "DOI": "10.1136/ard.2007.071092", "article-title": "Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)", "volume": "66", "author": "Verstappen", "year": "2007", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.21649-BIB5|cit5", "unstructured": "National Committee for Quality Assurance (NCQA), Physician Consortium for Performance Improvement (PCPI), American College of Rheumatology (ACR) 2008 http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/rheumatoid-arthritis.pdf"}, {"key": "10.1002/acr.21649-BIB6|cit6", "first-page": "198", "article-title": "The OMERACT filter for Outcome Measures in Rheumatology", "volume": "25", "author": "Boers", "year": "1998", "journal-title": "J Rheumatol"}, {"issue": "Suppl", "key": "10.1002/acr.21649-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "S14", "DOI": "10.1002/acr.20621", "article-title": "Measures of rheumatoid arthritis disease activity: patient (PtGA) and provider (PrGA) global assessment of disease activity, Disease Activity Score (DAS) and Disease Activity Score with 28-joint counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), patient-based Disease Activity Score with ESR (PDAS1) and patient-based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA)", "volume": "63", "author": "Anderson", "year": "2011", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/acr.21649-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1097/00000441-195609000-00009", "article-title": "Quantitation of the activity of rheumatoid arthritis. 5. A method for summation of the systemic indices of rheumatoid activity", "volume": "232", "author": "Lansbury", "year": "1956", "journal-title": "Am J Med Sci"}, {"key": "10.1002/acr.21649-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1002/acr.21641", "article-title": "2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis", "volume": "64", "author": "Singh", "year": "2012", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/acr.21649-BIB10|cit10", "first-page": "2410", "article-title": "A composite disease activity scale for clinical practice, observational studies, and clinical trials: the Patient Activity Scale (PAS/PAS-II)", "volume": "32", "author": "Wolfe", "year": "2005", "journal-title": "J Rheumatol"}, {"key": "10.1002/acr.21649-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "2136", "DOI": "10.3899/jrheum.080182", "article-title": "RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to Disease Activity Score and Clinical Disease Activity Index categories", "volume": "35", "author": "Pincus", "year": "2008", "journal-title": "J Rheumatol"}, {"key": "10.1002/acr.21649-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "729", "DOI": "10.1002/art.1780360601", "article-title": "The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials", "volume": "36", "author": "Felson", "year": "1993", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21649-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1002/art.1780230202", "article-title": "Measurement of patient outcome in arthritis", "volume": "23", "author": "Fries", "year": "1980", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21649-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "3296", "DOI": "10.1002/art.20549", "article-title": "Development and validation of the Health Assessment Questionnaire II: a revised version of the Health Assessment Questionnaire", "volume": "50", "author": "Wolfe", "year": "2004", "journal-title": "Arthritis Rheum"}, {"issue": "Suppl", "key": "10.1002/acr.21649-BIB15|cit15", "first-page": "S19", "article-title": "Development of a Multi-dimensional Health Assessment Questionnaire (MDHAQ) for the infrastructure of standard clinical care", "volume": "23", "author": "Pincus", "year": "2005", "journal-title": "Clin Exp Rheumatol"}, {"key": "10.1002/acr.21649-BIB16|cit16", "first-page": "892", "article-title": "Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials", "volume": "28", "author": "Lassere", "year": "2001", "journal-title": "J Rheumatol"}, {"key": "10.1002/acr.21649-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "932", "DOI": "10.3899/jrheum.090879", "article-title": "Reproducibility of joint swelling assessments in long-lasting rheumatoid arthritis: influence on Disease Activity Score-28 values (SEA-Repro study part I)", "volume": "37", "author": "Marhadour", "year": "2010", "journal-title": "J Rheumatol"}, {"key": "10.1002/acr.21649-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "2750", "DOI": "10.1002/art.11439", "article-title": "Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients", "volume": "48", "author": "Michaud", "year": "2003", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21649-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "1530", "DOI": "10.1002/art.11024", "article-title": "Predicting mortality in patients with rheumatoid arthritis", "volume": "48", "author": "Wolfe", "year": "2003", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21649-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "1072", "DOI": "10.1002/1529-0131(199806)41:6<1072::AID-ART14>3.0.CO;2-G", "article-title": "The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis", "volume": "41", "author": "Wolfe", "year": "1998", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21649-BIB21|cit21", "first-page": "2108", "article-title": "The longterm outcomes of rheumatoid arthritis. Work disability: a prospective 18 year study of 823 patients", "volume": "25", "author": "Wolfe", "year": "1998", "journal-title": "J Rheumatol"}, {"key": "10.1002/acr.21649-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "R796", "DOI": "10.1186/ar1740", "article-title": "Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score", "volume": "7", "author": "Aletaha", "year": "2005", "journal-title": "Arthritis Res Ther"}, {"key": "10.1002/acr.21649-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "244", "DOI": "10.1093/rheumatology/keg072", "article-title": "A Simplified Disease Activity Index for rheumatoid arthritis for use in clinical practice", "volume": "42", "author": "Smolen", "year": "2003", "journal-title": "Rheumatology (Oxford)"}, {"key": "10.1002/acr.21649-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1002/art.1780380107", "article-title": "Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis", "volume": "38", "author": "Prevoo", "year": "1995", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21649-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1136/ard.2008.097683", "article-title": "DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis", "volume": "69", "author": "Goekoop-Ruiterman", "year": "2010", "journal-title": "Ann Rheum Dis"}, {"issue": "Suppl", "key": "10.1002/acr.21649-BIB26|cit26", "first-page": "S29", "article-title": "DAS remission cut points", "volume": "24", "author": "Fransen", "year": "2006", "journal-title": "Clin Exp Rheumatol"}, {"key": "10.1002/acr.21649-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1002/art.27740", "article-title": "Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants", "volume": "63", "author": "Smolen", "year": "2011", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21649-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "1521", "DOI": "10.1093/rheumatology/keq117", "article-title": "Discrepancies in categorizing rheumatoid arthritis patients by DAS-28(ESR) and DAS-28(CRP): can they be reduced?", "volume": "49", "author": "Hensor", "year": "2010", "journal-title": "Rheumatology (Oxford)"}], "container-title": ["Arthritis Care & Research"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.21649", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/acr.21649", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 2]], "date-time": "2018-08-02T00:46:03Z", "timestamp": 1533170763000}, "score": 46.290268, "subtitle": ["ACR RA Disease Activity Measures Recommendations"], "issued": {"date-parts": [[2012, 4, 2]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[2012, 5]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1002/acr.21649", "relation": {"cites": []}, "ISSN": ["2151-464X"], "issn-type": [{"value": "2151-464X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:42:54Z", "timestamp": 1574296974521}, "reference-count": 72, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2002, 5, 1]], "date-time": "2002-05-01T00:00:00Z", "timestamp": 1020211200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Curr Rheumatol Rep"], "published-print": {"date-parts": [[2002, 5]]}, "DOI": "10.1007/s11926-002-0068-z", "type": "journal-article", "created": {"date-parts": [[2007, 6, 2]], "date-time": "2007-06-02T12:58:35Z", "timestamp": 1180789115000}, "page": "218-225", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Glucocorticoid use in rheumatoid arthritis"], "prefix": "10.1007", "volume": "4", "author": [{"given": "Kenneth G.", "family": "Saag", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "68_CR1", "doi-asserted-by": "crossref", "first-page": "344", "DOI": "10.1136/bmj.313.7053.344", "volume": "313", "author": "LJ Walsh", "year": "1996", "unstructured": "Walsh LJ, Wong CA, Pringle M, Tattersfield AE: Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 1996, 313:344\u2013346.", "journal-title": "BMJ"}, {"key": "68_CR2", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/0002-9343(94)90131-7", "volume": "96", "author": "KG Saag", "year": "1994", "unstructured": "Saag KG, Koehnke R, Caldwell JR, et al.: Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 1994, 96:115\u2013123.", "journal-title": "Am J Med"}, {"key": "68_CR3", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/S0049-0172(05)80039-3", "volume": "23", "author": "BLAM Weusten", "year": "1993", "unstructured": "Weusten BLAM, Jacobs JWG, Bijlsma JWJ: Corticosteroid pulse therapy in active rheumatoid arthritis. Semin Arthritis Rheum 1993, 23:183\u2013192.", "journal-title": "Semin Arthritis Rheum"}, {"key": "68_CR4", "doi-asserted-by": "crossref", "first-page": "761", "DOI": "10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M", "volume": "41", "author": "F Buttgereit", "year": "1998", "unstructured": "Buttgereit F, Wheling M, Burmester GR: A new hypothesis of modular glucocorticoid actions\u2014steroid treatment of rheumatic diseases revisited. Arthritis Rheum 1998, 41:761\u2013767.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR5", "doi-asserted-by": "crossref", "first-page": "1198", "DOI": "10.7326/0003-4819-119-12-199312150-00007", "volume": "119", "author": "DT Boumpas", "year": "1993", "unstructured": "Boumpas DT, Chrousos GP, Wilder RL, et al.: Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993, 119:1198\u20131208.", "journal-title": "Ann Intern Med"}, {"key": "68_CR6", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1016/0165-6147(93)90184-L", "volume": "14", "author": "PJ Barnes", "year": "1993", "unstructured": "Barnes PJ, Adcock I: Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993, 14:436\u2013441.", "journal-title": "Trends Pharmacol Sci"}, {"key": "68_CR7", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1016/S0960-0760(01)00058-9", "volume": "77", "author": "M Eggert", "year": "2001", "unstructured": "Eggert M, Schulz M, Neeck G: Molecular mechanisms of glucocorticoid action in rheumatic autoimmune diseases. J Steroid Biochem Mol Biol 2001, 77:185\u2013191. Sophisticated and clear overview of the state-of-the-art on mechanisms.", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "68_CR8", "first-page": "2383", "volume": "28", "author": "RH Derijk", "year": "2001", "unstructured": "Derijk RH, Schaaf MJM, Turner G, et al.: A human glucocorticoid receptor gene variant that increases the stability of glucocorticoid receptor \u03b2-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 2001, 28:2383\u20132388.", "journal-title": "J Rheumatol"}, {"key": "68_CR9", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1172/JCI113301", "volume": "81", "author": "JA Kern", "year": "1988", "unstructured": "Kern JA, Laumb RT, Reed JC, et al.: Dexamethasone inhibition of interleukin-1beta production by human monocytes: posttranscriptional mechanisms. J Clin Invest 1988, 81:237\u2013244.", "journal-title": "J Clin Invest"}, {"key": "68_CR10", "doi-asserted-by": "crossref", "first-page": "9991", "DOI": "10.1073/pnas.89.21.9991", "volume": "89", "author": "BN Cronstein", "year": "1992", "unstructured": "Cronstein BN, Kimmel SC, Levin RI, et al.: A mechanism for the anti-inflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1992, 89:9991\u20139995.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "68_CR11", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1002/art.1780370409", "volume": "37", "author": "A Szczepanski", "year": "1994", "unstructured": "Szczepanski A, Moatter T, Carley WW, Gerritsen ME: Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1: inhibition by glucocorticoids. Arthritis Rheum 1994, 37:495\u2013503.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR12", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1093/rheumatology/34.4.347", "volume": "34", "author": "AM Gestel Van", "year": "1995", "unstructured": "Van Gestel AM, Laan RFJM, Haagsma CJ, et al.: Low-dose oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold: a randomized double-blind placebo-controlled trial. Br J Rheumatol 1995, 34:347\u2013351.", "journal-title": "Br J Rheumatol"}, {"key": "68_CR13", "doi-asserted-by": "crossref", "first-page": "811", "DOI": "10.1136/bmj.316.7134.811", "volume": "316", "author": "PC Gotzsche", "year": "1998", "unstructured": "Gotzsche PC, Johansen HK: Meta-analysis of short term low dose prednisolone versus placebo and non-steroidal antiinflammatory drugs in rheumatoid arthritis. BMJ 1998, 316:811\u2013818.", "journal-title": "BMJ"}, {"key": "68_CR14", "doi-asserted-by": "crossref", "first-page": "1818", "DOI": "10.1002/art.1780391107", "volume": "39", "author": "KG Saag", "year": "1996", "unstructured": "Saag KG, Criswell LA, Sems KM, et al.: Low-dose corticosteroids in rheumatoid arthritis: a meta-analysis of their moderate-term effectiveness. Arthritis Rheum 1996, 39:1818\u20131825.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR15", "author": "LC Criswell", "year": "1999", "unstructured": "Criswell LC, Saag KG, Sems KM, et al.: Rheumatoid Arthritis (RA): Moderate-term Low Dose Corticosteroids for Rheumatoid Arthritis (Cochrane Review). The Cochrane Library. Oxford: Update Software; 1999.", "volume-title": "Rheumatoid Arthritis (RA): Moderate-term Low Dose Corticosteroids for Rheumatoid Arthritis (Cochrane Review). The Cochrane Library."}, {"key": "68_CR16", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1056/NEJM199507203330302", "volume": "333", "author": "JR Kirwan", "year": "1995", "unstructured": "Kirwan JR, and the Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group: The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995, 333:142\u2013146.", "journal-title": "N Engl J Med"}, {"key": "68_CR17", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/S0140-6736(97)01300-7", "volume": "350", "author": "M Boers", "year": "1997", "unstructured": "Boers M, Verhoven AC, Markusse HM, et al.: Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997, 350:309\u2013318.", "journal-title": "Lancet"}, {"key": "68_CR18", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1136/ard.58.11.713", "volume": "58", "author": "M Hansen", "year": "1999", "unstructured": "Hansen M, Podenphant J, Florescu A, et al.: A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis: clinical benefits and skeletal side effects. Ann Rheum Dis 1999, 58:713\u2013718.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR19", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.7326/0003-4819-136-1-200201010-00006", "volume": "136", "author": "AA Everdingen van", "year": "2002", "unstructured": "van Everdingen AA, Jacobs JWG, van Reesema DR, Bijlsma JWJ:Low dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease modifying properties and side effects. A double-blind placebocontrolled clinical trial. Ann Intern Med 2002, 136:1\u201312. The first large-scale randomized controlled trial to demonstrate a disease-modifying effect of glucocorticoid monotherapy for the treatment of RA. Unlikely to be reproduced because of the available therapeutic options, which make this clever design outmoded.", "journal-title": "Ann Intern Med"}, {"key": "68_CR20", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1007/s003930170085", "volume": "60", "author": "R Rau", "year": "2001", "unstructured": "Rau R: Low dose steroid therapy in rheumatoid arthritis: a model for therapy of inflammatory diseases?\u2014results of the LDPT study. Zeitschrift fur Rheumatologie 2001, 60:111\u2013112. An important large study suggesting disease-modifying potential of glucocorticoids.", "journal-title": "Zeitschrift fur Rheumatologie"}, {"key": "68_CR21", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1093/rheumatology/36.2.225", "volume": "36", "author": "JR Kirwan", "year": "1997", "unstructured": "Kirwan JR: The relationship between synovitis and erosions in rheumatoid arthritis. Br J Rheum 1997, 36:225\u2013228.", "journal-title": "Br J Rheum"}, {"key": "68_CR22", "doi-asserted-by": "crossref", "first-page": "930", "DOI": "10.1093/rheumatology/37.9.930", "volume": "37", "author": "P Hickling", "year": "1998", "unstructured": "Hickling P, Jacoby RK, Kirwan JR: Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Br J Rheumatol 1998, 37:930\u2013936.", "journal-title": "Br J Rheumatol"}, {"key": "68_CR23", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1136/ard.60.1.61", "volume": "60", "author": "JWG Jacobs", "year": "2000", "unstructured": "Jacobs JWG, Greenen R, Evers AWM, et al.: Short term effects of corticosteroid pulse treatment on disease activity and the well being of patients with active rheumatoid arthritis. Ann Rheum Dis 2000, 60:61\u201364. A sequel, in some respects, to the Dutch COBRA study, further investigating the benefit of pulse therapy in RA.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR24", "doi-asserted-by": "crossref", "first-page": "352", "DOI": "10.7326/0003-4819-112-5-352", "volume": "112", "author": "BP Lukert", "year": "1990", "unstructured": "Lukert BP, Raisz LG: Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990, 112:352\u2013364.", "journal-title": "Ann Intern Med"}, {"key": "68_CR25", "doi-asserted-by": "crossref", "first-page": "1061", "DOI": "10.1359/jbmr.1999.14.7.1061", "volume": "14", "author": "SC Manolagas", "year": "1999", "unstructured": "Manolagas SC, Weinstein RS: New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999, 14:1061\u20131066. An excellent review of presumptive mechanisms. Strongly supports a key role for the osteoblast in GIOP pathogenesis.", "journal-title": "J Bone Miner Res"}, {"key": "68_CR26", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1002/art.1780390215", "volume": "39", "author": "RD Emkey", "year": "1996", "unstructured": "Emkey RD, Lindsay R, Lyssy J, et al.: The systemic effect of intraarticular administration of corticosteroid on markers on bone formation and bone resorption in patients with rheumatoid arthritis. Arthritis Rheum 1996, 39:277\u2013282.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR27", "doi-asserted-by": "crossref", "first-page": "4382", "DOI": "10.1210/endo.140.10.7034", "volume": "140", "author": "LC Hofbauer", "year": "1999", "unstructured": "Hofbauer LC, Gori F, Riggs L, et al.: Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 1999, 140:4382\u20134389. Highlights the importance of osteoclast factors in GIOP pathogenesis.", "journal-title": "Endocrinology"}, {"key": "68_CR28", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1093/ndt/16.3.479", "volume": "16", "author": "N Sasaki", "year": "2001", "unstructured": "Sasaki N, Kusano E, Ando Y, et al.: Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis. Nephrol Dial Transplant 2001, 16:479\u2013482.", "journal-title": "Nephrol Dial Transplant"}, {"key": "68_CR29", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1002/art.1780280402", "volume": "28", "author": "TR Dykman", "year": "1985", "unstructured": "Dykman TR, Gluck OS, Murphy WA, et al.: Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985, 28:361\u2013368.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR30", "doi-asserted-by": "crossref", "first-page": "963", "DOI": "10.7326/0003-4819-119-10-199311150-00001", "volume": "119", "author": "RFJM Laan", "year": "1993", "unstructured": "Laan RFJM, van Riel PLCM, van de Putte LBA, et al.: Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 1993, 119:963\u2013968.", "journal-title": "Ann Intern Med"}, {"key": "68_CR31", "doi-asserted-by": "crossref", "first-page": "852", "DOI": "10.1136/ard.45.10.852", "volume": "45", "author": "A Verstraeten", "year": "1986", "unstructured": "Verstraeten A, Dequeker J: Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis 1986, 45:852\u2013857.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR32", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1016/S0950-3579(05)80080-9", "volume": "7", "author": "IR Reid", "year": "1993", "unstructured": "Reid IR, Grey AB: Corticosteroid osteoporosis. Bailliere\u2019s Clin Rheumatol 1993, 7:573\u2013587.", "journal-title": "Bailliere\u2019s Clin Rheumatol"}, {"key": "68_CR33", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/0169-6009(91)90139-Q", "volume": "8", "author": "V LoCasio", "year": "1984", "unstructured": "LoCasio V, Bonucci E, Imbimbo B, et al.: Bone loss after glucocorticoid therapy. Bone Mineral 1984, 8:39\u201351.", "journal-title": "Bone Mineral"}, {"key": "68_CR34", "doi-asserted-by": "crossref", "first-page": "522", "DOI": "10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y", "volume": "43", "author": "G Haugeberg", "year": "2000", "unstructured": "Haugeberg G, Uhlig T, Falch JA, et al.: Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Arthritis Rheum 2000, 43:522\u2013530. Population-based study documenting the scope of bone disease and potential risk factors among a sizable group of patients with RA.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR35", "doi-asserted-by": "crossref", "first-page": "801", "DOI": "10.1136/ard.54.10.801", "volume": "54", "author": "NFA Peel", "year": "1995", "unstructured": "Peel NFA, Moore DJ, Barrington NA, et al.: Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995, 54:801\u2013806.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR36", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1136/ard.45.11.950", "volume": "45", "author": "PN Sambrook", "year": "1986", "unstructured": "Sambrook PN, Eisman JA, Yeates MG, et al.: Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis 1986, 45:950\u2013953.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR37", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1148/radiology.170.2.2911675", "volume": "170", "author": "M O\u2019Malley", "year": "1989", "unstructured": "O\u2019Malley M, Kenrick AJ, Sartoris DJ, et al.: Axial bone density in rheumatoid arthritis: comparison of dual-energy projection radiography and dual-photon absorptiometry. Radiology 1989, 170:501\u2013505.", "journal-title": "Radiology"}, {"key": "68_CR38", "first-page": "1495", "volume": "24", "author": "AC Verhoeven", "year": "1997", "unstructured": "Verhoeven AC, Boers M: Limited bone loss due to corticosteroids: a systematic review of prospective studies in rheumatoid arthritis and other diseases. J Rheumatol 1997, 24:1495\u20131503.", "journal-title": "J Rheumatol"}, {"key": "68_CR39", "first-page": "1520", "volume": "19", "author": "OD Messina", "year": "1992", "unstructured": "Messina OD, Barreira JC, Zanchetta JR, et al.: Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis. J Rheumatol 1992, 19:1520\u20131526.", "journal-title": "J Rheumatol"}, {"key": "68_CR40", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1016/0021-9681(84)90100-0", "volume": "37", "author": "GH Guyatt", "year": "1984", "unstructured": "Guyatt GH, Webber CE, Mewa AA, et al.: Determining causation \u2014a case study: adrenocorticosteroids and osteoporosis. J Chronic Dis 1984, 37:343\u2013352.", "journal-title": "J Chronic Dis"}, {"key": "68_CR41", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1136/ard.48.7.535", "volume": "48", "author": "PN Sambrook", "year": "1989", "unstructured": "Sambrook PN, Cohen ML, Eisman JA, et al.: Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 1989, 48:535\u2013538.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR42", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1016/S0140-6736(94)91049-9", "volume": "344", "author": "KS Gough", "year": "1994", "unstructured": "Gough KS, Lilley J, Eyre S, et al.: Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994, 344:23\u201327.", "journal-title": "Lancet"}, {"key": "68_CR43", "doi-asserted-by": "crossref", "first-page": "1510", "DOI": "10.1002/art.1780361105", "volume": "36", "author": "GM Hall", "year": "1993", "unstructured": "Hall GM, Spector TD, Griffin JA, et al.: The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 1993, 36:1510\u20131516.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR44", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1002/jbmr.5650100212", "volume": "10", "author": "NE Lane", "year": "1995", "unstructured": "Lane NE, Pressman AR, Star VL, et al.: Rheumatoid arthritis and bone mineral density in elderly women. J Bone Miner Res 1995, 10:257\u2013263.", "journal-title": "J Bone Miner Res"}, {"key": "68_CR45", "first-page": "1282", "volume": "25", "author": "A Gough", "year": "1998", "unstructured": "Gough A, Sambrook P, Devlin J, et al.: Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 1998, 25:1282\u20131289.", "journal-title": "J Rheumatol"}, {"key": "68_CR46", "first-page": "440", "volume": "22", "author": "TE Towheed", "year": "1995", "unstructured": "Towheed TE, Brouillard D, Yendt E, Anastassiades T:Osteoporosis in rheumatoid arthritis: findings in the metacarpal, spine, and hip and a study of the determinants of both localized and generalized osteopenia. J Rheumatol 1995, 22:440\u2013443.", "journal-title": "J Rheumatol"}, {"key": "68_CR47", "doi-asserted-by": "crossref", "first-page": "558", "DOI": "10.1136/bmj.306.6877.558", "volume": "306", "author": "TD Spector", "year": "1993", "unstructured": "Spector TD, Hall GM, McCloskey EV, Kanis JA: Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 1993, 306:558.", "journal-title": "Br Med J"}, {"key": "68_CR48", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1136/ard.54.1.49", "volume": "54", "author": "C Cooper", "year": "1995", "unstructured": "Cooper C, Coupland C, Mitchell M: Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995, 54:49\u201352.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR49", "doi-asserted-by": "crossref", "first-page": "803", "DOI": "10.1136/thx.46.11.803", "volume": "46", "author": "M Luengo", "year": "1991", "unstructured": "Luengo M, Picado C, Del Rio L, et al.: Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 1991, 46:803\u2013806.", "journal-title": "Thorax"}, {"key": "68_CR50", "doi-asserted-by": "crossref", "first-page": "952", "DOI": "10.1359/jbmr.2000.15.5.952", "volume": "15", "author": "PL Selby", "year": "2000", "unstructured": "Selby PL, Halsey JP, Adams KRH, et al.: Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res 2000, 15:952\u2013956.", "journal-title": "J Bone Miner Res"}, {"key": "68_CR51", "doi-asserted-by": "crossref", "first-page": "2917", "DOI": "10.1001/archinte.160.19.2917", "volume": "160", "author": "V Naganatham", "year": "2000", "unstructured": "Naganatham V, Jones G, Nash P, et al.: Vertebral fracture risk with long-term corticosteroid therapy. Arch Int Med 2000, 160:2917\u20132922.", "journal-title": "Arch Int Med"}, {"key": "68_CR52", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1136/ard.59.4.269", "volume": "59", "author": "SF Evans", "year": "2000", "unstructured": "Evans SF, Davie MWJ: Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men. Ann Rheum Dis 2000, 59:269\u2013275.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR53", "first-page": "804", "volume": "18", "author": "BA Michel", "year": "1991", "unstructured": "Michel BA, Bloch DA, Fries JF: Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991, 18:804\u2013808.", "journal-title": "J Rheumatol"}, {"key": "68_CR54", "doi-asserted-by": "crossref", "first-page": "1327", "DOI": "10.1016/S0140-6736(98)04835-1", "volume": "353", "author": "MA Baltzan", "year": "1999", "unstructured": "Baltzan MA, Suissa S, Bauer DC, Cummings SR: Hip fractures attributable to corticosteroid use. Lancet 1999, 353:1327.", "journal-title": "Lancet"}, {"key": "68_CR55", "first-page": "1207", "volume": "21", "author": "R McDougall", "year": "1994", "unstructured": "McDougall R, Sibley J, Haga M, Russell A: Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. J Rheumatol 1994, 21:1207\u20131213.", "journal-title": "J Rheumatol"}, {"key": "68_CR56", "doi-asserted-by": "crossref", "first-page": "1231", "DOI": "10.1093/rheumatology/40.11.1231", "volume": "40", "author": "AC Verhoeven", "year": "2001", "unstructured": "Verhoeven AC, Boers M, te Koppele JM, et al.: Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including highdose prednisolone. Rheumatology (Oxford) 2001, 40:1231\u20131237. COBRA study data emphasizing the importance of disease activity and glucocorticoid use on bone loss.", "journal-title": "Rheumatology (Oxford)"}, {"key": "68_CR57", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1056/NEJM199807303390502", "volume": "339", "author": "KG Saag", "year": "1998", "unstructured": "Saag KG, Emkey R, Schnitzer T, et al.: Alendronate for the treatment and prevention of glucocorticoid-induced osteoporosis. N Engl J Med 1998, 339:292\u2013299.", "journal-title": "N Engl J Med"}, {"key": "68_CR58", "first-page": "S136", "volume": "41", "author": "D Reid", "year": "1998", "unstructured": "Reid D, Cohen C, Pack S, et al.: Risedronate reduces the incidence of vertebral fractures in patients on chronic corticosteroid therapy. Arthritis Rheum 1998, 41:S136.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR59", "doi-asserted-by": "crossref", "first-page": "2309", "DOI": "10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K", "volume": "42", "author": "S Cohen", "year": "1999", "unstructured": "Cohen S, Levy RM, Keller M, et al.: Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 1999, 42:2309\u20132318.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR60", "doi-asserted-by": "crossref", "first-page": "892", "DOI": "10.1002/art.1780240705", "volume": "24", "author": "OS Gluck", "year": "1981", "unstructured": "Gluck OS, Murphy WA, Hahn TJ, et al.: Bone loss in adults receiving alternate day glucocorticoid therapy. Arthritis Rheum 1981, 24:892\u2013898.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR61", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1136/ard.53.1.18", "volume": "53", "author": "H Kroger", "year": "1994", "unstructured": "Kroger H, Honaken R, Saarikoski S, Alhava E: Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis\u2014a population based study. Ann Rheum Dis 1994, 53:18\u201323.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR62", "doi-asserted-by": "crossref", "first-page": "2545", "DOI": "10.1001/archinte.1990.00390230093012", "volume": "150", "author": "IR Reid", "year": "1990", "unstructured": "Reid IR, Heap SW: Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 1990, 150:2545\u20132548.", "journal-title": "Arch Intern Med"}, {"key": "68_CR63", "doi-asserted-by": "crossref", "first-page": "1383", "DOI": "10.1093/rheumatology/39.12.1383", "volume": "39", "author": "TP Staa van", "year": "2000", "unstructured": "van Staa TP, Leukens HGM, Abenhaim L, et al.: Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 2000, 39:1383\u20131389. Raises concern that fractures may occur earlier than previously suspected in glucocorticoid users.", "journal-title": "Rheumatology (Oxford)"}, {"key": "68_CR64", "doi-asserted-by": "crossref", "first-page": "993", "DOI": "10.1359/jbmr.2000.15.6.993", "volume": "15", "author": "TP Staa van", "year": "2000", "unstructured": "van Staa TP, Leukens HGM, Abenhaim L, et al.: Use of oral corticosteroids and risk of fracture. J Bone Miner Res 2000, 15:993\u20131000. Landmark study using the General Practice Research Database of the United Kingdom. Demonstrates increased risk of fractures with even very low-dose glucocorticoids.", "journal-title": "J Bone Miner Res"}, {"key": "68_CR65", "doi-asserted-by": "crossref", "first-page": "1496", "DOI": "10.1002/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5", "volume": "44", "author": "American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis", "year": "2001", "unstructured": "American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis: Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 2001, 44:1496\u20131503. Updated recommendations based on evidence and consensus.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR66", "doi-asserted-by": "crossref", "first-page": "1967", "DOI": "10.1002/1529-0131(200009)43:9<1967::AID-ANR7>3.0.CO;2-W", "volume": "43", "author": "DH Solomon", "year": "2000", "unstructured": "Solomon DH, Kuntz KK: Should postmenopausal women with rheumatoid arthritis who are starting corticosteroid treatment be screened for osteoporosis? Arthritis Rheum 2000, 43:1967\u20131975. Provocative investigation arguing for a more conservative approach among lower risk patients.", "journal-title": "Arthritis Rheum"}, {"key": "68_CR67", "doi-asserted-by": "crossref", "first-page": "805", "DOI": "10.1136/ard.59.10.805", "volume": "59", "author": "TK Kvein", "year": "2000", "unstructured": "Kvein TK, Haugeberg G, Uhlig T, et al.: Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk for osteoporosis. Ann Rheum Dis 2000, 59:805\u2013811.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR68", "first-page": "713", "volume": "10", "author": "ED Harris", "year": "1983", "unstructured": "Harris ED, Emkey RD, Nichols JE, Newberg A: Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983, 10:713\u2013721.", "journal-title": "J Rheumatol"}, {"key": "68_CR69", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1136/ard.14.4.353", "volume": "14", "author": "Empire Rheumatism Council Sub-Committee", "year": "1955", "unstructured": "Empire Rheumatism Council Sub-Committee: Multi-center controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Ann Rheum Dis 1955, 14:353\u2013363.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR70", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1136/ard.18.3.173", "volume": "18", "author": "Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone A, and Other Therapeutic Measures in Chronic Rheumatic Diseases", "year": "1959", "unstructured": "Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone A, and Other Therapeutic Measures in Chronic Rheumatic Diseases: A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1959, 18:173\u2013187.", "journal-title": "Ann Rheum Dis"}, {"key": "68_CR71", "doi-asserted-by": "crossref", "first-page": "938", "DOI": "10.7326/0003-4819-54-5-938", "volume": "54", "author": "CA Bernsten", "year": "1961", "unstructured": "Bernsten CA, Freyberg RH: Rheumatoid patients after five or more years of corticosteroid treatment: a comparative analysis of 183 cases. Ann Intern Med 1961, 54:938\u2013953.", "journal-title": "Ann Intern Med"}, {"key": "68_CR72", "doi-asserted-by": "crossref", "first-page": "812", "DOI": "10.1016/S0140-6736(84)92270-0", "volume": "1", "author": "R Million", "year": "1984", "unstructured": "Million R, Poole P, Kellgren JH, Jayson MI: Long-term study management of rheumatoid arthritis. Lancet 1984, 1:812\u2013816.", "journal-title": "Lancet"}], "container-title": ["Current Rheumatology Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s11926-002-0068-z.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s11926-002-0068-z/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11926-002-0068-z", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 2]], "date-time": "2019-06-02T00:47:10Z", "timestamp": 1559436430000}, "score": 40.75699, "issued": {"date-parts": [[2002, 5]]}, "references-count": 72, "journal-issue": {"published-print": {"date-parts": [[2002, 5]]}, "issue": "3"}, "alternative-id": ["68"], "URL": "http://dx.doi.org/10.1007/s11926-002-0068-z", "relation": {"cites": []}, "ISSN": ["1523-3774", "1534-6307"], "issn-type": [{"value": "1523-3774", "type": "print"}, {"value": "1534-6307", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T23:37:52Z", "timestamp": 1574465872380}, "reference-count": 45, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1247, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis Care Res"], "published-print": {"date-parts": [[2012, 5]]}, "DOI": "10.1002/acr.21641", "type": "journal-article", "created": {"date-parts": [[2012, 4, 3]], "date-time": "2012-04-03T10:57:04Z", "timestamp": 1333450624000}, "page": "625-639", "source": "Crossref", "is-referenced-by-count": 998, "title": ["2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis"], "prefix": "10.1002", "volume": "64", "author": [{"given": "Jasvinder A.", "family": "Singh", "sequence": "first", "affiliation": []}, {"given": "Daniel E.", "family": "Furst", "sequence": "additional", "affiliation": []}, {"given": "Aseem", "family": "Bharat", "sequence": "additional", "affiliation": []}, {"given": "Jeffrey R.", "family": "Curtis", "sequence": "additional", "affiliation": []}, {"given": "Arthur F.", "family": "Kavanaugh", "sequence": "additional", "affiliation": []}, {"given": "Joel M.", "family": "Kremer", "sequence": "additional", "affiliation": []}, {"given": "Larry W.", "family": "Moreland", "sequence": "additional", "affiliation": []}, {"given": "James", "family": "O'Dell", "sequence": "additional", "affiliation": []}, {"given": "Kevin L.", "family": "Winthrop", "sequence": "additional", "affiliation": []}, {"given": "Timothy", "family": "Beukelman", "sequence": "additional", "affiliation": []}, {"suffix": "Jr.", "given": "S. Louis", "family": "Bridges", "sequence": "additional", "affiliation": []}, {"given": "W. Winn", "family": "Chatham", "sequence": "additional", "affiliation": []}, {"given": "Harold E.", "family": "Paulus", "sequence": "additional", "affiliation": []}, {"given": "Maria", "family": "Suarez-almazor", "sequence": "additional", "affiliation": []}, {"given": "Claire", "family": "Bombardier", "sequence": "additional", "affiliation": []}, {"given": "Maxime", "family": "Dougados", "sequence": "additional", "affiliation": []}, {"given": "Dinesh", "family": "Khanna", "sequence": "additional", "affiliation": []}, {"given": "Charles M.", "family": "King", "sequence": "additional", "affiliation": []}, {"given": "Amye L.", "family": "Leong", "sequence": "additional", "affiliation": []}, {"given": "Eric L.", "family": "Matteson", "sequence": "additional", "affiliation": []}, {"given": "John T.", "family": "Schousboe", "sequence": "additional", "affiliation": []}, {"given": "Eileen", "family": "Moynihan", "sequence": "additional", "affiliation": []}, {"given": "Karen S.", "family": "Kolba", "sequence": "additional", "affiliation": []}, {"given": "Archana", "family": "Jain", "sequence": "additional", "affiliation": []}, {"given": "Elizabeth R.", "family": "Volkmann", "sequence": "additional", "affiliation": []}, {"given": "Harsh", "family": "Agrawal", "sequence": "additional", "affiliation": []}, {"given": "Sangmee", "family": "Bae", "sequence": "additional", "affiliation": []}, {"given": "Amy S.", "family": "Mudano", "sequence": "additional", "affiliation": []}, {"given": "Nivedita M.", "family": "Patkar", "sequence": "additional", "affiliation": []}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 4, 2]]}, "reference": [{"key": "10.1002/acr.21641-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "762", "DOI": "10.1002/art.23721", "article-title": "American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis", "volume": "59", "author": "Saag", "year": "2008", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "870", "DOI": "10.1016/j.jamcollsurg.2005.07.009", "article-title": "Developing quality indicators for elderly patients undergoing abdominal operations", "volume": "201", "author": "McGory", "year": "2005", "journal-title": "J Am Coll Surg"}, {"key": "10.1002/acr.21641-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1177/0272989X04264212", "article-title": "The appropriateness method", "volume": "24", "author": "Shekelle", "year": "2004", "journal-title": "Med Decis Making"}, {"key": "10.1002/acr.21641-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1004", "DOI": "10.1016/S0895-4356(01)00365-1", "article-title": "Sensitivity and specificity of the RAND/UCLA Appropriateness Method to identify the overuse and underuse of coronary revascularization and hysterectomy", "volume": "54", "author": "Shekelle", "year": "2001", "journal-title": "J Clin Epidemiol"}, {"key": "10.1002/acr.21641-BIB5|cit5", "first-page": "CD008341", "article-title": "Golimumab for rheumatoid arthritis", "volume": "1", "author": "Singh", "year": "2010", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1002/acr.21641-BIB6|cit6", "first-page": "CD008331", "article-title": "Tocilizumab for rheumatoid arthritis", "volume": "7", "author": "Singh", "year": "2010", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1002/acr.21641-BIB7|cit7", "first-page": "CD007848", "article-title": "Biologics for rheumatoid arthritis: an overview of Cochrane reviews", "volume": "4", "author": "Singh", "year": "2009", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1002/acr.21641-BIB8|cit8", "first-page": "CD007649", "article-title": "Certolizumab pegol (CDP870) for rheumatoid arthritis in adults", "volume": "2", "author": "Ruiz Garcia", "year": "2009", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1002/acr.21641-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.2307/2529310", "article-title": "The measurement of observer agreement for categorical data", "volume": "33", "author": "Landis", "year": "1977", "journal-title": "Biometrics"}, {"key": "10.1002/acr.21641-BIB10|cit10", "unstructured": "FDA, US Department of Health and Human Services 2011 http://www.fda.gov/safety/medwatch/howtoreport/ucm053087.htm"}, {"key": "10.1002/acr.21641-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "e154", "DOI": "10.1161/CIRCULATIONAHA.105.167586", "article-title": "ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society", "volume": "112", "author": "Hunt", "year": "2005", "journal-title": "Circulation"}, {"key": "10.1002/acr.21641-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "430", "DOI": "10.1002/hep.1840040313", "article-title": "Prognostic value of Child-Turcotte criteria in medically treated cirrhosis", "volume": "4", "author": "Christensen", "year": "1984", "journal-title": "Hepatology"}, {"key": "10.1002/acr.21641-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.1002/clc.4960220604", "article-title": "The use of the New York Heart Association's classification of cardiovascular disease as part of the patient's complete Problem List", "volume": "22", "author": "Hurst", "year": "1999", "journal-title": "Clin Cardiol"}, {"key": "10.1002/acr.21641-BIB14|cit14", "first-page": "1", "article-title": "Targeted tuberculin testing and treatment of latent tuberculosis infection", "volume": "49", "author": "CDC", "year": "2000", "journal-title": "MMWR Mortal Morb Wkly Rep"}, {"key": "10.1002/acr.21641-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "1467", "DOI": "10.1002/art.24106", "article-title": "Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis", "volume": "59", "author": "Bejarano", "year": "2008", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1016/S0140-6736(08)61000-4", "article-title": "Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial", "volume": "372", "author": "Emery", "year": "2008", "journal-title": "Lancet"}, {"key": "10.1002/acr.21641-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "510", "DOI": "10.1002/art.23541", "article-title": "Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis", "volume": "59", "author": "Han", "year": "2008", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB18|cit18", "first-page": "206", "article-title": "Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA", "volume": "35", "author": "Kimel", "year": "2008", "journal-title": "J Rheumatol"}, {"key": "10.1002/acr.21641-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "716", "DOI": "10.1002/art.21661", "article-title": "Infliximab treatment maintains employability in patients with early rheumatoid arthritis", "volume": "54", "author": "Smolen", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "3432", "DOI": "10.1002/art.20568", "article-title": "Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial", "volume": "50", "author": "St.Clair", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "1153", "DOI": "10.1136/ard.2008.093294", "article-title": "Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis", "volume": "68", "author": "Van der Kooij", "year": "2009", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.21641-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "1586", "DOI": "10.1056/NEJM200011303432201", "article-title": "A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis", "volume": "22", "author": "Bathon", "year": "2000", "journal-title": "N Engl J Med"}, {"key": "10.1002/acr.21641-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "2569", "DOI": "10.1002/art.27584", "article-title": "2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative", "volume": "62", "author": "Aletaha", "year": "2010", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1002/art.1780310302", "article-title": "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis", "volume": "31", "author": "Arnett", "year": "1988", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "964", "DOI": "10.1136/ard.2009.126532", "article-title": "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs", "volume": "69", "author": "Smolen", "year": "2010", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.21641-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/j.rdc.2005.09.005", "article-title": "The definition and measurement of disease modification in inflammatory rheumatic diseases", "volume": "32", "author": "Aletaha", "year": "2006", "journal-title": "Rheum Dis Clin North Am"}, {"key": "10.1002/acr.21641-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "2625", "DOI": "10.1002/art.21235", "article-title": "Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states", "volume": "52", "author": "Aletaha", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.1002/art.1780380602", "article-title": "American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis", "volume": "38", "author": "Felson", "year": "1995", "journal-title": "Arthritis Rheum"}, {"issue": "Suppl", "key": "10.1002/acr.21641-BIB29|cit29", "first-page": "S109", "article-title": "The American College of Rheumatology (ACR) core data set and derivative \u201cpatient only\u201d indices to assess rheumatoid arthritis", "volume": "23", "author": "Pincus", "year": "2005", "journal-title": "Clin Exp Rheumatol"}, {"key": "10.1002/acr.21641-BIB30|cit30", "first-page": "2016", "article-title": "Minimal disease activity for rheumatoid arthritis: a preliminary definition", "volume": "32", "author": "Wells", "year": "2005", "journal-title": "J Rheumatol"}, {"key": "10.1002/acr.21641-BIB31|cit31", "first-page": "2410", "article-title": "A composite disease activity scale for clinical practice, observational studies, and clinical trials: the Patient Activity Scale (PAS/PAS-II)", "volume": "32", "author": "Wolfe", "year": "2005", "journal-title": "J Rheumatol"}, {"key": "10.1002/acr.21641-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "3873", "DOI": "10.1002/art.21494", "article-title": "The Disease Activity Score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes", "volume": "52", "author": "Wolfe", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1007/s10067-006-0275-5", "article-title": "Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA", "volume": "26", "author": "Agrawal", "year": "2007", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/acr.21641-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1007/s10067-006-0343-x", "article-title": "Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study", "volume": "26", "author": "Ates", "year": "2007", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/acr.21641-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1136/ard.2005.041376", "article-title": "Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset", "volume": "65", "author": "Berglin", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.21641-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1136/ard.62.2.120", "article-title": "Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage", "volume": "62", "author": "Meyer", "year": "2003", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.21641-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1136/ard.62.5.427", "article-title": "Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis", "volume": "62", "author": "Vencovsky", "year": "2003", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.21641-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1136/ard.36.1.71", "article-title": "Radiographic changes in early rheumatoid disease", "volume": "36", "author": "Brook", "year": "1977", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.21641-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "954", "DOI": "10.1136/ard.2007.084459", "article-title": "Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate", "volume": "68", "author": "Wells", "year": "2009", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.21641-BIB40|cit40", "first-page": "39", "article-title": "Preventing joint damage as the best measure of biologic drug therapy", "volume": "65", "author": "Bresnihan", "year": "2002", "journal-title": "J Rheumatol Suppl"}, {"key": "10.1002/acr.21641-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1002/art.30129", "article-title": "American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials", "volume": "63", "author": "Felson", "year": "2011", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1016/j.berh.2007.02.005", "article-title": "A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers", "volume": "21", "author": "Pincus", "year": "2007", "journal-title": "Best Pract Res Clin Rheumatol"}, {"key": "10.1002/acr.21641-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "R796", "DOI": "10.1186/ar1740", "article-title": "Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score", "volume": "7", "author": "Aletaha", "year": "2005", "journal-title": "Arthritis Res Ther"}, {"issue": "Suppl", "key": "10.1002/acr.21641-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "S214", "DOI": "10.1002/art.11407", "article-title": "Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI)", "volume": "49", "author": "Fransen", "year": "2003", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.21641-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "244", "DOI": "10.1093/rheumatology/keg072", "article-title": "A simplified disease activity index for rheumatoid arthritis for use in clinical practice", "volume": "42", "author": "Smolen", "year": "2003", "journal-title": "Rheumatology (Oxford)"}], "container-title": ["Arthritis Care & Research"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.21641", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/acr.21641", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 2]], "date-time": "2018-08-02T00:46:02Z", "timestamp": 1533170762000}, "score": 38.963467, "subtitle": ["2012 ACR RA Treatment Recommendations"], "issued": {"date-parts": [[2012, 4, 2]]}, "references-count": 45, "journal-issue": {"published-print": {"date-parts": [[2012, 5]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1002/acr.21641", "relation": {"cites": []}, "ISSN": ["2151-464X"], "issn-type": [{"value": "2151-464X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T08:24:44Z", "timestamp": 1574583884672}, "reference-count": 27, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 99, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100000133", "name": "Agency for Healthcare Research and Quality", "doi-asserted-by": "publisher", "award": ["5R01HS018517"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis & Rheumatology"], "published-print": {"date-parts": [[2015, 6]]}, "DOI": "10.1002/art.39075", "type": "journal-article", "created": {"date-parts": [[2015, 2, 23]], "date-time": "2015-02-23T16:17:53Z", "timestamp": 1424708273000}, "page": "1456-1464", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Risk of Hospitalized Infection Among Rheumatoid Arthritis Patients Concurrently Treated With a Biologic Agent and Denosumab"], "prefix": "10.1002", "volume": "67", "author": [{"given": "Jeffrey R.", "family": "Curtis", "sequence": "first", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Fenglong", "family": "Xie", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Huifeng", "family": "Yun", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Lang", "family": "Chen", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Elizabeth", "family": "Delzell", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}], "member": "311", "published-online": {"date-parts": [[2015, 5, 25]]}, "reference": [{"key": "10.1002/art.39075-BIB0001|art39075-cit-0001", "doi-asserted-by": "crossref", "first-page": "756", "DOI": "10.1056/NEJMoa0809493", "article-title": "Denosumab for prevention of fractures in postmenopausal women with osteoporosis", "volume": "361", "author": "Cummings", "year": "2009", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.39075-BIB0002|art39075-cit-0002", "doi-asserted-by": "crossref", "first-page": "687", "DOI": "10.1002/jbmr.1472", "article-title": "Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures", "volume": "27", "author": "Austin", "year": "2012", "journal-title": "J Bone Miner Res"}, {"key": "10.1002/art.39075-BIB0003|art39075-cit-0003", "doi-asserted-by": "crossref", "first-page": "1727", "DOI": "10.1210/jc.2010-2784", "article-title": "Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk", "volume": "96", "author": "Boonen", "year": "2011", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1002/art.39075-BIB0004|art39075-cit-0004", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1002/jbmr.536", "article-title": "Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis", "volume": "27", "author": "McClung", "year": "2012", "journal-title": "J Bone Miner Res"}, {"key": "10.1002/art.39075-BIB0005|art39075-cit-0005", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1016/j.rdc.2011.07.004", "article-title": "The RANKL pathway and denosumab", "volume": "37", "author": "Dore", "year": "2011", "journal-title": "Rheum Dis Clin North Am"}, {"key": "10.1002/art.39075-BIB0006|art39075-cit-0006", "doi-asserted-by": "crossref", "first-page": "872", "DOI": "10.1136/ard.2009.112920", "article-title": "Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates", "volume": "69", "author": "Dore", "year": "2010", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.39075-BIB0007|art39075-cit-0007", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1007/s00198-011-1755-2", "article-title": "Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?", "volume": "23", "author": "Watts", "year": "2012", "journal-title": "Osteoporos Int"}, {"key": "10.1002/art.39075-BIB0008|art39075-cit-0008", "doi-asserted-by": "crossref", "first-page": "1412", "DOI": "10.1002/art.20221", "article-title": "Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate", "volume": "50", "author": "Genovese", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39075-BIB0009|art39075-cit-0009", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1136/ard.2006.055111", "article-title": "Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial", "volume": "66", "author": "Weinblatt", "year": "2007", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.39075-BIB0010|art39075-cit-0010", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1002/acr.21641", "article-title": "2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis", "volume": "64", "author": "Singh", "year": "2012", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/art.39075-BIB0011|art39075-cit-0011", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.3899/jrheum.120924", "article-title": "Safety of rituximab in combination with other biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: an open-label study", "volume": "40", "author": "Rigby", "year": "2013", "journal-title": "J Rheumatol"}, {"key": "10.1002/art.39075-BIB0012|art39075-cit-0012", "doi-asserted-by": "crossref", "first-page": "1299", "DOI": "10.1002/art.23417", "article-title": "Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial", "volume": "58", "author": "Cohen", "year": "2008", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39075-BIB0013|art39075-cit-0013", "doi-asserted-by": "crossref", "first-page": "1480", "DOI": "10.1002/acr.21805", "article-title": "Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients", "volume": "64", "author": "Curtis", "year": "2012", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/art.39075-BIB0014|art39075-cit-0014", "doi-asserted-by": "crossref", "first-page": "262", "DOI": "10.1093/aje/kwj047", "article-title": "Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect", "volume": "163", "author": "Kurth", "year": "2006", "journal-title": "Am J Epidemiol"}, {"key": "10.1002/art.39075-BIB0015|art39075-cit-0015", "doi-asserted-by": "crossref", "first-page": "1214", "DOI": "10.1002/pds.3475", "article-title": "Identifying newly approved medications in Medicare claims data: a case study using tocilizumab", "volume": "22", "author": "Curtis", "year": "2013", "journal-title": "Pharmacoepidemiol Drug Saf"}, {"key": "10.1002/art.39075-BIB0016|art39075-cit-0016", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1016/j.jclinepi.2008.06.006", "article-title": "Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients", "volume": "62", "author": "Patkar", "year": "2009", "journal-title": "J Clin Epidemiol"}, {"key": "10.1002/art.39075-BIB0017|art39075-cit-0017", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1016/j.jclinepi.2006.07.011", "article-title": "Veteran's affairs hospital discharge databases coded serious bacterial infections accurately", "volume": "60", "author": "Schneeweiss", "year": "2007", "journal-title": "J Clin Epidemiol"}, {"key": "10.1002/art.39075-BIB0018|art39075-cit-0018", "doi-asserted-by": "crossref", "first-page": "1125", "DOI": "10.1002/art.22504", "article-title": "Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor \u03b1 antagonists", "volume": "56", "author": "Curtis", "year": "2007", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39075-BIB0019|art39075-cit-0019", "doi-asserted-by": "crossref", "first-page": "1228", "DOI": "10.1080/03610910902859574", "article-title": "Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research", "volume": "38", "author": "Austin", "year": "2009", "journal-title": "Commun Stat Simulat Comput"}, {"key": "10.1002/art.39075-BIB0020|art39075-cit-0020", "doi-asserted-by": "crossref", "first-page": "895", "DOI": "10.1136/annrheumdis-2012-201338", "article-title": "Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry", "volume": "72", "author": "Dartel", "year": "2013", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.39075-BIB0021|art39075-cit-0021", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1093/biomet/80.3.557", "article-title": "Checking the Cox model with cumulative sums of Martingale-based residuals", "volume": "80", "author": "Lin", "year": "1993", "journal-title": "Biometrika"}, {"key": "10.1002/art.39075-BIB0022|art39075-cit-0022", "doi-asserted-by": "crossref", "first-page": "2331", "DOI": "10.1001/jama.2011.1692", "article-title": "Initiation of tumor necrosis factor-\u03b1 antagonists and the risk of hospitalization for infection in patients with autoimmune diseases", "volume": "306", "author": "Grijalva", "year": "2011", "journal-title": "JAMA"}, {"key": "10.1002/art.39075-BIB0023|art39075-cit-0023", "author": "Yun", "article-title": "Comparative risk of hospitalized infection associated with biological agents among Medicare rheumatoid arthritis patients", "journal-title": "Submitted for publication."}, {"key": "10.1002/art.39075-BIB0024|art39075-cit-0024", "unstructured": "http://clinicaltrials.gov/show/NCT01575873"}, {"key": "10.1002/art.39075-BIB0025|art39075-cit-0025", "first-page": "1054", "article-title": "Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population", "volume": "64", "author": "Curtis", "year": "2012", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/art.39075-BIB0026|art39075-cit-0026", "doi-asserted-by": "crossref", "first-page": "2896", "DOI": "10.1002/art.22808", "article-title": "on behalf of the British Society for Rheumatology Biologics Register. Serious infection following anti-tumor necrosis factor \u03b1 therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies", "volume": "56", "author": "Dixon", "year": "2007", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39075-BIB0027|art39075-cit-0027", "doi-asserted-by": "crossref", "first-page": "4226", "DOI": "10.1002/art.23050", "article-title": "Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor \u03b1 antagonists", "volume": "56", "author": "Curtis", "year": "2007", "journal-title": "Arthritis Rheum"}], "container-title": ["Arthritis & Rheumatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39075", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T06:04:56Z", "timestamp": 1498197896000}, "score": 38.8039, "subtitle": ["CONCOMITANT DENOSUMAB AND A BIOLOGIC AGENT FOR RA"], "issued": {"date-parts": [[2015, 5, 25]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2015, 6]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1002/art.39075", "relation": {"cites": []}, "ISSN": ["2326-5191"], "issn-type": [{"value": "2326-5191", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T21:29:55Z", "timestamp": 1574544595029}, "reference-count": 20, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 130, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100000133", "name": "Agency for Healthcare Research and Quality", "doi-asserted-by": "crossref", "award": ["R01-HS-8517", "1 K12-HS-1694"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis Care & Research"], "published-print": {"date-parts": [[2015, 5]]}, "DOI": "10.1002/acr.22470", "type": "journal-article", "created": {"date-parts": [[2014, 9, 8]], "date-time": "2014-09-08T19:58:04Z", "timestamp": 1410206284000}, "page": "731-736", "source": "Crossref", "is-referenced-by-count": 47, "title": ["Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease-Modifying Therapy"], "prefix": "10.1002", "volume": "67", "author": [{"given": "Huifeng", "family": "Yun", "sequence": "first", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Fenglong", "family": "Xie", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Elizabeth", "family": "Delzell", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Lang", "family": "Chen", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Emily B.", "family": "Levitan", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "James D.", "family": "Lewis", "sequence": "additional", "affiliation": [{"name": "University of Pennsylvania; Philadelphia"}]}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Timothy", "family": "Beukelman", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Kevin", "family": "Winthrop", "sequence": "additional", "affiliation": [{"name": "Oregon Health and Science University; Portland"}]}, {"given": "John W.", "family": "Baddley", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Jeffrey R.", "family": "Curtis", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}], "member": "311", "published-online": {"date-parts": [[2015, 4, 24]]}, "reference": [{"key": "10.1002/acr.22470-BIB0001|acr22470-cit-0001", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1056/NEJMcp1302674", "article-title": "Clinical practice: herpes zoster", "volume": "369", "author": "Cohen", "year": "2013", "journal-title": "N Engl J Med"}, {"key": "10.1002/acr.22470-BIB0002|acr22470-cit-0002", "doi-asserted-by": "crossref", "first-page": "737", "DOI": "10.1001/jama.2009.146", "article-title": "Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-\u03b1 agents", "volume": "301", "author": "Strangfeld", "year": "2009", "journal-title": "JAMA"}, {"key": "10.1002/acr.22470-BIB0003|acr22470-cit-0003", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.4065/84.9.787", "article-title": "Health care utilization and cost burden of herpes zoster in a community population", "volume": "84", "author": "Yawn", "year": "2009", "journal-title": "Mayo Clin Proc"}, {"key": "10.1002/acr.22470-BIB0004|acr22470-cit-0004", "doi-asserted-by": "crossref", "first-page": "1341", "DOI": "10.4065/82.11.1341", "article-title": "A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction", "volume": "82", "author": "Yawn", "year": "2007", "journal-title": "Mayo Clin Proc"}, {"key": "10.1002/acr.22470-BIB0005|acr22470-cit-0005", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1056/NEJMcp013211", "article-title": "Clinical practice: herpes zoster", "volume": "347", "author": "Gnann", "year": "2002", "journal-title": "N Engl J Med"}, {"key": "10.1002/acr.22470-BIB0006|acr22470-cit-0006", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1136/annrheumdis-2011-201108", "article-title": "Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register", "volume": "72", "author": "Galloway", "year": "2013", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.22470-BIB0007|acr22470-cit-0007", "doi-asserted-by": "crossref", "first-page": "R32", "DOI": "10.1186/ar3260", "article-title": "Validation of rheumatoid arthritis diagnoses in health care utilization data", "volume": "13", "author": "Kim", "year": "2011", "journal-title": "Arthritis Res Ther"}, {"key": "10.1002/acr.22470-BIB0008|acr22470-cit-0008", "first-page": "S106", "article-title": "Positive predictive value (PPV) of an administrative data-based algorithm for the identification of patients with rheumatoid arthritis (RA) [abstract]", "volume": "44", "author": "MacLean", "year": "2001", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.22470-BIB0009|acr22470-cit-0009", "doi-asserted-by": "crossref", "first-page": "952", "DOI": "10.1002/art.20827", "article-title": "Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis", "volume": "51", "author": "Singh", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.22470-BIB0010|acr22470-cit-0010", "doi-asserted-by": "crossref", "first-page": "2331", "DOI": "10.1001/jama.2011.1692", "article-title": "Initiation of tumor necrosis factor-\u03b1 antagonists and the risk of hospitalization for infection in patients with autoimmune diseases", "volume": "306", "author": "Grijalva", "year": "2011", "journal-title": "JAMA"}, {"key": "10.1002/acr.22470-BIB0011|acr22470-cit-0011", "doi-asserted-by": "crossref", "first-page": "1605", "DOI": "10.1001/archinte.1995.00430150071008", "article-title": "The incidence of herpes zoster", "volume": "155", "author": "Donahue", "year": "1995", "journal-title": "Arch Intern Med"}, {"key": "10.1002/acr.22470-BIB0012|acr22470-cit-0012", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1017/S095026880400281X", "article-title": "Incidence of herpes zoster, 1997-2002", "volume": "133", "author": "Mullooly", "year": "2005", "journal-title": "Epidemiol Infect"}, {"key": "10.1002/acr.22470-BIB0013|acr22470-cit-0013", "doi-asserted-by": "crossref", "first-page": "887", "DOI": "10.1001/jama.2013.1099", "article-title": "Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster", "volume": "309", "author": "Winthrop", "year": "2013", "journal-title": "JAMA"}, {"key": "10.1002/acr.22470-BIB0014|acr22470-cit-0014", "first-page": "27", "article-title": "More accurate racial and ethnic codes for Medicare administrative data", "volume": "29", "author": "Eicheldinger", "year": "2008", "journal-title": "Health Care Financ Rev"}, {"key": "10.1002/acr.22470-BIB0015|acr22470-cit-0015", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1001/jama.2012.7304", "article-title": "Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases", "volume": "308", "author": "Zhang", "year": "2012", "journal-title": "JAMA"}, {"key": "10.1002/acr.22470-BIB0016|acr22470-cit-0016", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1111/j.1756-185X.2012.01715.x", "article-title": "Lack of adverse effect of anti-tumor necrosis factor-\u03b1 biologics in treatment of rheumatoid arthritis: 5 years follow-up", "volume": "15", "author": "Dewedar", "year": "2012", "journal-title": "Int J Rheum Dis"}, {"key": "10.1002/acr.22470-BIB0017|acr22470-cit-0017", "unstructured": "Centers for Disease Control and Prevention. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6104a2.htm"}, {"key": "10.1002/acr.22470-BIB0018|acr22470-cit-0018", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1002/acr.21641", "article-title": "2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis", "volume": "64", "author": "Singh", "year": "2012", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/acr.22470-BIB0019|acr22470-cit-0019", "doi-asserted-by": "crossref", "first-page": "2053", "DOI": "10.1002/jmv.21599", "article-title": "Epidemiology of herpes zoster and its relationship to varicella in Japan: a 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture", "volume": "81", "author": "Toyama", "year": "2009", "journal-title": "J Med Virol"}, {"key": "10.1002/acr.22470-BIB0020|acr22470-cit-0020", "doi-asserted-by": "crossref", "first-page": "e1001420", "DOI": "10.1371/journal.pmed.1001420", "article-title": "Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study", "volume": "10", "author": "Langan", "year": "2013", "journal-title": "PLoS Med"}], "container-title": ["Arthritis Care & Research"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.22470", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/acr.22470", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T21:52:17Z", "timestamp": 1533505937000}, "score": 38.23227, "subtitle": ["Herpes Zoster in RA Patients Taking Biologic Agents"], "issued": {"date-parts": [[2015, 4, 24]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[2015, 5]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1002/acr.22470", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["2151-464X"], "issn-type": [{"value": "2151-464X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T18:47:48Z", "timestamp": 1574275668879}, "reference-count": 13, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3165, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis Rheum"], "published-print": {"date-parts": [[2007, 3, 15]]}, "DOI": "10.1002/art.22544", "type": "journal-article", "created": {"date-parts": [[2007, 2, 28]], "date-time": "2007-02-28T23:50:12Z", "timestamp": 1172706612000}, "page": "343-346", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor \u03b1 antagonists and disease-modifying antirheumatic drugs"], "prefix": "10.1002", "volume": "57", "author": [{"given": "J. R.", "family": "Curtis", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Martin", "sequence": "additional", "affiliation": []}, {"given": "K. G.", "family": "Saag", "sequence": "additional", "affiliation": []}, {"given": "N. M.", "family": "Patkar", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Kramer", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Shatin", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Allison", "sequence": "additional", "affiliation": []}, {"given": "M. M.", "family": "Braun", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2007]]}, "reference": [{"key": "10.1002/art.22544-BIB1", "author": "Keane", "volume": "345", "first-page": "1098", "year": "2001", "journal-title": "New Engl J Med", "DOI": "10.1056/NEJMoa011110", "doi-asserted-by": "crossref"}, {"key": "10.1002/art.22544-BIB2", "author": "Bergstrom", "volume": "50", "first-page": "1959", "year": "2004", "journal-title": "Arthritis Rheum", "DOI": "10.1002/art.20454", "doi-asserted-by": "crossref"}, {"key": "10.1002/art.22544-BIB3", "author": "Seddik", "volume": "10", "first-page": "436", "year": "2004", "journal-title": "Inflamm Bowel Dis", "DOI": "10.1097/00054725-200407000-00017", "doi-asserted-by": "crossref"}, {"key": "10.1002/art.22544-BIB4", "author": "Velayos", "volume": "10", "first-page": "657", "year": "2004", "journal-title": "Inflamm Bowel Dis", "DOI": "10.1097/00054725-200409000-00025", "doi-asserted-by": "crossref"}, {"key": "10.1002/art.22544-BIB5", "author": "Shatin", "year": "2005", "unstructured": ", . UnitedHealthGroup. In: editor. Pharmacoepidemiology. 4th ed. West Sussex: John Wiley & Sons; 2005.", "volume-title": "Pharmacoepidemiology"}, {"key": "10.1002/art.22544-BIB6", "author": "Kiyota", "volume": "148", "first-page": "99", "year": "2004", "journal-title": "Am Heart J", "DOI": "10.1016/j.ahj.2004.02.013", "doi-asserted-by": "crossref"}, {"key": "10.1002/art.22544-BIB7", "author": "West", "year": "2005", "unstructured": ", . Validity of pharmacoepidemiologic drug and diagnosis data. In: editor. Pharmacoepidemiology. 4th ed. West Sussex: John Wiley & Sons; 2005.", "volume-title": "Pharmacoepidemiology"}, {"key": "10.1002/art.22544-BIB8", "author": "Choquette", "volume": "52", "first-page": "s349", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.22544-BIB9", "author": "Smitten", "volume": "50", "first-page": "s478", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.22544-BIB10", "author": "Metlay", "volume": "12", "first-page": "s163", "year": "2003", "journal-title": "Pharmacoepidemiol Drug Saf", "DOI": "10.1002/pds.772", "doi-asserted-by": "crossref"}, {"key": "10.1002/art.22544-BIB11", "author": "Leveille", "volume": "53", "first-page": "1069", "year": "2000", "journal-title": "J Clin Epidemiol", "DOI": "10.1016/S0895-4356(00)00235-3", "doi-asserted-by": "crossref"}, {"key": "10.1002/art.22544-BIB12", "author": "Sands", "volume": "179", "first-page": "434", "year": "1999", "journal-title": "J Infect Dis", "DOI": "10.1086/314586", "doi-asserted-by": "crossref"}, {"key": "10.1002/art.22544-BIB13", "author": "Yokoe", "volume": "10", "first-page": "1426", "year": "2004", "journal-title": "Emerg Infect Dis", "DOI": "10.3201/eid1008.031075", "doi-asserted-by": "crossref"}], "container-title": ["Arthritis & Rheumatism"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.22544", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/art.22544", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 18]], "date-time": "2019-01-18T03:21:14Z", "timestamp": 1547781674000}, "score": 35.49417, "issued": {"date-parts": [[2007]]}, "references-count": 13, "journal-issue": {"published-print": {"date-parts": [[2007, 3, 15]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1002/art.22544", "relation": {"cites": []}, "ISSN": ["0004-3591", "1529-0131"], "issn-type": [{"value": "0004-3591", "type": "print"}, {"value": "1529-0131", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:43:05Z", "timestamp": 1574296985841}, "reference-count": 11, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2006, 2, 1]], "date-time": "2006-02-01T00:00:00Z", "timestamp": 1138752000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Curr Rheumatol Rep"], "published-print": {"date-parts": [[2006, 2]]}, "DOI": "10.1007/s11926-006-0025-3", "type": "journal-article", "created": {"date-parts": [[2007, 6, 2]], "date-time": "2007-06-02T15:40:23Z", "timestamp": 1180798823000}, "page": "48-49", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Low- dose prednisolone in early rheumatoid arthritis"], "prefix": "10.1007", "volume": "8", "author": [{"given": "Raj", "family": "Nair", "sequence": "first", "affiliation": []}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "25_CR1", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1001/archinte.1950.00230100002001", "volume": "85", "author": "PS Hench", "year": "1950", "unstructured": "Hench PS, Kendall EC, Slocumb CH, Polley HF: Effects of cortisone acetate and pituitar y ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Med Interna 1950, 85:545\u2013666.", "journal-title": "Arch Med Interna"}, {"key": "25_CR2", "author": "K Saag", "year": "2001", "unstructured": "Saag K, Kirwan J: Glucocorticoid therapy in rheumatoid arthritis. In Modern Therapeutics in Rheumatic Diseases. Edited by Tsokos GC. Totowa, NJ: Humana Press, Inc.; 2001.", "volume-title": "Modern Therapeutics in Rheumatic Diseases"}, {"key": "25_CR3", "first-page": "1666", "volume": "20", "author": "BA Michel", "year": "1993", "unstructured": "Michel BA, Bloch DA, Wolfe F, Fries J: Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheum 1993, 20:1666\u20131669.", "journal-title": "J Rheum"}, {"key": "25_CR4", "doi-asserted-by": "crossref", "first-page": "797", "DOI": "10.1136/ard.2003.014050", "volume": "63", "author": "HA Capell", "year": "2004", "unstructured": "Capell HA, Madhok R, Hunter JA, et al.: Lack of radiological and clinical bene.t over two years of low dose prednisolone for rheumatoid arthritis: results of a randomized, controlled trial. Ann Rheum Dis 2004, 63:797\u2013803.", "journal-title": "Ann Rheum Dis"}, {"key": "25_CR5", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1056/NEJM199507203330302", "volume": "333", "author": "JR Kirwan", "year": "1995", "unstructured": "Kirwan JR: The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-dose Glucocorticoid Study Group. N Engl J Med 1995, 333:142\u2013146.", "journal-title": "N Engl J Med"}, {"issue": "suppl 2", "key": "25_CR6", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1007/s003930070026", "volume": "59", "author": "R Rau", "year": "2000", "unstructured": "Rau R, Wassenberg S, Zeidler H: Low-dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis: preliminary results of a multicenter, randomized, parallel, doubleblind study. Z Rheumatol 2000, 59(suppl 2):90\u201396.", "journal-title": "Z Rheumatol"}, {"key": "25_CR7", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.7326/0003-4819-136-1-200201010-00006", "volume": "136", "author": "AA Everdingenm van", "year": "2002", "unstructured": "van Everdingenm AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW: Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, diseasemodifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002, 136:1\u201312.", "journal-title": "Ann Intern Med"}, {"key": "25_CR8", "first-page": "155", "volume": "21", "author": "AA Everdingenm van", "year": "2003", "unstructured": "van Everdingenm AA, Siewertsz van Reesema DR, Jacobs JW, Bijlsma JW: Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures? Clin Exp Rheumatol 2003, 21:155\u2013160.", "journal-title": "Clin Exp Rheumatol"}, {"key": "25_CR9", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/S0140-6736(97)01300-7", "volume": "350", "author": "M Boers", "year": "1997", "unstructured": "Boers M, Verhoeven AC, Markusse HM, et al.: Randomised comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone in early rheumatoid arthritis. Lancet 1997, 350:309\u2013318.", "journal-title": "Lancet"}, {"key": "25_CR10", "doi-asserted-by": "crossref", "first-page": "1033", "DOI": "10.1136/ard.62.11.1033", "volume": "62", "author": "JW Bijlsma", "year": "2003", "unstructured": "Bijlsma JW, Boers M, Saag KG, Furst DE: Glucocorticoids in the treatment of early and late R A. Ann Rheum Dis 2003, 62:1033\u20131037.", "journal-title": "Ann Rheum Dis"}, {"key": "25_CR11", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1172/JCI2799", "volume": "102", "author": "RS Weinstein", "year": "1998", "unstructured": "Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC: Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblast and osteocytes by glucocorticoids. J Clin Invest 1998, 102:274\u2013282.", "journal-title": "J Clin Invest"}], "container-title": ["Current Rheumatology Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s11926-006-0025-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s11926-006-0025-3/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11926-006-0025-3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 2]], "date-time": "2019-06-02T00:47:18Z", "timestamp": 1559436438000}, "score": 34.868492, "issued": {"date-parts": [[2006, 2]]}, "references-count": 11, "journal-issue": {"published-print": {"date-parts": [[2006, 2]]}, "issue": "1"}, "alternative-id": ["25"], "URL": "http://dx.doi.org/10.1007/s11926-006-0025-3", "relation": {"cites": []}, "ISSN": ["1523-3774", "1534-6307"], "issn-type": [{"value": "1523-3774", "type": "print"}, {"value": "1534-6307", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T19:04:39Z", "timestamp": 1574881479396}, "reference-count": 97, "publisher": "Springer Science and Business Media LLC", "issue": "7", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T00:00:00Z", "timestamp": 1558569600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Curr Rheumatol Rep"], "published-print": {"date-parts": [[2019, 7]]}, "DOI": "10.1007/s11926-019-0836-7", "type": "journal-article", "created": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T07:02:20Z", "timestamp": 1558594940000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis"], "prefix": "10.1007", "volume": "21", "author": [{"given": "Giovanni", "family": "Adami", "sequence": "first", "affiliation": []}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2019, 5, 23]]}, "reference": [{"key": "836_CR1", "doi-asserted-by": "crossref", "first-page": "2205", "DOI": "10.1056/NEJMra1004965", "volume": "365", "author": "IB McInnes", "year": "2011", "unstructured": "McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u201319.", "journal-title": "N Engl J Med"}, {"key": "836_CR2", "doi-asserted-by": "crossref", "first-page": "2118", "DOI": "10.1002/jbmr.2221", "volume": "29", "author": "TY Zhu", "year": "2014", "unstructured": "Zhu TY, Griffith JF, Qin L, Hung VW, Fong T-N, Au S-K, et al. Alterations of bone density, microstructure, and strength of the distal radius in male patients with rheumatoid arthritis: a case-control study with HR-pQCT. J Bone Miner Res Off J Am Soc Bone Miner Res. 2014;29:2118\u201329.", "journal-title": "J Bone Miner Res Off J Am Soc Bone Miner Res"}, {"key": "836_CR3", "first-page": "330", "volume": "62", "author": "CM Stach", "year": "2010", "unstructured": "Stach CM, B\u00e4uerle M, Englbrecht M, Kronke G, Engelke K, Manger B, et al. Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography. Arthritis Rheum. 2010;62:330\u20139.", "journal-title": "Arthritis Rheum"}, {"key": "836_CR4", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1186/s13075-017-1403-0", "volume": "19", "author": "M Ziegelasch", "year": "2017", "unstructured": "Ziegelasch M, Forslind K, Skogh T, Riklund K, Kastbom A, Berglin E. Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year. Arthritis Res Ther. 2017;19:195.", "journal-title": "Arthritis Res Ther"}, {"key": "836_CR5", "first-page": "1080", "volume": "68", "author": "WP Nieuwenhuis", "year": "2016", "unstructured": "Nieuwenhuis WP, van Steenbergen HW, Stomp W, Stijnen T, Huizinga TWJ, Bloem JL, et al. The course of bone marrow edema in early undifferentiated arthritis and rheumatoid arthritis: a longitudinal magnetic resonance imaging study at bone level. Arthritis Rheumatol Hoboken NJ. 2016;68:1080\u20138.", "journal-title": "Arthritis Rheumatol Hoboken NJ."}, {"key": "836_CR6", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1002/acr.22199", "volume": "66", "author": "RJ Black", "year": "2014", "unstructured": "Black RJ, Spargo L, Schultz C, Chatterton B, Cleland L, Lester S, et al. Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis. Arthritis Care Res. 2014;66:515\u201322.", "journal-title": "Arthritis Care Res"}, {"key": "836_CR7", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1080/03009742.2017.1299217", "volume": "46", "author": "L Mangnus", "year": "2017", "unstructured": "Mangnus L, van Steenbergen HW, Reijnierse M, K\u00e4lvesten J, van der Helm-Van Mil A. Bone mineral density loss in clinically suspect arthralgia is associated with subclinical inflammation and progression to clinical arthritis. Scand J Rheumatol. 2017;46:364\u20138.", "journal-title": "Scand J Rheumatol"}, {"key": "836_CR8", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1186/s13075-015-0753-8", "volume": "17", "author": "G Kato", "year": "2015", "unstructured": "Kato G, Shimizu Y, Arai Y, Suzuki N, Sugamori Y, Maeda M, et al. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study. Arthritis Res Ther. 2015;17:251.", "journal-title": "Arthritis Res Ther."}, {"key": "836_CR9", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.3389/fimmu.2018.00095", "volume": "9", "author": "J Fessler", "year": "2018", "unstructured": "Fessler J, Husic R, Schwetz V, Lerchbaum E, Aberer F, Fasching P, et al. Senescent T-cells promote bone loss in rheumatoid arthritis. Front Immunol. 2018;9:95.", "journal-title": "Front Immunol"}, {"key": "836_CR10", "doi-asserted-by": "crossref", "first-page": "2151", "DOI": "10.1136/annrheumdis-2014-205428", "volume": "74", "author": "C Hecht", "year": "2015", "unstructured": "Hecht C, Englbrecht M, Rech J, Schmidt S, Araujo E, Engelke K, et al. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis. 2015;74:2151\u20136.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR11", "doi-asserted-by": "crossref", "first-page": "1681", "DOI": "10.1002/jbmr.3158", "volume": "32", "author": "C Engdahl", "year": "2017", "unstructured": "Engdahl C, Bang H, Dietel K, Lang SC, Harre U, Schett G. Periarticular bone loss in arthritis is induced by autoantibodies against citrullinated vimentin. J Bone Miner Res Off J Am Soc Bone Miner Res. 2017;32:1681\u201391.", "journal-title": "J Bone Miner Res Off J Am Soc Bone Miner Res"}, {"key": "836_CR12", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1016/j.bone.2018.07.017", "volume": "116", "author": "D Simon", "year": "2018", "unstructured": "Simon D, Kleyer A, Englbrecht M, Stemmler F, Simon C, Berlin A, et al. A comparative analysis of articular bone in large cohort of patients with chronic inflammatory diseases of the joints, the gut and the skin. Bone. 2018;116:87\u201393.", "journal-title": "Bone."}, {"key": "836_CR13", "doi-asserted-by": "crossref", "first-page": "1791", "DOI": "10.1093/rheumatology/kew229", "volume": "55", "author": "F Behrens", "year": "2016", "unstructured": "Behrens F, Koehm M, Tha\u00e7i D, Gnann H, Greger G, Maria Wittig B, et al. Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis. Rheumatol Oxf Engl. 2016;55:1791\u20135.", "journal-title": "Rheumatol Oxf Engl"}, {"key": "836_CR14", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1007/s11926-013-0366-7", "volume": "15", "author": "R Kocijan", "year": "2013", "unstructured": "Kocijan R, Harre U, Schett G. ACPA and bone loss in rheumatoid arthritis. Curr Rheumatol Rep. 2013;15:366.", "journal-title": "Curr Rheumatol Rep"}, {"key": "836_CR15", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1136/annrheumdis-2015-208093", "volume": "75", "author": "A Krishnamurthy", "year": "2016", "unstructured": "Krishnamurthy A, Joshua V, Haj Hensvold A, Jin T, Sun M, Vivar N, et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis. 2016;75:721\u20139.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR16", "doi-asserted-by": "crossref", "first-page": "854", "DOI": "10.1136/annrheumdis-2012-202958", "volume": "73", "author": "A Kleyer", "year": "2014", "unstructured": "\u2022\u2022 Kleyer A, Finzel S, Rech J, Manger B, Krieter M, Faustini F, et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis. 2014;73:854\u201360. This article provides evidence on the independent activity of ACPA on bone health. The authors found that bone loss ACPA-positive patients experience bone loss even before the onset of clinical RA.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR17", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1186/1471-2474-15-289", "volume": "15", "author": "G Haugeberg", "year": "2014", "unstructured": "Haugeberg G, Helgetveit KB, F\u00f8rre \u00d8, Garen T, Sommerseth H, Pr\u00f8ven A. Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era. BMC Musculoskelet Disord. 2014;15:289.", "journal-title": "BMC Musculoskelet Disord"}, {"key": "836_CR18", "doi-asserted-by": "crossref", "first-page": "684", "DOI": "10.1038/nrrheum.2012.167", "volume": "8", "author": "H Takayanagi", "year": "2012", "unstructured": "Takayanagi H. New developments in osteoimmunology. Nat Rev Rheumatol. 2012;8:684\u20139.", "journal-title": "Nat Rev Rheumatol"}, {"key": "836_CR19", "doi-asserted-by": "crossref", "first-page": "1631", "DOI": "10.1136/annrheumdis-2014-207219", "volume": "74", "author": "B Hauser", "year": "2015", "unstructured": "Hauser B, Riches PL, Gilchrist T, Visconti MR, Wilson JF, Ralston SH. Autoantibodies to osteoprotegerin are associated with increased bone resorption in rheumatoid arthritis. Ann Rheum Dis. 2015;74:1631\u20132.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR20", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1038/nm1538", "volume": "13", "author": "D Diarra", "year": "2007", "unstructured": "\u2022\u2022 Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007;13:156\u201363. This important pre-clinical paper provides evidence on the crucial role of Dkk-1 in bone loss and bone erosions.", "journal-title": "Nat Med"}, {"key": "836_CR21", "first-page": "77", "volume": "33", "author": "M Rossini", "year": "2015", "unstructured": "Rossini M, Viapiana O, Adami S, Fracassi E, Idolazzi L, Dartizio C, et al. In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density. Clin Exp Rheumatol. 2015;33:77\u201383.", "journal-title": "Clin Exp Rheumatol"}, {"key": "836_CR22", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/j.intimp.2018.04.019", "volume": "59", "author": "Y Ma", "year": "2018", "unstructured": "Ma Y, Zhang X, Wang M, Xia Q, Yang J, Wu M, et al. The serum level of Dickkopf-1 in patients with rheumatoid arthritis: a systematic review and meta-analysis. Int Immunopharmacol. 2018;59:227\u201332.", "journal-title": "Int Immunopharmacol"}, {"key": "836_CR23", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1007/s00223-017-0253-8", "volume": "101", "author": "G Orsolini", "year": "2017", "unstructured": "Orsolini G, Caimmi C, Viapiana O, Idolazzi L, Fracassi E, Gatti D, et al. Titer-dependent effect of anti-citrullinated protein antibodies on systemic bone mass in rheumatoid arthritis patients. Calcif Tissue Int. 2017;101:17\u201323.", "journal-title": "Calcif Tissue Int"}, {"key": "836_CR24", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1007/s11657-018-0424-x", "volume": "13", "author": "MA Amiche", "year": "2018", "unstructured": "Amiche MA, Abtahi S, Driessen JHM, Vestergaard P, de Vries F, Cadarette SM, et al. Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study. Arch Osteoporos. 2018;13:30.", "journal-title": "Arch Osteoporos"}, {"key": "836_CR25", "doi-asserted-by": "crossref", "first-page": "1709", "DOI": "10.1007/s00198-015-3455-9", "volume": "27", "author": "MA Amiche", "year": "2016", "unstructured": "Amiche MA, Albaum JM, Tadrous M, Pechlivanoglou P, L\u00e9vesque LE, Adachi JD, et al. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2016;27:1709\u201318.", "journal-title": "Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA."}, {"key": "836_CR26", "doi-asserted-by": "crossref", "first-page": "1881", "DOI": "10.1002/jbmr.3523", "volume": "33", "author": "A Balasubramanian", "year": "2018", "unstructured": "Balasubramanian A, Wade SW, Adler RA, Saag K, Pannacciulli N, Curtis JR. Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions. J Bone Miner Res Off J Am Soc Bone Miner Res. 2018;33:1881\u20138.", "journal-title": "J Bone Miner Res Off J Am Soc Bone Miner Res"}, {"key": "836_CR27", "doi-asserted-by": "crossref", "first-page": "3239", "DOI": "10.1007/s00198-016-3646-z", "volume": "27", "author": "A Balasubramanian", "year": "2016", "unstructured": "\u2022 Balasubramanian A, Wade SW, Adler RA, Lin CJF, Maricic M, O\u2019Malley CD, et al. Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2016;27:3239\u201349. This is a cross-sectional study on fracture risk associated with glucocorticoid use in RA patients. The authors found an increased risk of fracture among young and newly diagnosed RA patients. The fracture risk was directly related to daily and cumulative dose of glucocorticoids.", "journal-title": "Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"}, {"key": "836_CR28", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1136/ard.2005.038638", "volume": "65", "author": "JAP Silva Da", "year": "2006", "unstructured": "Da Silva JAP, Jacobs JWG, Kirwan JR, Boers M, Saag KG, In\u00eas LBS, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006;65:285\u201393.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR29", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1136/ard.45.11.950", "volume": "45", "author": "PN Sambrook", "year": "1986", "unstructured": "Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Eberl S, Champion GD. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis. 1986;45:950\u20133.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR30", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1016/j.bone.2018.06.008", "volume": "114", "author": "A-BG Blavnsfeldt", "year": "2018", "unstructured": "Blavnsfeldt A-BG, de Thurah A, Thomsen MD, Tarp S, Langdahl B, Hauge E-M. The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized, controlled trials. Bone. 2018;114:172\u201380.", "journal-title": "Bone."}, {"key": "836_CR31", "doi-asserted-by": "crossref", "first-page": "754", "DOI": "10.1002/acr.22519", "volume": "67", "author": "S Siu", "year": "2015", "unstructured": "Siu S, Haraoui B, Bissonnette R, Bessette L, Roubille C, Richer V, et al. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials. Arthritis Care Res. 2015;67:754\u201364.", "journal-title": "Arthritis Care Res"}, {"key": "836_CR32", "doi-asserted-by": "crossref", "first-page": "3104", "DOI": "10.1002/art.22117", "volume": "54", "author": "TP Staa van", "year": "2006", "unstructured": "van Staa TP, Geusens P, Bijlsma JWJ, Leufkens HGM, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54:3104\u201312.", "journal-title": "Arthritis Rheum"}, {"key": "836_CR33", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1002/art.1780390215", "volume": "39", "author": "RD Emkey", "year": "1996", "unstructured": "Emkey RD, Lindsay R, Lyssy J, Weisberg JS, Dempster DW, Shen V. The systemic effect of intraarticular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:277\u201382.", "journal-title": "Arthritis Rheum"}, {"key": "836_CR34", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1136/ard.54.1.49", "volume": "54", "author": "C Cooper", "year": "1995", "unstructured": "Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 1995;54:49\u201352.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR35", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.1002/jbmr.3025", "volume": "32", "author": "D Simon", "year": "2017", "unstructured": "Simon D, Kleyer A, Stemmler F, Simon C, Berlin A, Hueber AJ, et al. Age- and sex-dependent changes of intra-articular cortical and trabecular bone structure and the effects of rheumatoid arthritis. J Bone Miner Res Off J Am Soc Bone Miner Res. 2017;32:722\u201330.", "journal-title": "J Bone Miner Res Off J Am Soc Bone Miner Res"}, {"key": "836_CR36", "doi-asserted-by": "crossref", "first-page": "2142", "DOI": "10.1002/jbmr.3209", "volume": "32", "author": "M Rossini", "year": "2017", "unstructured": "Rossini M, Adami G, Viapiana O, Idolazzi L, Orsolini G, Fassio A, et al. Osteoporosis: an independent determinant of bone erosions in rheumatoid arthritis? J Bone Miner Res Off J Am Soc Bone Miner Res. 2017;32:2142\u20133.", "journal-title": "J Bone Miner Res Off J Am Soc Bone Miner Res"}, {"key": "836_CR37", "doi-asserted-by": "crossref", "first-page": "1931", "DOI": "10.1007/s00198-017-3972-9", "volume": "28", "author": "MH Han", "year": "2017", "unstructured": "Han MH, Ryu JI, Kim CH, Kim JM, Cheong JH, Bak KH, et al. Influence of systemic bone mineral density on atlantoaxial subluxation in patients with rheumatoid arthritis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2017;28:1931\u20138.", "journal-title": "Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA."}, {"key": "836_CR38", "doi-asserted-by": "crossref", "first-page": "498", "DOI": "10.1002/acr.23611", "volume": "71", "author": "JC Wilson", "year": "2019", "unstructured": "Wilson JC, Sarsour K, Gale S, Peth\u00f6-Schramm A, Jick SS, Meier CR. Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis. Arthritis Care Res. 2019;71:498\u2013511.", "journal-title": "Arthritis Care Res"}, {"key": "836_CR39", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1007/s00774-015-0716-9", "volume": "35", "author": "Y Mori", "year": "2017", "unstructured": "Mori Y, Kuwahara Y, Chiba S, Kogre A, Baba K, Kamimura M, et al. Bone mineral density of postmenopausal women with rheumatoid arthritis depends on disease duration regardless of treatment. J Bone Miner Metab. 2017;35:52\u20137.", "journal-title": "J Bone Miner Metab"}, {"key": "836_CR40", "doi-asserted-by": "crossref", "first-page": "522", "DOI": "10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y", "volume": "43", "author": "G Haugeberg", "year": "2000", "unstructured": "Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum. 2000;43:522\u201330.", "journal-title": "Arthritis Rheum"}, {"key": "836_CR41", "first-page": "2582", "volume": "27", "author": "L Sinigaglia", "year": "2000", "unstructured": "Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O, et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol. 2000;27:2582\u20139.", "journal-title": "J Rheumatol"}, {"key": "836_CR42", "doi-asserted-by": "crossref", "first-page": "1759", "DOI": "10.1093/rheumatology/keu162", "volume": "53", "author": "B Hauser", "year": "2014", "unstructured": "Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH. Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatol Oxf Engl. 2014;53:1759\u201366.", "journal-title": "Rheumatol Oxf Engl."}, {"key": "836_CR43", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1186/s12891-016-0952-8", "volume": "17", "author": "J-H Lee", "year": "2016", "unstructured": "Lee J-H, Sung Y-K, Choi C-B, Cho S-K, Bang S-Y, Choe J-Y, et al. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2016;17:98.", "journal-title": "BMC Musculoskelet Disord"}, {"key": "836_CR44", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.4081/reumatismo.2016.878", "volume": "68", "author": "A Fassio", "year": "2016", "unstructured": "Fassio A, Idolazzi L, Jaber MA, Dartizio C, Viapiana O, Rossini M, et al. The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis. Reumatismo. 2016;68:65\u201371.", "journal-title": "Reumatismo."}, {"key": "836_CR45", "doi-asserted-by": "crossref", "first-page": "e11122", "DOI": "10.1097/MD.0000000000011122", "volume": "97", "author": "S-M Kweon", "year": "2018", "unstructured": "Kweon S-M, Sohn DH, Park J-H, Koh JH, Park E-K, Lee H-N, et al. Male patients with rheumatoid arthritis have an increased risk of osteoporosis: frequency and risk factors. Medicine (Baltimore). 2018;97:e11122.", "journal-title": "Medicine (Baltimore)"}, {"key": "836_CR46", "doi-asserted-by": "crossref", "first-page": "1263", "DOI": "10.1007/s00198-018-4473-1", "volume": "29", "author": "S Jin", "year": "2018", "unstructured": "Jin S, Hsieh E, Peng L, Yu C, Wang Y, Wu C, et al. Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2018;29:1263\u201375.", "journal-title": "Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA."}, {"key": "836_CR47", "doi-asserted-by": "crossref", "first-page": "e000671", "DOI": "10.1136/rmdopen-2018-000671", "volume": "4", "author": "R Mazzucchelli", "year": "2018", "unstructured": "Mazzucchelli R, P\u00e9rez Fernandez E, Cresp\u00ed-Villar\u00edas N, Quir\u00f3s-Donate J, Garc\u00eda Vadillo A, Espinosa M, et al. Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study. RMD Open. 2018;4:e000671.", "journal-title": "RMD Open."}, {"key": "836_CR48", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1002/acr.21930", "volume": "65", "author": "J Yazdany", "year": "2013", "unstructured": "Yazdany J, Schmajuk G, Robbins M, Daikh D, Beall A, Yelin E, et al. Choosing wisely: the American College of Rheumatology\u2019s top 5 list of things physicians and patients should question. Arthritis Care Res. 2013;65:329\u201339.", "journal-title": "Arthritis Care Res"}, {"key": "836_CR49", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1136/annrheumdis-2013-204223", "volume": "73", "author": "M Dougados", "year": "2014", "unstructured": "Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014;73:62\u20138.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR50", "first-page": "15", "volume": "21", "author": "M Venegas-Pont", "year": "2015", "unstructured": "Venegas-Pont M, Davis JM, Crowson CS, Gabriel SE, Matteson EL. Frequency of radiologic procedures in patients with rheumatoid arthritis. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2015;21:15\u20138.", "journal-title": "J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"}, {"key": "836_CR51", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1002/acr.23331", "volume": "70", "author": "G Ozen", "year": "2018", "unstructured": "Ozen G, Kamen DL, Mikuls TR, England BR, Wolfe F, Michaud K. Trends and determinants of osteoporosis treatment and screening in patients with rheumatoid arthritis compared to osteoarthritis. Arthritis Care Res. 2018;70:713\u201323.", "journal-title": "Arthritis Care Res"}, {"key": "836_CR52", "doi-asserted-by": "crossref", "first-page": "1733", "DOI": "10.1007/s11606-015-3349-8", "volume": "30", "author": "ALD Amarnath", "year": "2015", "unstructured": "Amarnath ALD, Franks P, Robbins JA, Xing G, Fenton JJ. Underuse and overuse of osteoporosis screening in a regional health system: a retrospective cohort study. J Gen Intern Med. 2015;30:1733\u201340.", "journal-title": "J Gen Intern Med"}, {"key": "836_CR53", "doi-asserted-by": "crossref", "first-page": "642", "DOI": "10.1002/acr.22988", "volume": "69", "author": "G Schmajuk", "year": "2017", "unstructured": "Schmajuk G, Tonner C, Trupin L, Yazdany J. Variations in radiographic procedure use for Medicare patients with rheumatoid arthritis. Arthritis Care Res. 2017;69:642\u20138.", "journal-title": "Arthritis Care Res"}, {"key": "836_CR54", "doi-asserted-by": "crossref", "first-page": "1505", "DOI": "10.1007/s00198-008-0716-x", "volume": "19", "author": "EM Lewiecki", "year": "2008", "unstructured": "Lewiecki EM, Baim S, Siris ES. Osteoporosis care at risk in the United States. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2008;19:1505\u20139.", "journal-title": "Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA."}, {"key": "836_CR55", "doi-asserted-by": "crossref", "first-page": "1864", "DOI": "10.1002/acr.21777", "volume": "64", "author": "JS Richards", "year": "2012", "unstructured": "Richards JS, Cannon GW, Hayden CL, Amdur RL, Lazaro D, Mikuls TR, et al. Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis. Arthritis Care Res. 2012;64:1864\u201370.", "journal-title": "Arthritis Care Res"}, {"key": "836_CR56", "doi-asserted-by": "crossref", "first-page": "765", "DOI": "10.1359/jbmr.060119", "volume": "21", "author": "JA Udell", "year": "2006", "unstructured": "Udell JA, Fischer MA, Brookhart MA, Solomon DH, Choudhry NK. Effect of the women\u2019s health initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res. 2006;21:765\u201371.", "journal-title": "J Bone Miner Res"}, {"key": "836_CR57", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1016/j.bone.2013.09.008", "volume": "57", "author": "DK Wysowski", "year": "2013", "unstructured": "Wysowski DK, Greene P. Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002-2012. Bone. 2013;57:423\u20138.", "journal-title": "Bone."}, {"key": "836_CR58", "doi-asserted-by": "crossref", "first-page": "965", "DOI": "10.1136/annrheumdis-2016-209233", "volume": "75", "author": "A Baillet", "year": "2016", "unstructured": "Baillet A, Gossec L, Carmona L, de Wit M, van Eijk-Hustings Y, Bertheussen H, et al. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis. 2016;75:965\u201373.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR59", "doi-asserted-by": "crossref", "first-page": "1521", "DOI": "10.1002/art.40137", "volume": "69", "author": "L Buckley", "year": "2017", "unstructured": "Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, et al. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol Hoboken NJ. 2017;69:1521\u201337.", "journal-title": "Arthritis Rheumatol Hoboken NJ"}, {"key": "836_CR60", "doi-asserted-by": "crossref", "first-page": "1725", "DOI": "10.1136/annrheumdis-2013-204733", "volume": "74", "author": "M Dougados", "year": "2015", "unstructured": "Dougados M, Soubrier M, Perrodeau E, Gossec L, Fayet F, Gilson M, et al. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Ann Rheum Dis. 2015;74:1725\u201333.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR61", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/j.jbspin.2018.03.016", "volume": "86", "author": "CI Da\u00efen", "year": "2019", "unstructured": "Da\u00efen CI, Tubery A, Beurai-Weber M, du Cailar G, Picot M-C, Jaussent A, et al. Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases. Joint Bone Spine. 2019;86:49\u201354.", "journal-title": "Joint Bone Spine."}, {"key": "836_CR62", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1007/s00198-004-1811-2", "volume": "16", "author": "JA Kanis", "year": "2005", "unstructured": "Kanis JA, Johnell O. Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2005;16:229\u201338.", "journal-title": "Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA."}, {"key": "836_CR63", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.1007/s00198-007-0543-5", "volume": "19", "author": "JA Kanis", "year": "2008", "unstructured": "Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2008;19:385\u201397.", "journal-title": "Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA"}, {"key": "836_CR64", "doi-asserted-by": "crossref", "first-page": "1568", "DOI": "10.1002/jbmr.3124", "volume": "32", "author": "P Martineau", "year": "2017", "unstructured": "Martineau P, Leslie WD, Johansson H, Oden A, McCloskey EV, Hans D, et al. Clinical utility of using lumbar spine trabecular bone score to adjust fracture probability: the Manitoba BMD cohort. J Bone Miner Res Off J Am Soc Bone Miner Res. 2017;32:1568\u201374.", "journal-title": "J Bone Miner Res Off J Am Soc Bone Miner Res"}, {"key": "836_CR65", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/j.bone.2018.05.026", "volume": "113", "author": "P Martineau", "year": "2018", "unstructured": "Martineau P, Leslie WD, Johansson H, Harvey NC, McCloskey EV, Hans D, et al. In which patients does lumbar spine trabecular bone score (TBS) have the largest effect? Bone. 2018;113:161\u20138.", "journal-title": "Bone."}, {"key": "836_CR66", "doi-asserted-by": "crossref", "first-page": "540", "DOI": "10.3109/14397595.2015.1101212", "volume": "26", "author": "D Kim", "year": "2016", "unstructured": "Kim D, Cho S-K, Kim JY, Choi YY, Sung Y-K. Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis. Mod Rheumatol. 2016;26:540\u20135.", "journal-title": "Mod Rheumatol"}, {"key": "836_CR67", "doi-asserted-by": "crossref", "first-page": "e8661", "DOI": "10.1097/MD.0000000000008661", "volume": "96", "author": "YJ Choi", "year": "2017", "unstructured": "Choi YJ, Chung Y-S, Suh C-H, Jung J-Y, Kim H-A. Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore). 2017;96:e8661.", "journal-title": "Medicine (Baltimore)"}, {"key": "836_CR68", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1136/ard.53.10.685", "volume": "53", "author": "AA Deodhar", "year": "1994", "unstructured": "Deodhar AA, Brabyn J, Jones PW, Davis MJ, Woolf AD. Measurement of hand bone mineral content by dual energy x-ray absorptiometry: development of the method, and its application in normal volunteers and in patients with rheumatoid arthritis. Ann Rheum Dis. 1994;53:685\u201390.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR69", "doi-asserted-by": "crossref", "first-page": "400", "DOI": "10.1007/s001980070106", "volume": "11", "author": "FE Alenfeld", "year": "2000", "unstructured": "Alenfeld FE, Diessel E, Brezger M, Sieper J, Felsenberg D, Braun J. Detailed analyses of periarticular osteoporosis in rheumatoid arthritis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2000;11:400\u20137.", "journal-title": "Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA."}, {"key": "836_CR70", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1385/JCD:4:3:263", "volume": "4", "author": "O Ardicoglu", "year": "2001", "unstructured": "Ardicoglu O, Ozgocmen S, Kamanli A, Pekkutucu I. Relationship between bone mineral density and radiologic scores of hands in rheumatoid arthritis. J Clin Densitom Off J Int Soc Clin Densitom. 2001;4:263\u20139.", "journal-title": "J Clin Densitom Off J Int Soc Clin Densitom"}, {"key": "836_CR71", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1136/annrheumdis-2013-203749", "volume": "74", "author": "KVC Wevers-de Boer", "year": "2015", "unstructured": "Wevers-de Boer KVC, Heimans L, Visser K, K\u00e4lvesten J, Goekoop RJ, van Oosterhout M, et al. Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study. Ann Rheum Dis. 2015;74:341\u20136.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR72", "doi-asserted-by": "crossref", "first-page": "324", "DOI": "10.1136/ard.2007.085985", "volume": "68", "author": "M Hoff", "year": "2009", "unstructured": "Hoff M, Haugeberg G, Odeg\u00e5rd S, Syversen S, Landew\u00e9 R, van der Heijde D, et al. Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis. 2009;68:324\u20139.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR73", "doi-asserted-by": "crossref", "first-page": "736", "DOI": "10.1136/ard.2005.043869", "volume": "65", "author": "G Haugeberg", "year": "2006", "unstructured": "Haugeberg G, Green MJ, Quinn MA, Marzo-Ortega H, Proudman S, Karim Z, et al. Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis. Ann Rheum Dis. 2006;65:736\u201340.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR74", "doi-asserted-by": "crossref", "first-page": "2095", "DOI": "10.1136/annrheumdis-2015-208958", "volume": "75", "author": "C Klop", "year": "2016", "unstructured": "Klop C, de Vries F, Bijlsma JWJ, Leufkens HGM, Welsing PMJ. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density. Ann Rheum Dis. 2016;75:2095\u2013100.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR75", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1186/s13075-018-1515-1", "volume": "20", "author": "T-T Cheng", "year": "2018", "unstructured": "Cheng T-T, Yu S-F, Su F-M, Chen Y-C, Su BY-J, Chiu W-C, et al. Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX\u00ae: a registry study of RA with osteoporosis/fracture. Arthritis Res Ther. 2018;20:16.", "journal-title": "Arthritis Res Ther."}, {"key": "836_CR76", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.1186/s13075-016-1116-9", "volume": "18", "author": "S Bugatti", "year": "2016", "unstructured": "Bugatti S, Bogliolo L, Vitolo B, Manzo A, Montecucco C, Caporali R. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Res Ther. 2016;18:226.", "journal-title": "Arthritis Res Ther."}, {"key": "836_CR77", "first-page": "827", "volume": "34", "author": "YH Lee", "year": "2016", "unstructured": "Lee YH, Bae S-C. Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis. Clin Exp Rheumatol. 2016;34:827\u201333.", "journal-title": "Clin Exp Rheumatol"}, {"key": "836_CR78", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1007/s00198-015-3386-5", "volume": "27", "author": "CM Weaver", "year": "2016", "unstructured": "Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27:367\u201376.", "journal-title": "Osteoporos Int"}, {"key": "836_CR79", "doi-asserted-by": "crossref", "first-page": "499", "DOI": "10.1007/s00296-014-3071-6", "volume": "35", "author": "ML Brance", "year": "2015", "unstructured": "Brance ML, Brun LR, Lioi S, S\u00e1nchez A, Abdala M, Oliveri B. Vitamin D levels and bone mass in rheumatoid arthritis. Rheumatol Int. 2015;35:499\u2013505.", "journal-title": "Rheumatol Int"}, {"key": "836_CR80", "doi-asserted-by": "crossref", "first-page": "1994", "DOI": "10.1093/rheumatology/keu173", "volume": "53", "author": "Q Hong", "year": "2014", "unstructured": "Hong Q, Xu J, Xu S, Lian L, Zhang M, Ding C. Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis. Rheumatol Oxf Engl. 2014;53:1994\u20132001.", "journal-title": "Rheumatol Oxf Engl."}, {"key": "836_CR81", "doi-asserted-by": "crossref", "first-page": "e0146351", "DOI": "10.1371/journal.pone.0146351", "volume": "11", "author": "J Lin", "year": "2016", "unstructured": "Lin J, Liu J, Davies ML, Chen W. Serum vitamin D level and rheumatoid arthritis disease activity: review and meta-analysis. PLoS One. 2016;11:e0146351.", "journal-title": "PLoS One"}, {"key": "836_CR82", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1080/14397595.2018.1532622", "volume": "0", "author": "G Adami", "year": "2018", "unstructured": "Adami G, Rossini M, Bogliolo L, Cantatore FP, Varenna M, Malavolta N, et al. An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis. Mod Rheumatol. 2018;0:1\u20138.", "journal-title": "Mod Rheumatol"}, {"key": "836_CR83", "first-page": "1056", "volume": "36", "author": "M Soubrier", "year": "2018", "unstructured": "Soubrier M, Lambert C, Combe B, Gaudin P, Thomas T, Sibilia J, et al. A randomised, double-blind, placebo-controlled study assessing the efficacy of high doses of vitamin D on functional disability in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2018;36:1056\u201360.", "journal-title": "Clin Exp Rheumatol"}, {"key": "836_CR84", "doi-asserted-by": "crossref", "first-page": "250", "DOI": "10.1016/j.jbspin.2012.08.004", "volume": "80", "author": "G Coiffier", "year": "2013", "unstructured": "Coiffier G, Bouvard B, Chopin F, Biver E, Funck-Brentano T, Garnero P, et al. Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: a literature review. Joint Bone Spine. 2013;80:250\u20137.", "journal-title": "Joint Bone Spine"}, {"key": "836_CR85", "doi-asserted-by": "crossref", "first-page": "1303", "DOI": "10.3899/jrheum.121392", "volume": "40", "author": "A Krabben", "year": "2013", "unstructured": "Krabben A, Knevel R, Huizinga TWJ, Cavet G, van der Helm-van Mil AH. Serum pyridinoline levels and prediction of severity of joint destruction in rheumatoid arthritis. J Rheumatol. 2013;40:1303\u20136.", "journal-title": "J Rheumatol"}, {"key": "836_CR86", "doi-asserted-by": "crossref", "first-page": "2847", "DOI": "10.1002/art.10616", "volume": "46", "author": "P Garnero", "year": "2002", "unstructured": "Garnero P, Landew\u00e9 R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum. 2002;46:2847\u201356.", "journal-title": "Arthritis Rheum"}, {"key": "836_CR87", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1007/s00296-005-0608-8", "volume": "26", "author": "K Loddenkemper", "year": "2006", "unstructured": "Loddenkemper K, Bohl N, Perka C, Burmester G-R, Buttgereit F. Correlation of different bone markers with bone density in patients with rheumatic diseases on glucocorticoid therapy. Rheumatol Int. 2006;26:331\u20136.", "journal-title": "Rheumatol Int"}, {"key": "836_CR88", "doi-asserted-by": "crossref", "first-page": "314", "DOI": "10.1007/s00774-004-0605-0", "volume": "23", "author": "T Nonaka", "year": "2005", "unstructured": "Nonaka T, Nishisaka F, Fukuda K, Sohen S, Hamanishi C. Relationship between bone mineral density and urine level of NTx in rheumatoid arthritis. J Bone Miner Metab. 2005;23:314\u20137.", "journal-title": "J Bone Miner Metab"}, {"key": "836_CR89", "first-page": "683", "volume": "18", "author": "B Cortet", "year": "2000", "unstructured": "Cortet B, Guyot MH, Solau E, Pigny P, Dumoulin F, Flipo RM, et al. Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. Clin Exp Rheumatol. 2000;18:683\u201390.", "journal-title": "Clin Exp Rheumatol"}, {"key": "836_CR90", "doi-asserted-by": "crossref", "first-page": "360", "DOI": "10.1007/s00223-016-0161-3", "volume": "99", "author": "G Adami", "year": "2016", "unstructured": "Adami G, Orsolini G, Adami S, Viapiana O, Idolazzi L, Gatti D, et al. Effects of TNF inhibitors on parathyroid hormone and Wnt signaling antagonists in rheumatoid arthritis. Calcif Tissue Int. 2016;99:360\u20134.", "journal-title": "Calcif Tissue Int"}, {"key": "836_CR91", "doi-asserted-by": "crossref", "first-page": "e000065", "DOI": "10.1136/rmdopen-2015-000065", "volume": "1", "author": "M Manara", "year": "2015", "unstructured": "Manara M, Sinigaglia L. Bone and TNF in rheumatoid arthritis: clinical implications. RMD Open. 2015;1:e000065.", "journal-title": "RMD Open"}, {"key": "836_CR92", "doi-asserted-by": "crossref", "first-page": "484280", "DOI": "10.1155/2014/484280", "volume": "2014", "author": "P Fardellone", "year": "2014", "unstructured": "Fardellone P, S\u00e9journ\u00e9 A, Paccou J, Go\u00ebb V. Bone remodelling markers in rheumatoid arthritis. Mediat Inflamm. 2014;2014:484280.", "journal-title": "Mediat Inflamm"}, {"key": "836_CR93", "doi-asserted-by": "crossref", "first-page": "580", "DOI": "10.1007/s00223-016-0114-x", "volume": "98", "author": "G Orsolini", "year": "2016", "unstructured": "Orsolini G, Adami G, Adami S, Viapiana O, Idolazzi L, Gatti D, et al. Short-term effects of TNF inhibitors on bone turnover markers and bone mineral density in rheumatoid arthritis. Calcif Tissue Int. 2016;98:580\u20135.", "journal-title": "Calcif Tissue Int"}, {"key": "836_CR94", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1007/s11914-013-0140-9", "volume": "11", "author": "AM Cheung", "year": "2013", "unstructured": "Cheung AM, Adachi JD, Hanley DA, Kendler DL, Davison KS, Josse R, et al. High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr Osteoporos Rep. 2013;11:136\u201346.", "journal-title": "Curr Osteoporos Rep"}, {"key": "836_CR95", "doi-asserted-by": "crossref", "first-page": "1671", "DOI": "10.1136/ard.2009.114512", "volume": "69", "author": "A Fouque-Aubert", "year": "2010", "unstructured": "Fouque-Aubert A, Boutroy S, Marotte H, Vilayphiou N, Bacchetta J, Miossec P, et al. Assessment of hand bone loss in rheumatoid arthritis by high-resolution peripheral quantitative CT. Ann Rheum Dis. 2010;69:1671\u20136.", "journal-title": "Ann Rheum Dis"}, {"key": "836_CR96", "doi-asserted-by": "crossref", "first-page": "1935", "DOI": "10.3899/jrheum.160648", "volume": "43", "author": "C Barnabe", "year": "2016", "unstructured": "Barnabe C, Toepfer D, Marotte H, Hauge E-M, Scharmga A, Kocijan R, et al. Definition for rheumatoid arthritis erosions imaged with high resolution peripheral quantitative computed tomography and interreader reliability for detection and measurement. J Rheumatol. 2016;43:1935\u201340.", "journal-title": "J Rheumatol"}, {"key": "836_CR97", "doi-asserted-by": "crossref", "first-page": "973", "DOI": "10.1136/annrheumdis-2017-212404", "volume": "77", "author": "F Stemmler", "year": "2018", "unstructured": "Stemmler F, Simon D, Liphardt A-M, Englbrecht M, Rech J, Hueber AJ, et al. Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures. Ann Rheum Dis. 2018;77:973\u201380.", "journal-title": "Ann Rheum Dis"}], "container-title": ["Current Rheumatology Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s11926-019-0836-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s11926-019-0836-7/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11926-019-0836-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 20]], "date-time": "2019-06-20T02:10:44Z", "timestamp": 1560996644000}, "score": 34.868492, "issued": {"date-parts": [[2019, 5, 23]]}, "references-count": 97, "journal-issue": {"published-print": {"date-parts": [[2019, 7]]}, "issue": "7"}, "alternative-id": ["836"], "URL": "http://dx.doi.org/10.1007/s11926-019-0836-7", "relation": {"cites": []}, "ISSN": ["1523-3774", "1534-6307"], "issn-type": [{"value": "1523-3774", "type": "print"}, {"value": "1534-6307", "type": "electronic"}], "assertion": [{"value": "23 May 2019", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Compliance with Ethical Standards"}}, {"value": "Giovanni Adami declares that he has no conflict of interest. Kenneth G Saag declares research grant from Amgen and Merck and consultant fee from Amgen, Lilly, Merck, Radius, and Roche.", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of Interest"}}, {"value": "This article does not contain any studies with human or animal subjects performed by any of the authors.", "order": 3, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Human and Animal Rights and Informed Consent"}}], "article-number": "34"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T00:26:51Z", "timestamp": 1574728011765}, "reference-count": 0, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2017, 3, 31]], "date-time": "2017-03-31T00:00:00Z", "timestamp": 1490918400000}, "delay-in-days": 0, "content-version": "vor"}, {"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 3, 31]], "date-time": "2017-03-31T00:00:00Z", "timestamp": 1490918400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis & Rheumatology"], "published-print": {"date-parts": [[2017, 5]]}, "DOI": "10.1002/art.40024", "type": "journal-article", "created": {"date-parts": [[2016, 12, 19]], "date-time": "2016-12-19T21:16:43Z", "timestamp": 1482182203000}, "page": "1122-1122", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Reply"], "prefix": "10.1002", "volume": "69", "author": [{"given": "Kenneth G.", "family": "Saag", "sequence": "first", "affiliation": [{"name": "University of AlabamaBirmingham AL"}]}], "member": "311", "published-online": {"date-parts": [[2017, 3, 31]]}, "container-title": ["Arthritis & Rheumatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40024", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.40024", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1002/art.40024", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.40024", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 5]], "date-time": "2019-04-05T04:01:15Z", "timestamp": 1554436875000}, "score": 34.735935, "issued": {"date-parts": [[2017, 3, 31]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2017, 4, 26]]}, "published-print": {"date-parts": [[2017, 5]]}, "issue": "5"}, "alternative-id": ["10.1002/art.40024"], "URL": "http://dx.doi.org/10.1002/art.40024", "archive": ["Portico"], "ISSN": ["2326-5191", "2326-5205"], "issn-type": [{"value": "2326-5191", "type": "print"}, {"value": "2326-5205", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T22:18:10Z", "timestamp": 1574806690543}, "reference-count": 0, "publisher": "Wiley", "issue": "10", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis & Rheumatology"], "published-print": {"date-parts": [[2016, 10]]}, "DOI": "10.1002/art.39768", "type": "journal-article", "created": {"date-parts": [[2016, 6, 6]], "date-time": "2016-06-06T13:02:51Z", "timestamp": 1465218171000}, "page": "2564-2564", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Reply"], "prefix": "10.1002", "volume": "68", "author": [{"given": "Kenneth", "family": "Saag", "sequence": "first", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Lhanoo", "family": "Gunawardhana", "sequence": "additional", "affiliation": [{"name": "Takeda Development Center Americas, Inc."}]}], "member": "311", "published-online": {"date-parts": [[2016, 9, 28]]}, "container-title": ["Arthritis & Rheumatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39768", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/art.39768", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T20:04:59Z", "timestamp": 1533585899000}, "score": 34.735935, "subtitle": ["LETTERS"], "issued": {"date-parts": [[2016, 9, 28]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 10]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.1002/art.39768", "archive": ["Portico"], "ISSN": ["2326-5191"], "issn-type": [{"value": "2326-5191", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T04:41:01Z", "timestamp": 1574743261315}, "reference-count": 87, "publisher": "Elsevier BV", "issue": "4-5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 8, 1]], "date-time": "2015-08-01T00:00:00Z", "timestamp": 1438387200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "bprclinrheum.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Best Practice & Research Clinical Rheumatology"], "published-print": {"date-parts": [[2015, 8]]}, "DOI": "10.1016/j.berh.2015.09.005", "type": "journal-article", "created": {"date-parts": [[2015, 11, 13]], "date-time": "2015-11-13T00:59:39Z", "timestamp": 1447376379000}, "page": "614-627", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Evaluating and mitigating fracture risk in established rheumatoid arthritis"], "prefix": "10.1016", "volume": "29", "author": [{"given": "Matthew B.", "family": "Mullen", "sequence": "first", "affiliation": []}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Best Practice & Research Clinical Rheumatology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1521694215000996?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1521694215000996?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 17]], "date-time": "2018-09-17T19:20:11Z", "timestamp": 1537212011000}, "score": 33.036156, "issued": {"date-parts": [[2015, 8]]}, "references-count": 87, "journal-issue": {"published-print": {"date-parts": [[2015, 8]]}, "issue": "4-5"}, "alternative-id": ["S1521694215000996"], "URL": "http://dx.doi.org/10.1016/j.berh.2015.09.005", "ISSN": ["1521-6942"], "issn-type": [{"value": "1521-6942", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Evaluating and mitigating fracture risk in established rheumatoid arthritis", "name": "articletitle", "label": "Article Title"}, {"value": "Best Practice & Research Clinical Rheumatology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.berh.2015.09.005", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T19:46:59Z", "timestamp": 1574797619879}, "reference-count": 27, "publisher": "Wiley", "issue": "9", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 8, 13]], "date-time": "2017-08-13T00:00:00Z", "timestamp": 1502582400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2017, 8, 13]], "date-time": "2017-08-13T00:00:00Z", "timestamp": 1502582400000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis & Rheumatology"], "published-print": {"date-parts": [[2017, 9]]}, "DOI": "10.1002/art.40152", "type": "journal-article", "created": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T05:02:40Z", "timestamp": 1498021360000}, "page": "1733-1740", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States"], "prefix": "10.1002", "volume": "69", "author": [{"given": "Jeffrey R.", "family": "Curtis", "sequence": "first", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Fenglong", "family": "Xie", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Christian", "family": "Smith", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Lang", "family": "Chen", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Timothy", "family": "Beukelman", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Melissa", "family": "Mannion", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Huifeng", "family": "Yun", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Stefan", "family": "Kertesz", "sequence": "additional", "affiliation": [{"name": "Birmingham VA Medical Center and University of Alabama at Birmingham"}]}], "member": "311", "published-online": {"date-parts": [[2017, 8, 13]]}, "reference": [{"key": "10.1002/art.40152-BIB0001|art40152-cit-0001", "first-page": "1487", "article-title": "Vital signs: overdoses of prescription opioid pain relievers: United States, 1999-2008", "volume": "60", "author": "Paulozzi", "year": "2011", "journal-title": "MMWR Morb Mortal Wkly Rep"}, {"key": "10.1002/art.40152-BIB0002|art40152-cit-0002", "unstructured": "Hedden SL Kennet J Lipari R Medley G Tice P for the Substance Abuse and Mental Health Services Administration 2015 https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf"}, {"key": "10.1002/art.40152-BIB0003|art40152-cit-0003", "doi-asserted-by": "crossref", "first-page": "772", "DOI": "10.4088/JCP.15m10386", "article-title": "Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States", "volume": "77", "author": "Saha", "year": "2016", "journal-title": "J Clin Psychiatry"}, {"key": "10.1002/art.40152-BIB0004|art40152-cit-0004", "unstructured": "Goodnough A Tavernise S. 2016 https://www.nytimes.com/2016/05/21/health/opioid-prescriptions-drop-for-first-time-in-two-decades.html?_r=0"}, {"key": "10.1002/art.40152-BIB0005|art40152-cit-0005", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1056/NEJMsa1406143", "article-title": "Trends in opioid analgesic abuse and mortality in the United States", "volume": "372", "author": "Dart", "year": "2015", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.40152-BIB0006|art40152-cit-0006", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.15585/mmwr.rr6501e1", "article-title": "CDC guideline for prescribing opioids for chronic pain: United States, 2016", "volume": "65", "author": "Dowell", "year": "2016", "journal-title": "MMWR Recomm Rep"}, {"key": "10.1002/art.40152-BIB0007|art40152-cit-0007", "unstructured": "US Food and Drug Administration 2016 https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm491739.htm"}, {"key": "10.1002/art.40152-BIB0008|art40152-cit-0008", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1046/j.1365-2710.2002.00430.x", "article-title": "Segmented regression analysis of interrupted time series studies in medication use research", "volume": "27", "author": "Wagner", "year": "2002", "journal-title": "J Clin Pharm Ther"}, {"key": "10.1002/art.40152-BIB0009|art40152-cit-0009", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1093/biomet/80.3.517", "article-title": "Modelling multivariate binary data with alternating logistic regressions", "volume": "80", "author": "Carey", "year": "1993", "journal-title": "Biometrika"}, {"key": "10.1002/art.40152-BIB0010|art40152-cit-0010", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1093/aje/kwg169", "article-title": "Detecting patterns of occupational illness clustering with alternating logistic regressions applied to longitudinal data", "volume": "158", "author": "Preisser", "year": "2003", "journal-title": "Am J Epidemiol"}, {"key": "10.1002/art.40152-BIB0011|art40152-cit-0011", "doi-asserted-by": "crossref", "first-page": "2427", "DOI": "10.1007/s10067-016-3335-5", "article-title": "Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014", "volume": "35", "author": "Zamora-Legoff", "year": "2016", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/art.40152-BIB0012|art40152-cit-0012", "doi-asserted-by": "crossref", "first-page": "1137", "DOI": "10.1007/s10067-016-3239-4", "article-title": "Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study", "volume": "35", "author": "Zamora-Legoff", "year": "2016", "journal-title": "Clin Rheumatol"}, {"key": "10.1002/art.40152-BIB0013|art40152-cit-0013", "doi-asserted-by": "crossref", "first-page": "221.e221", "DOI": "10.1016/j.amjmed.2015.10.002", "article-title": "Trends in opioid prescriptions among part D Medicare recipients from 2007 to 2012", "volume": "129", "author": "Kuo", "year": "2016", "journal-title": "Am J Med"}, {"key": "10.1002/art.40152-BIB0014|art40152-cit-0014", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1002/art.10515", "article-title": "Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority", "volume": "47", "author": "Heiberg", "year": "2002", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.40152-BIB0015|art40152-cit-0015", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1001/jama.2012.193412", "article-title": "Opioid analgesics for rheumatoid arthritis pain", "volume": "309", "author": "Whittle", "year": "2013", "journal-title": "JAMA"}, {"key": "10.1002/art.40152-BIB0016|art40152-cit-0016", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.3899/jrheum.120341", "article-title": "The efficacy and safety of opioids in inflammatory arthritis: a Cochrane systematic review", "volume": "90", "author": "Whittle", "year": "2012", "journal-title": "J Rheumatol Suppl"}, {"key": "10.1002/art.40152-BIB0017|art40152-cit-0017", "unstructured": "2015 https://www.cadth.ca/sites/default/files/pdf/htis/aug-2015/RC0698%20Opioids%20Final.pdf"}, {"key": "10.1002/art.40152-BIB0018|art40152-cit-0018", "doi-asserted-by": "crossref", "first-page": "1315", "DOI": "10.1001/jama.2011.370", "article-title": "Association between opioid prescribing patterns and opioid overdose-related deaths", "volume": "305", "author": "Bohnert", "year": "2011", "journal-title": "JAMA"}, {"key": "10.1002/art.40152-BIB0019|art40152-cit-0019", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1002/art.39462", "article-title": "Opioid analgesics and the risk of serious infections among patients with rheumatoid arthritis: a self-controlled case series study", "volume": "68", "author": "Wiese", "year": "2016", "journal-title": "Arthritis Rheumatol"}, {"key": "10.1002/art.40152-BIB0020|art40152-cit-0020", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1002/art.39422", "article-title": "Opioid use and risk of nonvertebral fractures in adults with rheumatoid arthritis: a nested case-control study using administrative databases", "volume": "68", "author": "Acurcio", "year": "2016", "journal-title": "Arthritis Rheumatol"}, {"key": "10.1002/art.40152-BIB0021|art40152-cit-0021", "first-page": "S3", "article-title": "Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines", "volume": "20", "author": "Manchikanti", "year": "2017", "journal-title": "Pain Physician"}, {"key": "10.1002/art.40152-BIB0022|art40152-cit-0022", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1097/AJP.0000000000000079", "article-title": "Long-term evaluation of opioid treatment in fibromyalgia", "volume": "31", "author": "Peng", "year": "2015", "journal-title": "Clin J Pain"}, {"key": "10.1002/art.40152-BIB0023|art40152-cit-0023", "first-page": "1", "article-title": "CDC guideline for prescribing opioids for chronic pain: United States, 2016", "volume": "65", "author": "Dowell", "year": "2016", "journal-title": "MMWR Morb Mortal Wkly Rep"}, {"key": "10.1002/art.40152-BIB0024|art40152-cit-0024", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1001/jama.2007.64", "article-title": "Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments", "volume": "299", "author": "Pletcher", "year": "2008", "journal-title": "JAMA"}, {"key": "10.1002/art.40152-BIB0025|art40152-cit-0025", "unstructured": "2010 http://facts.kff.org/chartbook.aspx?cb=58"}, {"key": "10.1002/art.40152-BIB0026|art40152-cit-0026", "author": "Chaparro", "first-page": "CD004959", "year": "2013", "article-title": "Opioids compared to placebo or other treatments for chronic low-back pain", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1002/art.40152-BIB0027|art40152-cit-0027", "doi-asserted-by": "crossref", "first-page": "2036", "DOI": "10.1093/pm/pnw245", "article-title": "Durations of opioid, nonopioid drug, and behavioral clinical trials for chronic pain: adequate or inadequate?", "volume": "17", "author": "Tayeb", "year": "2016", "journal-title": "Pain Med"}], "container-title": ["Arthritis & Rheumatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40152", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/art.40152", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T05:50:13Z", "timestamp": 1533534613000}, "score": 32.904182, "subtitle": ["TRENDS IN OPIOID USE IN RA PATIENTS"], "issued": {"date-parts": [[2017, 8, 13]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2017, 9]]}, "issue": "9"}, "URL": "http://dx.doi.org/10.1002/art.40152", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["2326-5191"], "issn-type": [{"value": "2326-5191", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T23:07:10Z", "timestamp": 1574723230764}, "reference-count": 48, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100000133", "name": "Agency for Healthcare Research and Quality", "doi-asserted-by": "crossref", "award": ["R01-HS-018517", "1 K12-HS-021694"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis & Rheumatology"], "published-print": {"date-parts": [[2016, 1]]}, "DOI": "10.1002/art.39399", "type": "journal-article", "created": {"date-parts": [[2015, 8, 28]], "date-time": "2015-08-28T14:47:24Z", "timestamp": 1440773244000}, "page": "56-66", "source": "Crossref", "is-referenced-by-count": 62, "title": ["Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare"], "prefix": "10.1002", "volume": "68", "author": [{"given": "Huifeng", "family": "Yun", "sequence": "first", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Fenglong", "family": "Xie", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Elizabeth", "family": "Delzell", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Emily B.", "family": "Levitan", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Lang", "family": "Chen", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "James D.", "family": "Lewis", "sequence": "additional", "affiliation": [{"name": "University of Pennsylvania; Philadelphia"}]}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Timothy", "family": "Beukelman", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Kevin L.", "family": "Winthrop", "sequence": "additional", "affiliation": [{"name": "Oregon Health & Science University; Portland"}]}, {"given": "John W.", "family": "Baddley", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}, {"given": "Jeffrey R.", "family": "Curtis", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}], "member": "311", "published-online": {"date-parts": [[2015, 12, 23]]}, "reference": [{"key": "10.1002/art.39399-BIB0001|art39399-cit-0001", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1016/j.semarthrit.2008.10.002", "article-title": "The risk of infections with biologic therapies for rheumatoid arthritis", "volume": "39", "author": "Furst", "year": "2010", "journal-title": "Semin Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0002|art39399-cit-0002", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1016/j.clinthera.2011.05.044", "article-title": "Use of biologics in rheumatoid arthritis: current and emerging paradigms of care", "volume": "33", "author": "Curtis", "year": "2011", "journal-title": "Clin Ther"}, {"issue": "Suppl 6", "key": "10.1002/art.39399-BIB0003|art39399-cit-0003", "doi-asserted-by": "crossref", "first-page": "vi37", "DOI": "10.1093/rheumatology/kes283", "article-title": "Overview of safety of non-biologic and biologic DMARDs", "volume": "51", "author": "Ruderman", "year": "2012", "journal-title": "Rheumatology (Oxford)"}, {"key": "10.1002/art.39399-BIB0004|art39399-cit-0004", "doi-asserted-by": "crossref", "first-page": "1400", "DOI": "10.1002/art.20217", "article-title": "Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial", "volume": "50", "author": "Keystone", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0005|art39399-cit-0005", "doi-asserted-by": "crossref", "first-page": "3432", "DOI": "10.1002/art.20568", "article-title": "Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial", "volume": "50", "author": "St.Clair", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0006|art39399-cit-0006", "doi-asserted-by": "crossref", "first-page": "2275", "DOI": "10.1001/jama.295.19.2275", "article-title": "Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials", "volume": "295", "author": "Bongartz", "year": "2006", "journal-title": "JAMA"}, {"key": "10.1002/art.39399-BIB0007|art39399-cit-0007", "author": "Singh", "first-page": "CD008794", "year": "2011", "article-title": "Adverse effects of biologics: a network meta-analysis and Cochrane overview", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1002/art.39399-BIB0008|art39399-cit-0008", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1016/S0140-6736(04)15640-7", "article-title": "Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial", "volume": "363", "author": "Klareskog", "year": "2004", "journal-title": "Lancet"}, {"key": "10.1002/art.39399-BIB0009|art39399-cit-0009", "doi-asserted-by": "crossref", "first-page": "1478", "DOI": "10.1136/ard.2005.043299", "article-title": "Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study", "volume": "65", "author": "Riel", "year": "2006", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.39399-BIB0010|art39399-cit-0010", "doi-asserted-by": "crossref", "first-page": "1051", "DOI": "10.1002/art.20159", "article-title": "Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate", "volume": "50", "author": "Maini", "year": "2004", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0011|art39399-cit-0011", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1002/art.10697", "article-title": "Adalimumab, a fully human anti-tumor necrosis factor \u03b1 monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial", "volume": "48", "author": "Weinblatt", "year": "2003", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0012|art39399-cit-0012", "doi-asserted-by": "crossref", "first-page": "964", "DOI": "10.1002/art.23383", "article-title": "Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study", "volume": "58", "author": "Kay", "year": "2008", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0013|art39399-cit-0013", "doi-asserted-by": "crossref", "first-page": "805", "DOI": "10.1136/ard.2008.099291", "article-title": "Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study", "volume": "68", "author": "Fleischmann", "year": "2009", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.39399-BIB0014|art39399-cit-0014", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.7326/0003-4819-144-12-200606200-00003", "article-title": "Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial", "volume": "144", "author": "Kremer", "year": "2006", "journal-title": "Ann Intern Med"}, {"key": "10.1002/art.39399-BIB0015|art39399-cit-0015", "doi-asserted-by": "crossref", "first-page": "2807", "DOI": "10.1002/art.22070", "article-title": "Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: a one-year randomized, placebo-controlled study", "volume": "54", "author": "Weinblatt", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0016|art39399-cit-0016", "doi-asserted-by": "crossref", "first-page": "1390", "DOI": "10.1002/art.21778", "article-title": "The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial", "volume": "54", "author": "Emery", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0017|art39399-cit-0017", "doi-asserted-by": "crossref", "first-page": "2793", "DOI": "10.1002/art.22025", "article-title": "Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks", "volume": "54", "author": "Cohen", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0018|art39399-cit-0018", "doi-asserted-by": "crossref", "first-page": "2817", "DOI": "10.1002/art.22033", "article-title": "Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate", "volume": "54", "author": "Maini", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0019|art39399-cit-0019", "doi-asserted-by": "crossref", "first-page": "2331", "DOI": "10.1001/jama.2011.1692", "article-title": "Initiation of tumor necrosis factor-\u03b1 antagonists and the risk of hospitalization for infection in patients with autoimmune diseases", "volume": "306", "author": "Grijalva", "year": "2011", "journal-title": "JAMA"}, {"key": "10.1002/art.39399-BIB0020|art39399-cit-0020", "doi-asserted-by": "crossref", "first-page": "1125", "DOI": "10.1002/art.22504", "article-title": "Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor \u03b1 antagonists", "volume": "56", "author": "Curtis", "year": "2007", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0021|art39399-cit-0021", "doi-asserted-by": "crossref", "first-page": "990", "DOI": "10.1002/acr.22281", "article-title": "Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis", "volume": "66", "author": "Curtis", "year": "2014", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/art.39399-BIB0022|art39399-cit-0022", "doi-asserted-by": "crossref", "first-page": "3403", "DOI": "10.1002/art.21386", "article-title": "Infections in patients with rheumatoid arthritis treated with biologic agents", "volume": "52", "author": "Listing", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0023|art39399-cit-0023", "doi-asserted-by": "crossref", "first-page": "2896", "DOI": "10.1002/art.22808", "article-title": "on behalf of the British Society for Rheumatology Biologics Register. Serious infection following anti-tumor necrosis factor \u03b1 therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies", "volume": "56", "author": "Dixon", "year": "2007", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0024|art39399-cit-0024", "doi-asserted-by": "crossref", "first-page": "2368", "DOI": "10.1002/art.21978", "article-title": "on behalf of the British Society for Rheumatology Biologics Register. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register", "volume": "54", "author": "Dixon", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0025|art39399-cit-0025", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1136/annrheumdis-2011-201108", "article-title": "Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register", "volume": "72", "author": "Galloway", "year": "2013", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.39399-BIB0026|art39399-cit-0026", "doi-asserted-by": "crossref", "first-page": "1401", "DOI": "10.1136/ard.2010.146365", "article-title": "The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents", "volume": "70", "author": "Curtis", "year": "2011", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.39399-BIB0027|art39399-cit-0027", "unstructured": "https://www.ccwdata.org/web/guest/about-ccw"}, {"key": "10.1002/art.39399-BIB0028|art39399-cit-0028", "unstructured": "http://kff.org/medicare/fact-sheet/medicare-at-a-glance-fact-sheet/"}, {"key": "10.1002/art.39399-BIB0029|art39399-cit-0029", "doi-asserted-by": "crossref", "first-page": "344", "DOI": "10.1016/j.jclinepi.2007.11.008", "article-title": "The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies", "volume": "61", "author": "Von Elm", "year": "2008", "journal-title": "J Clin Epidemiol"}, {"key": "10.1002/art.39399-BIB0030|art39399-cit-0030", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1016/j.jclinepi.2008.06.006", "article-title": "Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients", "volume": "62", "author": "Patkar", "year": "2009", "journal-title": "J Clin Epidemiol"}, {"issue": "Suppl 2", "key": "10.1002/art.39399-BIB0031|art39399-cit-0031", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1002/pds.3231", "article-title": "Role of disease risk scores in comparative effectiveness research with emerging therapies", "volume": "21", "author": "Glynn", "year": "2012", "journal-title": "Pharmacoepidemiol Drug Saf"}, {"key": "10.1002/art.39399-BIB0032|art39399-cit-0032", "doi-asserted-by": "crossref", "first-page": "1480", "DOI": "10.1002/acr.21805", "article-title": "Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients", "volume": "64", "author": "Curtis", "year": "2012", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/art.39399-BIB0033|art39399-cit-0033", "doi-asserted-by": "crossref", "first-page": "2294", "DOI": "10.1002/art.10529", "article-title": "Predictors of infection in rheumatoid arthritis", "volume": "46", "author": "Doran", "year": "2002", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0034|art39399-cit-0034", "doi-asserted-by": "crossref", "first-page": "1074", "DOI": "10.1080/01621459.1989.10478874", "article-title": "The robust inference for the Cox proportional hazards model", "volume": "84", "author": "Lin", "year": "1989", "journal-title": "J Am Stat Assoc"}, {"key": "10.1002/art.39399-BIB0035|art39399-cit-0035", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1503/cmaj.091391", "article-title": "A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview [published erratum appears in CMAJ 2010;182:806]", "volume": "181", "author": "Singh", "year": "2009", "journal-title": "CMAJ"}, {"key": "10.1002/art.39399-BIB0036|art39399-cit-0036", "author": "Singh", "first-page": "CD007848", "year": "2009", "article-title": "Biologics for rheumatoid arthritis: an overview of Cochrane reviews", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1002/art.39399-BIB0037|art39399-cit-0037", "first-page": "10", "article-title": "Disease modifying antirheumatic drugs: longterm safety issues", "volume": "62", "author": "Capell", "year": "2001", "journal-title": "J Rheumatol Suppl"}, {"key": "10.1002/art.39399-BIB0038|art39399-cit-0038", "doi-asserted-by": "crossref", "first-page": "4226", "DOI": "10.1002/art.23050", "article-title": "Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor \u03b1 antagonists", "volume": "56", "author": "Curtis", "year": "2007", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0039|art39399-cit-0039", "doi-asserted-by": "crossref", "first-page": "522", "DOI": "10.1136/ard.2009.118935", "article-title": "Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)", "volume": "69", "author": "Dixon", "year": "2010", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.39399-BIB0040|art39399-cit-0040", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/j.semarthrit.2012.12.024", "article-title": "Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis", "volume": "43", "author": "Johnston", "year": "2013", "journal-title": "Semin Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0041|art39399-cit-0041", "doi-asserted-by": "crossref", "first-page": "1754", "DOI": "10.1002/art.22600", "article-title": "Anti-tumor necrosis factor \u03b1 therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis", "volume": "56", "author": "Schneeweiss", "year": "2007", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0042|art39399-cit-0042", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1111/j.1756-185X.2012.01715.x", "article-title": "Lack of adverse effect of anti-tumor necrosis factor-\u03b1 biologics in treatment of rheumatoid arthritis: 5 years follow-up", "volume": "15", "author": "Dewedar", "year": "2012", "journal-title": "Int J Rheum Dis"}, {"key": "10.1002/art.39399-BIB0043|art39399-cit-0043", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.2174/157339711794474620", "article-title": "Choice of biologic therapy for patients with rheumatoid arthritis: the infection perspective", "volume": "7", "author": "Keyser", "year": "2011", "journal-title": "Curr Rheumatol Rev"}, {"key": "10.1002/art.39399-BIB0044|art39399-cit-0044", "doi-asserted-by": "crossref", "first-page": "895", "DOI": "10.1136/annrheumdis-2012-201338", "article-title": "Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry", "volume": "72", "author": "Dartel", "year": "2013", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.39399-BIB0045|art39399-cit-0045", "doi-asserted-by": "crossref", "first-page": "1914", "DOI": "10.1136/ard.2011.151043", "article-title": "Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?", "volume": "70", "author": "Strangfeld", "year": "2011", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/art.39399-BIB0046|art39399-cit-0046", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1002/art.22544", "article-title": "Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor \u03b1 antagonists and disease-modifying antirheumatic drugs", "volume": "57", "author": "Curtis", "year": "2007", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0047|art39399-cit-0047", "first-page": "4085", "article-title": "Validation of claims-identified serious adverse events in rheumatoid arthritis and Crohn's disease patients [poster]", "volume": "52", "author": "Curtis", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.39399-BIB0048|art39399-cit-0048", "doi-asserted-by": "crossref", "first-page": "1065", "DOI": "10.1136/annrheumdis-2013-204011", "article-title": "Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy", "volume": "74", "author": "Yun", "year": "2015", "journal-title": "Ann Rheum Dis"}], "container-title": ["Arthritis & Rheumatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.39399", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T18:30:20Z", "timestamp": 1498242620000}, "score": 32.694954, "subtitle": ["RISK OF HOSPITALIZED INFECTION ASSOCIATED WITH DIFFERENT BIOLOGIC AGENTS"], "issued": {"date-parts": [[2015, 12, 23]]}, "references-count": 48, "journal-issue": {"published-print": {"date-parts": [[2016, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1002/art.39399", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["2326-5191"], "issn-type": [{"value": "2326-5191", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T05:16:27Z", "timestamp": 1574831787267}, "reference-count": 43, "publisher": "Wiley", "issue": "11", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 10, 17]], "date-time": "2017-10-17T00:00:00Z", "timestamp": 1508198400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2017, 10, 17]], "date-time": "2017-10-17T00:00:00Z", "timestamp": 1508198400000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis Rheumatol"], "published-print": {"date-parts": [[2017, 11]]}, "DOI": "10.1002/art.40305", "type": "journal-article", "created": {"date-parts": [[2017, 9, 7]], "date-time": "2017-09-07T20:14:59Z", "timestamp": 1504815299000}, "page": "2097-2101", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Editorial: Response to the American College of Physicians Osteoporosis Guideline, 2017 Update"], "prefix": "10.1002", "volume": "69", "author": [{"given": "Liron", "family": "Caplan", "sequence": "first", "affiliation": [{"name": "University of Colorado Denver School of Medicine and Denver Veterans Affairs Medical Center; Denver Colorado"}]}, {"given": "Karen E.", "family": "Hansen", "sequence": "additional", "affiliation": [{"name": "University of Wisconsin School of Medicine & Public Health; Madison"}]}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": [{"name": "University of Alabama at Birmingham"}]}], "member": "311", "published-online": {"date-parts": [[2017, 10, 17]]}, "reference": [{"key": "10.1002/art.40305-BIB0001|art40305-cit-0001", "doi-asserted-by": "crossref", "first-page": "818", "DOI": "10.7326/M15-1361", "article-title": "Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians", "volume": "166", "author": "Qaseem", "year": "2017", "journal-title": "Ann Intern Med"}, {"key": "10.1002/art.40305-BIB0002|art40305-cit-0002", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1007/s00198-003-1463-7", "article-title": "The risk and burden of vertebral fractures in Sweden", "volume": "15", "author": "Kanis", "year": "2004", "journal-title": "Osteoporos Int"}, {"key": "10.1002/art.40305-BIB0003|art40305-cit-0003", "doi-asserted-by": "crossref", "first-page": "4528", "DOI": "10.1210/jc.2002-020334", "article-title": "A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis", "volume": "87", "author": "Body", "year": "2002", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "Suppl 1", "key": "10.1002/art.40305-BIB0004|art40305-cit-0004", "article-title": "Effects of 24 months treatment of teriparatide compared with risedronate on new fractures in postmenopausal women with severe osteoporosis: a randomized, double-dummy, clinical trial", "volume": "28", "author": "Kendler", "year": "2017", "journal-title": "Osteoporos Int"}, {"key": "10.1002/art.40305-BIB0005|art40305-cit-0005", "doi-asserted-by": "crossref", "first-page": "CR442", "DOI": "10.12659/MSM.881905", "article-title": "Teriparatide vs. alendronate as a treatment for osteoporosis: changes in biochemical markers of bone turnover, BMD and quality of life", "volume": "17", "author": "Panico", "year": "2011", "journal-title": "Med Sci Monit"}, {"key": "10.1002/art.40305-BIB0006|art40305-cit-0006", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1007/s00198-012-2068-9", "article-title": "Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis", "volume": "24", "author": "Freemantle", "year": "2013", "journal-title": "Osteoporos Int"}, {"key": "10.1002/art.40305-BIB0007|art40305-cit-0007", "first-page": "658", "article-title": "Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison metaanalysis", "volume": "17", "author": "Migliore", "year": "2013", "journal-title": "Eur Rev Med Pharmacol Sci"}, {"key": "10.1002/art.40305-BIB0008|art40305-cit-0008", "doi-asserted-by": "crossref", "first-page": "1861", "DOI": "10.1185/03007990903035281", "article-title": "Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies", "volume": "25", "author": "Jansen", "year": "2009", "journal-title": "Curr Med Res Opin"}, {"key": "10.1002/art.40305-BIB0009|art40305-cit-0009", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1016/j.semarthrit.2010.06.001", "article-title": "The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis", "volume": "40", "author": "Jansen", "year": "2011", "journal-title": "Semin Arthritis Rheum"}, {"key": "10.1002/art.40305-BIB0010|art40305-cit-0010", "doi-asserted-by": "crossref", "first-page": "3346", "DOI": "10.1002/art.24879", "article-title": "Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial", "volume": "60", "author": "Saag", "year": "2009", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/art.40305-BIB0011|art40305-cit-0011", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.1001/jama.2016.11136", "article-title": "Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial", "volume": "316", "author": "Miller", "year": "2016", "journal-title": "JAMA"}, {"key": "10.1002/art.40305-BIB0012|art40305-cit-0012", "doi-asserted-by": "crossref", "first-page": "3117", "DOI": "10.1185/03007990802466595", "article-title": "Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study", "volume": "24", "author": "Minne", "year": "2008", "journal-title": "Curr Med Res Opin"}, {"key": "10.1002/art.40305-BIB0013|art40305-cit-0013", "doi-asserted-by": "crossref", "first-page": "1147", "DOI": "10.1016/S0140-6736(15)61120-5", "article-title": "Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial", "volume": "386", "author": "Leder", "year": "2015", "journal-title": "Lancet"}, {"key": "10.1002/art.40305-BIB0014|art40305-cit-0014", "author": "Cosman", "volume": "32", "first-page": "198", "article-title": "Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis", "journal-title": "J Bone Miner Res", "DOI": "10.1002/jbmr.3051", "doi-asserted-by": "crossref"}, {"key": "10.1002/art.40305-BIB0015|art40305-cit-0015", "doi-asserted-by": "crossref", "first-page": "697", "DOI": "10.1177/0300060513480917", "article-title": "Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women", "volume": "41", "author": "Bai", "year": "2013", "journal-title": "J Int Med Res"}, {"key": "10.1002/art.40305-BIB0016|art40305-cit-0016", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.4103/2230-8210.146871", "article-title": "A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis", "volume": "19", "author": "Pitale", "year": "2015", "journal-title": "Indian J Endocrinol Metab"}, {"key": "10.1002/art.40305-BIB0017|art40305-cit-0017", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1359/jbmr.090716", "article-title": "Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy", "volume": "25", "author": "Kendler", "year": "2010", "journal-title": "J Bone Miner Res"}, {"key": "10.1002/art.40305-BIB0018|art40305-cit-0018", "doi-asserted-by": "crossref", "first-page": "2915", "DOI": "10.1210/jc.2008-2630", "article-title": "Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis", "volume": "94", "author": "Leder", "year": "2009", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1002/art.40305-BIB0019|art40305-cit-0019", "doi-asserted-by": "crossref", "first-page": "992", "DOI": "10.1007/s00198-004-1636-z", "article-title": "The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1-34)]", "volume": "15", "author": "Kurland", "year": "2004", "journal-title": "Osteoporos Int"}, {"key": "10.1002/art.40305-BIB0020|art40305-cit-0020", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1016/j.bone.2008.04.007", "article-title": "Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial", "volume": "43", "author": "Miller", "year": "2008", "journal-title": "Bone"}, {"key": "10.1002/art.40305-BIB0021|art40305-cit-0021", "doi-asserted-by": "crossref", "first-page": "1723", "DOI": "10.1007/s00198-017-3919-1", "article-title": "Observations following discontinuation of long-term denosumab therapy", "volume": "28", "author": "McClung", "year": "2017", "journal-title": "Osteoporos Int"}, {"key": "10.1002/art.40305-BIB0022|art40305-cit-0022", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1016/j.bone.2017.03.006", "article-title": "Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: the Denosumab and Teriparatide Follow-up study (DATA-Follow-up)", "volume": "98", "author": "Leder", "year": "2017", "journal-title": "Bone"}, {"key": "10.1002/art.40305-BIB0023|art40305-cit-0023", "doi-asserted-by": "crossref", "first-page": "354", "DOI": "10.1210/jc.2017-00096", "article-title": "Severe rebound-associated vertebral fractures after denosumab discontinuation: 9 Clinical Cases report", "volume": "102", "author": "Lamy", "year": "2017", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1002/art.40305-BIB0024|art40305-cit-0024", "doi-asserted-by": "crossref", "first-page": "976", "DOI": "10.1002/jbmr.11", "article-title": "Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial", "volume": "25", "author": "Schwartz", "year": "2010", "journal-title": "J Bone Miner Res"}, {"key": "10.1002/art.40305-BIB0025|art40305-cit-0025", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1007/s11657-017-0324-5", "article-title": "UK clinical guideline for the prevention and treatment of osteoporosis", "volume": "12", "author": "Compston", "year": "2017", "journal-title": "Arch Osteoporos"}, {"key": "10.1002/art.40305-BIB0026|art40305-cit-0026", "doi-asserted-by": "crossref", "first-page": "1521", "DOI": "10.1002/art.40137", "article-title": "2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis", "volume": "69", "author": "Buckley", "year": "2017", "journal-title": "Arthritis Rheumatol"}, {"key": "10.1002/art.40305-BIB0027|art40305-cit-0027", "doi-asserted-by": "crossref", "first-page": "604", "DOI": "10.1056/NEJM200008313430902", "article-title": "Alendronate for the treatment of osteoporosis in men", "volume": "343", "author": "Orwoll", "year": "2000", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.40305-BIB0028|art40305-cit-0028", "doi-asserted-by": "crossref", "first-page": "1799", "DOI": "10.1056/NEJMoa074941", "article-title": "Zoledronic acid and clinical fractures and mortality after hip fracture: HORIZON Recurrent Fracture trial", "volume": "357", "author": "Lyles", "year": "2007", "journal-title": "N Engl J Med"}, {"key": "10.1002/art.40305-BIB0029|art40305-cit-0029", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1007/s00774-009-0136-9", "article-title": "The effects of weekly alendronate therapy in Taiwanese males with osteoporosis", "volume": "28", "author": "Hwang", "year": "2010", "journal-title": "J Bone Miner Metab"}, {"key": "10.1002/art.40305-BIB0030|art40305-cit-0030", "doi-asserted-by": "crossref", "first-page": "970", "DOI": "10.1016/j.bone.2009.12.034", "article-title": "Efficacy and safety of monthly ibandronate in men with low bone density", "volume": "46", "author": "Orwoll", "year": "2010", "journal-title": "Bone"}, {"key": "10.1002/art.40305-BIB0031|art40305-cit-0031", "doi-asserted-by": "crossref", "first-page": "2239", "DOI": "10.1002/jbmr.119", "article-title": "Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study", "volume": "25", "author": "Orwoll", "year": "2010", "journal-title": "J Bone Miner Res"}, {"key": "10.1002/art.40305-BIB0032|art40305-cit-0032", "doi-asserted-by": "crossref", "first-page": "3161", "DOI": "10.1210/jc.2012-1569", "article-title": "A randomized, placebo-controlled study of\u00a0the effects of denosumab for the treatment of men with low\u00a0bone mineral density", "volume": "97", "author": "Orwoll", "year": "2012", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1002/art.40305-BIB0033|art40305-cit-0033", "doi-asserted-by": "crossref", "first-page": "719", "DOI": "10.1359/jbmr.081214", "article-title": "Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study", "volume": "24", "author": "Boonen", "year": "2009", "journal-title": "J Bone Miner Res"}, {"key": "10.1002/art.40305-BIB0034|art40305-cit-0034", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1210/jcem.85.1.6267", "article-title": "Antifracture efficacy of antiresorptive agents are related to changes in bone density", "volume": "85", "author": "Wasnich", "year": "2000", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1002/art.40305-BIB0035|art40305-cit-0035", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1016/S0002-9343(01)01124-X", "article-title": "Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs", "volume": "112", "author": "Cummings", "year": "2002", "journal-title": "Am J Med"}, {"key": "10.1002/art.40305-BIB0036|art40305-cit-0036", "doi-asserted-by": "crossref", "first-page": "1586", "DOI": "10.1210/jcem.87.4.8415", "article-title": "Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents", "volume": "87", "author": "Hochberg", "year": "2002", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1002/art.40305-BIB0037|art40305-cit-0037", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1007/s00198-007-0471-4", "article-title": "Adherence to alendronate in male veterans", "volume": "19", "author": "Hansen", "year": "2008", "journal-title": "Osteoporos Int"}, {"key": "10.1002/art.40305-BIB0038|art40305-cit-0038", "doi-asserted-by": "crossref", "first-page": "3513", "DOI": "10.1007/s00198-016-3681-9", "article-title": "Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial", "volume": "27", "author": "Cram", "year": "2016", "journal-title": "Osteoporos Int"}, {"key": "10.1002/art.40305-BIB0039|art40305-cit-0039", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1002/jbmr.2708", "article-title": "Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research", "volume": "31", "author": "Adler", "year": "2016", "journal-title": "J Bone Miner Res"}, {"key": "10.1002/art.40305-BIB0040|art40305-cit-0040", "doi-asserted-by": "crossref", "first-page": "2359", "DOI": "10.1007/s00198-014-2794-2", "article-title": "Clinician's guide to prevention and treatment of osteoporosis", "volume": "25", "author": "Cosman", "year": "2014", "journal-title": "Osteoporos Int"}, {"key": "10.1002/art.40305-BIB0041|art40305-cit-0041", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1002/acr.21930", "article-title": "Choosing wisely: the American College of Rheumatology's top 5 list of things physicians and patients should question", "volume": "65", "author": "Yazdany", "year": "2013", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/art.40305-BIB0042|art40305-cit-0042", "doi-asserted-by": "crossref", "first-page": "1270", "DOI": "10.1359/JBMR.040406", "article-title": "Risk-benefit profile for raloxifene: 4-year data from the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial", "volume": "19", "author": "Barrett-Connor", "year": "2004", "journal-title": "J Bone Miner Res"}, {"key": "10.1002/art.40305-BIB0043|art40305-cit-0043", "doi-asserted-by": "crossref", "first-page": "2179", "DOI": "10.1002/jbmr.2565", "article-title": "Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: an ecological analysis", "volume": "30", "author": "Jha", "year": "2015", "journal-title": "J Bone Miner Res"}], "container-title": ["Arthritis & Rheumatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.40305", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.40305/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 9, 29]], "date-time": "2018-09-29T13:02:55Z", "timestamp": 1538226175000}, "score": 32.557793, "issued": {"date-parts": [[2017, 10, 17]]}, "references-count": 43, "journal-issue": {"published-print": {"date-parts": [[2017, 11]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1002/art.40305", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["2326-5191"], "issn-type": [{"value": "2326-5191", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T20:52:21Z", "timestamp": 1575233541277}, "reference-count": 23, "publisher": "Wiley", "issue": "11", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 669, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arthritis & Rheumatism"], "published-print": {"date-parts": [[2013, 11]]}, "DOI": "10.1002/acr.22055", "type": "journal-article", "created": {"date-parts": [[2013, 6, 10]], "date-time": "2013-06-10T14:42:30Z", "timestamp": 1370875350000}, "page": "1743-1751", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Trends in the Use of Biologic Agents Among Rheumatoid Arthritis Patients Enrolled in the US Medicare Program"], "prefix": "10.1002", "volume": "65", "author": [{"given": "Jie", "family": "Zhang", "sequence": "first", "affiliation": [{"name": "University of Alabama; Birmingham"}]}, {"given": "Fenglong", "family": "Xie", "sequence": "additional", "affiliation": [{"name": "University of Alabama; Birmingham"}]}, {"given": "Elizabeth", "family": "Delzell", "sequence": "additional", "affiliation": [{"name": "University of Alabama; Birmingham"}]}, {"given": "Lang", "family": "Chen", "sequence": "additional", "affiliation": [{"name": "University of Alabama; Birmingham"}]}, {"given": "Meredith L.", "family": "Kilgore", "sequence": "additional", "affiliation": [{"name": "University of Alabama; Birmingham"}]}, {"given": "Huifeng", "family": "Yun", "sequence": "additional", "affiliation": [{"name": "University of Alabama; Birmingham"}]}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": [{"name": "University of Alabama; Birmingham"}]}, {"given": "James D.", "family": "Lewis", "sequence": "additional", "affiliation": [{"name": "University of Pennsylvania; Philadelphia"}]}, {"given": "Jeffrey R.", "family": "Curtis", "sequence": "additional", "affiliation": [{"name": "University of Alabama; Birmingham"}]}], "member": "311", "published-online": {"date-parts": [[2013, 11, 1]]}, "reference": [{"key": "10.1002/acr.22055-BIB0001|acr22055-cit-0001", "doi-asserted-by": "crossref", "first-page": "480", "DOI": "10.1001/jama.2011.67", "article-title": "Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans", "volume": "305", "author": "Schmajuk", "year": "2011", "journal-title": "JAMA"}, {"key": "10.1002/acr.22055-BIB0002|acr22055-cit-0002", "doi-asserted-by": "crossref", "first-page": "928", "DOI": "10.1002/art.22890", "article-title": "Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal", "volume": "57", "author": "Schmajuk", "year": "2007", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.22055-BIB0003|acr22055-cit-0003", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1002/acr.20674", "article-title": "Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey", "volume": "64", "author": "Solomon", "year": "2012", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/acr.22055-BIB0004|acr22055-cit-0004", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1002/acr.21713", "article-title": "Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US medicare physician quality reporting system", "volume": "65", "author": "Curtis", "year": "2013", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/acr.22055-BIB0005|acr22055-cit-0005", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1002/art.21077", "article-title": "Gaps in care for rheumatoid arthritis: a population study", "volume": "53", "author": "Lacaille", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.22055-BIB0006|acr22055-cit-0006", "doi-asserted-by": "crossref", "first-page": "1672", "DOI": "10.1002/acr.20643", "article-title": "Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large US cohort", "volume": "63", "author": "Zhang", "year": "2011", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/acr.22055-BIB0007|acr22055-cit-0007", "first-page": "77", "article-title": "Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy", "volume": "66", "author": "Yazici", "year": "2008", "journal-title": "Bull NYU Hosp Jt Dis"}, {"key": "10.1002/acr.22055-BIB0008|acr22055-cit-0008", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1001/archinte.166.1.57", "article-title": "Medicare coverage of tumor necrosis factor \u03b1 inhibitors as an influence on physicians' prescribing behavior", "volume": "166", "author": "DeWitt", "year": "2006", "journal-title": "Arch Intern Med"}, {"key": "10.1002/acr.22055-BIB0009|acr22055-cit-0009", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1002/acr.20088", "article-title": "Medicare reimbursement and the use of biologic agents: incentives, access, the public good, and optimal care", "volume": "62", "author": "Ward", "year": "2010", "journal-title": "Arthritis Care Res (Hoboken)"}, {"key": "10.1002/acr.22055-BIB0010|acr22055-cit-0010", "doi-asserted-by": "crossref", "first-page": "R32", "DOI": "10.1186/ar3260", "article-title": "Validation of rheumatoid arthritis diagnoses in health care utilization data", "volume": "13", "author": "Kim", "year": "2011", "journal-title": "Arthritis Res Ther"}, {"key": "10.1002/acr.22055-BIB0011|acr22055-cit-0011", "doi-asserted-by": "crossref", "first-page": "915", "DOI": "10.1093/aje/kwg231", "article-title": "Evaluating medication effects outside of clinical trials: new-user designs", "volume": "158", "author": "Ray", "year": "2003", "journal-title": "Am J Epidemiol"}, {"key": "10.1002/acr.22055-BIB0012|acr22055-cit-0012", "doi-asserted-by": "crossref", "first-page": "939", "DOI": "10.1002/art.23374", "article-title": "Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysis", "volume": "58", "author": "Wailoo", "year": "2008", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.22055-BIB0013|acr22055-cit-0013", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.3310/hta10420", "article-title": "A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness", "volume": "10", "author": "Chen", "year": "2006", "journal-title": "Health Technol Assess"}, {"key": "10.1002/acr.22055-BIB0014|acr22055-cit-0014", "author": "Medicare Payment Advisory Committee", "year": "2011", "volume-title": "A data book: health care spending and the Medicare Program Medicare Payment Advisory Committee"}, {"key": "10.1002/acr.22055-BIB0015|acr22055-cit-0015", "doi-asserted-by": "crossref", "first-page": "1335", "DOI": "10.1503/cmaj.045146", "article-title": "When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions", "volume": "173", "author": "Anis", "year": "2005", "journal-title": "CMAJ"}, {"issue": "Suppl 5", "key": "10.1002/acr.22055-BIB0016|acr22055-cit-0016", "doi-asserted-by": "crossref", "first-page": "v31", "DOI": "10.1093/rheumatology/kes116", "article-title": "Biologic monotherapy as initial treatment in patients with early rheumatoid arthritis", "volume": "51", "author": "Gomez-Reino", "year": "2012", "journal-title": "Rheumatology (Oxford)"}, {"key": "10.1002/acr.22055-BIB0017|acr22055-cit-0017", "doi-asserted-by": "crossref", "first-page": "1586", "DOI": "10.1056/NEJM200011303432201", "article-title": "A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis", "volume": "343", "author": "Bathon", "year": "2000", "journal-title": "N Engl J Med"}, {"key": "10.1002/acr.22055-BIB0018|acr22055-cit-0018", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1002/art.21519", "article-title": "The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment", "volume": "54", "author": "Breedveld", "year": "2006", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.22055-BIB0019|acr22055-cit-0019", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1002/art.33383", "article-title": "Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs", "volume": "64", "author": "Fleischmann", "year": "2012", "journal-title": "Arthritis Rheum"}, {"key": "10.1002/acr.22055-BIB0020|acr22055-cit-0020", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1136/ard.2008.105197", "article-title": "Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study", "volume": "69", "author": "Jones", "year": "2010", "journal-title": "Ann Rheum Dis"}, {"key": "10.1002/acr.22055-BIB0021|acr22055-cit-0021", "doi-asserted-by": "crossref", "first-page": "1541", "DOI": "10.1016/S0140-6736(13)60250-0", "article-title": "Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial", "volume": "381", "author": "Gabay", "year": "2013", "journal-title": "Lancet"}, {"key": "10.1002/acr.22055-BIB0022|acr22055-cit-0022", "unstructured": "http://facts.kff.org/chartbook.aspx?cb=58"}, {"key": "10.1002/acr.22055-BIB0023|acr22055-cit-0023", "author": "Curtis", "year": "2013", "article-title": "Identifying newly approved medications in Medicare claims data: a case study using tocilizumab", "journal-title": "Pharmacoepidemiol Drug Saf", "DOI": "10.1002/pds.3475", "doi-asserted-by": "crossref"}], "container-title": ["Arthritis Care & Research"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.22055", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T14:24:46Z", "timestamp": 1498055086000}, "score": 32.149734, "subtitle": ["Biologic Agents Among US Medicare Beneficiaries With RA"], "issued": {"date-parts": [[2013, 11]]}, "references-count": 23, "journal-issue": {"published-print": {"date-parts": [[2013, 11]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1002/acr.22055", "relation": {"cites": []}, "ISSN": ["2151-464X"], "issn-type": [{"value": "2151-464X", "type": "print"}], "subject": ["Rheumatology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:28:23Z", "timestamp": 1574285303628}, "reference-count": 91, "publisher": "Future Medicine Ltd", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Future Rheumatology"], "published-print": {"date-parts": [[2007, 4]]}, "DOI": "10.2217/17460816.2.2.177", "type": "journal-article", "created": {"date-parts": [[2007, 3, 30]], "date-time": "2007-03-30T13:30:40Z", "timestamp": 1175261440000}, "page": "177-183", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Effect of reproductive factors on rheumatoid arthritis"], "prefix": "10.2217", "volume": "2", "author": [{"given": "John M", "family": "Cafardi", "sequence": "first", "affiliation": []}, {"given": "Graciela S", "family": "Alarc\u00f3n", "sequence": "additional", "affiliation": []}, {"given": "Kenneth G", "family": "Saag", "sequence": "additional", "affiliation": []}], "member": "1057", "reference": [{"key": "ref-1", "DOI": "10.1038/nri1838", "doi-asserted-by": "publisher"}, {"key": "ref-2", "DOI": "10.7326/0003-4819-136-12-200206180-00012", "doi-asserted-by": "publisher"}, {"key": "ref-3", "DOI": "10.1056/NEJM200103223441207", "doi-asserted-by": "publisher"}, {"key": "ref-4", "DOI": "10.1097/01.bor.0000159924.97019.25", "doi-asserted-by": "publisher"}, {"key": "ref-5", "DOI": "10.1093/rheumatology/kei055", "doi-asserted-by": "publisher"}, {"key": "ref-6", "DOI": "10.1186/ar1814", "doi-asserted-by": "publisher"}, {"key": "ref-7", "DOI": "10.1016/j.berh.2004.02.007", "doi-asserted-by": "publisher"}, {"key": "ref-8", "DOI": "10.7326/0003-4819-144-4-200602210-00006", "doi-asserted-by": "publisher"}, {"key": "ref-9", "DOI": "10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V", "doi-asserted-by": "publisher"}, {"key": "ref-10", "author": "Linos", "volume": "111", "first-page": "87", "year": "1980", "journal-title": "Am. J. Epidemiol.", "DOI": "10.1093/oxfordjournals.aje.a112878", "doi-asserted-by": "crossref"}, {"key": "ref-11", "DOI": "10.1016/j.autrev.2004.09.002", "doi-asserted-by": "publisher"}, {"key": "ref-12", "DOI": "10.1196/annals.1351.019", "doi-asserted-by": "publisher"}, {"key": "ref-13", "DOI": "10.1016/S0889-857X(05)70201-5", "doi-asserted-by": "publisher"}, {"key": "ref-14", "DOI": "10.1016/j.berh.2004.08.008", "doi-asserted-by": "publisher"}, {"key": "ref-15", "DOI": "10.1093/rheumatology/38.3.228", "doi-asserted-by": "publisher"}, {"key": "ref-16", "author": "Kerr", "volume": "59", "first-page": "32", "year": "2004", "journal-title": "Geriatrics"}, {"key": "ref-17", "author": "van Schaardenburg", "volume": "20", "first-page": "45", "year": "1993", "journal-title": "J.\u00a0Rheumatol."}, {"key": "ref-18", "DOI": "10.2165/00019053-200422001-00002", "doi-asserted-by": "publisher"}, {"key": "ref-19", "DOI": "10.1136/ard.61.11.994", "doi-asserted-by": "publisher"}, {"key": "ref-20", "DOI": "10.1001/jama.294.21.2751", "doi-asserted-by": "publisher"}, {"key": "ref-21", "DOI": "10.3109/03009748309102886", "doi-asserted-by": "publisher"}, {"key": "ref-22", "DOI": "10.1016/S0889-857X(05)70171-X", "doi-asserted-by": "publisher"}, {"key": "ref-23", "DOI": "10.1016/j.rdc.2004.10.001", "doi-asserted-by": "publisher"}, {"key": "ref-24", "author": "Castagnetta", "volume": "30", "first-page": "2597", "year": "2003", "journal-title": "J.\u00a0Rheumatol."}, {"key": "ref-25", "DOI": "10.1111/j.1749-6632.1998.tb09547.x", "doi-asserted-by": "publisher"}, {"key": "ref-26", "DOI": "10.1210/jc.86.10.4933", "doi-asserted-by": "publisher"}, {"key": "ref-27", "DOI": "10.1136/ard.56.5.281", "doi-asserted-by": "publisher"}, {"key": "ref-28", "author": "Latham", "volume": "171", "first-page": "5820", "year": "2003", "journal-title": "J.\u00a0Immunol.", "DOI": "10.4049/jimmunol.171.11.5820", "doi-asserted-by": "crossref"}, {"key": "ref-29", "DOI": "10.1111/j.1749-6632.1999.tb07622.x", "doi-asserted-by": "publisher"}, {"key": "ref-30", "DOI": "10.1196/annals.1351.020", "doi-asserted-by": "publisher"}, {"key": "ref-31", "DOI": "10.1136/ard.2003.019844", "doi-asserted-by": "publisher"}, {"key": "ref-32", "DOI": "10.1002/art.21112", "doi-asserted-by": "publisher"}, {"key": "ref-33", "author": "Hench", "volume": "13", "first-page": "161", "year": "1938", "journal-title": "Proceedings of the Staff Meetings of the Mayo Clinic"}, {"key": "ref-34", "author": "Neely", "volume": "73", "first-page": "59", "year": "1977", "journal-title": "Tex.\u00a0Med."}, {"key": "ref-35", "DOI": "10.1002/art.1780310302", "doi-asserted-by": "publisher"}, {"key": "ref-36", "DOI": "10.1002/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G", "doi-asserted-by": "publisher"}, {"key": "ref-37", "author": "de Man", "volume": "54", "first-page": "S310", "year": "2006", "journal-title": "Arthritis Rheum."}, {"key": "ref-38", "DOI": "10.1136/ard.12.3.227", "doi-asserted-by": "publisher"}, {"key": "ref-39", "DOI": "10.1111/j.1600-0897.1992.tb00799.x", "doi-asserted-by": "publisher"}, {"key": "ref-40", "DOI": "10.1056/NEJM199308123290704", "doi-asserted-by": "publisher"}, {"key": "ref-41", "DOI": "10.1056/NEJM199308123290711", "doi-asserted-by": "publisher"}, {"key": "ref-42", "DOI": "10.1136/ard.57.5.286", "doi-asserted-by": "publisher"}, {"key": "ref-43", "author": "Brennan", "volume": "27", "first-page": "2843", "year": "2000", "journal-title": "J.\u00a0Rheumatol."}, {"key": "ref-44", "DOI": "10.1001/jama.291.9.1127", "doi-asserted-by": "publisher"}, {"key": "ref-45", "DOI": "10.1530/eje.0.1500421", "doi-asserted-by": "publisher"}, {"key": "ref-46", "DOI": "10.1002/art.21966", "doi-asserted-by": "publisher"}, {"key": "ref-47", "DOI": "10.1016/j.amjmed.2005.03.037", "doi-asserted-by": "publisher"}, {"key": "ref-48", "DOI": "10.1136/ard.58.9.518", "doi-asserted-by": "publisher"}, {"key": "ref-49", "DOI": "10.1016/S1471-4914(01)02269-9", "doi-asserted-by": "publisher"}, {"key": "ref-50", "unstructured": "OslerW: The principles and practice of medicine: designed for the use of practitioners and students of medicine. Sixth edition, thoroughly revised from new plates. D. Appleton and Company, NY, USA,1143(1905)."}, {"key": "ref-51", "DOI": "10.1136/ard.55.2.94", "doi-asserted-by": "publisher"}, {"key": "ref-52", "DOI": "10.1002/1529-0131(200005)43:5<1010::AID-ANR8>3.0.CO;2-O", "doi-asserted-by": "publisher"}, {"key": "ref-53", "DOI": "10.1136/ard.60.10.934", "doi-asserted-by": "publisher"}, {"key": "ref-54", "DOI": "10.1093/rheumatology/34.6.542", "doi-asserted-by": "publisher"}, {"key": "ref-55", "DOI": "10.1002/art.20621", "doi-asserted-by": "publisher"}, {"key": "ref-56", "author": "Willett", "volume": "122", "first-page": "731", "year": "1985", "journal-title": "Am. J. Epidemiol.", "DOI": "10.1093/oxfordjournals.aje.a114156", "doi-asserted-by": "crossref"}, {"key": "ref-57", "DOI": "10.1056/NEJM198510243131703", "doi-asserted-by": "publisher"}, {"key": "ref-58", "DOI": "10.1016/S0140-6736(96)02037-5", "doi-asserted-by": "publisher"}, {"key": "ref-59", "DOI": "10.1111/j.1749-6632.1998.tb09615.x", "doi-asserted-by": "publisher"}, {"key": "ref-60", "DOI": "10.1093/rheumatology/32.6.445", "doi-asserted-by": "publisher"}, {"key": "ref-61", "DOI": "10.1016/S0165-5728(00)00302-7", "doi-asserted-by": "publisher"}, {"key": "ref-62", "DOI": "10.1146/annurev.iy.07.040189.001045", "doi-asserted-by": "publisher"}, {"key": "ref-63", "DOI": "10.1056/NEJMra055446", "doi-asserted-by": "publisher"}, {"key": "ref-64", "DOI": "10.1136/ard.61.suppl_2.ii25", "doi-asserted-by": "publisher"}, {"key": "ref-65", "DOI": "10.1111/j.1749-6632.1999.tb07630.x", "doi-asserted-by": "publisher"}, {"key": "ref-66", "DOI": "10.1002/art.1780360103", "doi-asserted-by": "publisher"}, {"key": "ref-67", "DOI": "10.1016/S0049-0172(99)80019-5", "doi-asserted-by": "publisher"}, {"key": "ref-68", "DOI": "10.1093/rheumatology/34.7.625", "doi-asserted-by": "publisher"}, {"key": "ref-69", "DOI": "10.1136/ard.2002.004291", "doi-asserted-by": "publisher"}, {"key": "ref-70", "DOI": "10.1136/ard.61.5.405", "doi-asserted-by": "publisher"}, {"key": "ref-71", "DOI": "10.1016/0021-9681(86)90086-X", "doi-asserted-by": "publisher"}, {"key": "ref-72", "DOI": "10.1136/ard.52.6.470", "doi-asserted-by": "publisher"}, {"key": "ref-73", "author": "Masi", "volume": "13", "first-page": "227", "year": "1995", "journal-title": "Clin. Exp. Rheumatol."}, {"key": "ref-74", "volume": "1", "first-page": "569", "year": "1978", "journal-title": "Lancet"}, {"key": "ref-75", "DOI": "10.1016/S0140-6736(82)90809-1", "doi-asserted-by": "publisher"}, {"key": "ref-76", "DOI": "10.1001/jama.255.10.1299", "doi-asserted-by": "publisher"}, {"key": "ref-77", "DOI": "10.1016/S0140-6736(83)92413-3", "doi-asserted-by": "publisher"}, {"key": "ref-78", "DOI": "10.1001/jama.254.14.1938", "doi-asserted-by": "publisher"}, {"key": "ref-79", "DOI": "10.1002/art.1780330204", "doi-asserted-by": "publisher"}, {"key": "ref-80", "DOI": "10.1016/S0049-0172(97)80025-X", "doi-asserted-by": "publisher"}, {"key": "ref-81", "DOI": "10.1093/rheumatology/XXVIII.suppl_1.13", "doi-asserted-by": "publisher"}, {"key": "ref-82", "DOI": "10.1016/0895-4356(90)90023-I", "doi-asserted-by": "publisher"}, {"key": "ref-83", "DOI": "10.2105/AJPH.78.8.961", "doi-asserted-by": "publisher"}, {"key": "ref-84", "DOI": "10.1016/S0049-0172(03)00084-2", "doi-asserted-by": "publisher"}, {"key": "ref-85", "author": "Folsom", "volume": "131", "first-page": "794", "year": "1990", "journal-title": "Am. J. Epidemiol.", "DOI": "10.1093/oxfordjournals.aje.a115570", "doi-asserted-by": "crossref"}, {"key": "ref-86", "DOI": "10.1001/jama.269.4.483", "doi-asserted-by": "publisher"}, {"key": "ref-87", "author": "Doran", "volume": "31", "first-page": "207", "year": "2004", "journal-title": "J.\u00a0Rheumatol."}, {"key": "ref-88", "author": "Spector", "volume": "18", "first-page": "1473", "year": "1991", "journal-title": "J.\u00a0Rheumatol."}, {"key": "ref-89", "author": "Carette", "volume": "16", "first-page": "911", "year": "1989", "journal-title": "J.\u00a0Rheumatol."}, {"key": "ref-90", "DOI": "10.1002/art.1780330705", "doi-asserted-by": "publisher"}, {"key": "ref-91", "DOI": "10.1093/ije/23.6.1248", "doi-asserted-by": "publisher"}], "container-title": ["Future Rheumatology"], "language": "en", "link": [{"URL": "https://www.futuremedicine.com/doi/pdf/10.2217/17460816.2.2.177", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:23:37Z", "timestamp": 1574245417000}, "score": 31.353065, "issued": {"date-parts": [[2007, 4]]}, "references-count": 91, "journal-issue": {"published-print": {"date-parts": [[2007, 4]]}, "issue": "2"}, "alternative-id": ["10.2217/17460816.2.2.177"], "URL": "http://dx.doi.org/10.2217/17460816.2.2.177", "relation": {"cites": []}, "ISSN": ["1746-0816", "1746-0824"], "issn-type": [{"value": "1746-0816", "type": "print"}, {"value": "1746-0824", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:46:06Z", "timestamp": 1574491566609}, "reference-count": 4, "publisher": "OMICS Publishing Group", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["International Journal of Clinical Rheumatology"], "published-print": {"date-parts": [[2009, 2]]}, "DOI": "10.2217/17584272.4.1.3", "type": "journal-article", "created": {"date-parts": [[2011, 1, 26]], "date-time": "2011-01-26T20:15:32Z", "timestamp": 1296072932000}, "page": "3-5", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Strategies for treating rheumatoid arthritis: new guidelines from the ACR"], "prefix": "10.4172", "volume": "4", "author": [{"given": "Daniel E", "family": "Furst", "sequence": "first", "affiliation": []}, {"given": "Kenneth G", "family": "Saag", "sequence": "additional", "affiliation": []}, {"given": "Jonathan R", "family": "Melin", "sequence": "additional", "affiliation": []}], "member": "2674", "container-title": ["International Journal of Clinical Rheumatology"], "language": "en", "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T19:00:50Z", "timestamp": 1497898850000}, "score": 31.353065, "issued": {"date-parts": [[2009, 2]]}, "references-count": 4, "journal-issue": {"published-print": {"date-parts": [[2009, 2]]}, "issue": "1"}, "alternative-id": ["10.2217/17584272.4.1.3"], "URL": "http://dx.doi.org/10.2217/17584272.4.1.3", "ISSN": ["1758-4272"], "issn-type": [{"value": "1758-4272", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:43:05Z", "timestamp": 1574296985816}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2006, 2, 1]], "date-time": "2006-02-01T00:00:00Z", "timestamp": 1138752000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Curr Rheumatol Rep"], "published-print": {"date-parts": [[2006, 2]]}, "DOI": "10.1007/s11926-006-0024-4", "type": "journal-article", "created": {"date-parts": [[2007, 6, 2]], "date-time": "2007-06-02T15:40:23Z", "timestamp": 1180798823000}, "page": "47-48", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The use of low- dose glucocorticoids for the treatment of early rheumatoid arthritis: What can we learn about bone effects of glucocorticoids from randomized controlled trials?"], "prefix": "10.1007", "volume": "8", "author": [{"given": "Raj", "family": "Nair", "sequence": "first", "affiliation": []}, {"given": "Kenneth G.", "family": "Saag", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Current Rheumatology Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s11926-006-0024-4.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s11926-006-0024-4/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11926-006-0024-4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 2]], "date-time": "2019-06-02T00:47:18Z", "timestamp": 1559436438000}, "score": 31.093098, "issued": {"date-parts": [[2006, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 2]]}, "issue": "1"}, "alternative-id": ["24"], "URL": "http://dx.doi.org/10.1007/s11926-006-0024-4", "ISSN": ["1523-3774", "1534-6307"], "issn-type": [{"value": "1523-3774", "type": "print"}, {"value": "1534-6307", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:26:07Z", "timestamp": 1574133967650}, "reference-count": 80, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1997, 12, 1]], "date-time": "1997-12-01T00:00:00Z", "timestamp": 880934400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The American Journal of Medicine"], "published-print": {"date-parts": [[1997, 12]]}, "DOI": "10.1016/s0002-9343(97)90006-1", "type": "journal-article", "created": {"date-parts": [[2004, 8, 5]], "date-time": "2004-08-05T00:34:56Z", "timestamp": 1091666096000}, "page": "S31-S39", "source": "Crossref", "is-referenced-by-count": 29, "title": ["Low-dose corticosteroid therapy in rheumatoid arthritis: Balancing the evidence"], "prefix": "10.1016", "volume": "103", "author": [{"given": "Kenneth G.", "family": "Saag", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["The American Journal of Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0002934397900061?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0002934397900061?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 5]], "date-time": "2019-02-05T06:53:30Z", "timestamp": 1549349610000}, "score": 30.636883, "issued": {"date-parts": [[1997, 12]]}, "references-count": 80, "journal-issue": {"published-print": {"date-parts": [[1997, 12]]}, "issue": "6"}, "alternative-id": ["S0002934397900061"], "URL": "http://dx.doi.org/10.1016/s0002-9343(97)90006-1", "ISSN": ["0002-9343"], "issn-type": [{"value": "0002-9343", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}